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1 Introduction 
 
1.1 The history of drugs 
 
In the beginning, people attributed sickness to 
various modes of evil spirits or divine intervention1. 
One of the first to separate drugs from religion and 
applying reasoning and observation to medical 
practice was Hippocrates (ca. 460 - 375 BC), who is 
now referred to as the “father of medicine” (fig. 1.1)2. 
He was the founder of the Hippocratic School of 
Medicine, and due to Hippocrates, medicine was 
now recognized as a science2. But even in Greek 
times, opinions about this new science “medicine” 
were mixed, since the word pharmakos meant both 
remedy and poison as well2.  
 
Figure 1.1 Hippocrates2 
 
The earliest form of drugs consisted of the use of plants and animal parts as part of 
remedies. The majority of these “recipes” of plants and animal parts were passed on 
from one generation to the next4. The first to write about the use of herbs against 
illnesses was a Greek physician, Pedanius Dioscorides (ca. 40 - 90 AD), who was a 
surgeon in Nero’s army2. He wrote the Materia Medica (fig. 1.2), which is the basis of 
modern pharmacy, and has been used for almost 1600 years2. 
 
 
Figure 1.2 De medicinali materia libri sex. (1549)3. 
The Materia medica consisted of 
five volumes: the first book deals 
with aromatics, while the second 
book covers animals, cereals and 
herbs, the third and fourth book 
describe the use of roots, juices, 
herbs and seeds, while the last 
book describes the uses of wines 
and minerals2.  
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About 40 years later, another Greek physician, Galen (ca. 129 - ca. 200 AD), wrote 
about 350 authentic titles on drugs, which was about as much as all other Greek 
medical writings together at that time. Galen described 473 recipes where he used 
plants and animal parts, but also components from mineral origin. The descriptions 
were supplemented by drawings of the herbs used2. 
 
The collapse of the Roman Empire stopped the further development of drugs. 
However, the original medical manuscripts were preserved throughout Mediaeval 
times. The revival of formal drugs took place in the 12th century in Italy. Around 1200, 
hospital building started in Europe and coincided with the flourishing of universities in 
Italy, Spain, France, and England2.  
 
The modern pharmaceutical industry began around 1860, with the discovery of the 
transmission of diseases by bacteria, by Louis Pasteur (1822 – 1896) in France and 
Robert Koch (1843 – 1910) in Germany2. Shortly after, antibiotics were discovered in 
the early 19th century, and from then onwards, science made enormous leaps forward 
in the understanding of diseases2.  
 
1.2 Counterfeiting of drugs 
 
Counterfeiting of pharmaceutical products is 
an age-old practice, which flourishes in many 
countries, and is motivated mainly by the 
huge profits which can be made4. First 
concerns about the quality of drugs date back 
as far as the 4th century BC. The first one to 
mention counterfeit drugs was Pedanius 
Dioscorides5. The caricature in figure 1.3, 
from the early 19th century, shows the feelings 
of the public towards the pharmacists and 
counterfeiting2.  
 
 
         Figure 1.3 caricature by A.Park2. 
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Since then, the problem has increased, and currently, it is estimated that about 10% 
of the drugs sold worldwide are counterfeited6. The production of these counterfeit 
drugs is usually done in ordinary households, in their kitchen or just in a shed in the 
backyard6. Sophisticated equipment for the manufacture and packaging of these 
drugs has increased the difficulty of detecting the counterfeit products4. Since, there 
is a high demand for drugs, which are often quite expensive, the counterfeiting 
business has become extremely lucrative. The absence of any deterrent legislation in 
many countries encourages these counterfeiters, since there is only a small change 
of being apprehended and prosecuted6. 
 
1.3 Legislation against counterfeiting 
 
It was not until the middle of the 19th century, before the first regulation on the trade 
of drugs was implemented5. This regulation only involved the trade of drugs and did 
not mention the production of counterfeit drugs. The first time that resolutions against 
counterfeit drugs were adopted, was not until 19885.  
 
The trade of counterfeit drugs affects people worldwide, irrespective on whether they 
live in the developing or developed countries4. There are certain factors enabling the 
spread of these counterfeit drugs. The main reason for counterfeiting drugs is, 
evidently, the huge profit that can be made. The pharmaceutical industry is 
immensely capital-intensive, and spends billions to develop a single drug. The 
average total research and development cost for new drugs in the late 1990s was 
$897 million, according to a report by the Tufts Centre for the Study of Drug 
Development7. These investments have to be recovered afterwards, by adding a 
significant premium over the production costs; costs which counterfeiters of course 
lack.  
 
Moreover, there is also a lack of legislation. Penal sanctions are usually very weak or 
absent at all4. In some countries, counterfeiters have to pay a penalty that is usually 
just a fraction of the profit that they make with their trade in counterfeit drugs5.  
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These counterfeit drugs have a tremendous effect on people’s health, causing 
morbidity, mortality, and reducing the effectiveness of the health care system. They 
are also difficult to detect, since the existing analytical methods have a long analysis 
time or are just too expensive, especially for developing countries. One of the 
possibilities to stop or to reduce this problem, is a fast, easy, and cheap detection 
system. 
 
1.4 Identification of counterfeit drugs 
 
The first step in the identification of possible counterfeit drugs, is the visual 
inspection. Based on packaging, labelling, and physical appearance of the dosage 
form, e.g. shape, colour, etc., counterfeit drugs could be detected5. But lately, 
counterfeiters have become so sophisticated, that simple visual inspection is not 
sufficient anymore, and a more advanced analytical approach is needed.  
 
In the middle of the 19th century, counterfeit drugs were often made from clay. A fast 
and easy method to identify the counterfeits, was to place the tablets in an oven. 
When, after incineration, only 2% dry matter was left, it was a genuine tablet, where 
as the counterfeit tablets left 29% dry matter2. Nowadays, the detection of counterfeit 
drugs is much more complicated. 
 
However, there are some cheap and easy methods available for this purpose. For 
example, test-tube colour reactions, melting-point determination or thin-layer 
chromatography (TLC) can be used to easily identify the active ingredient in drugs4. 
The disadvantage of these methods is that they are only qualitative. Moreover, other 
additives, which may be harmful, are not detected. These methods can only be used 
as a fast screening procedure, and could identify the products that require further 
investigation4. Techniques that could be used for quantitative detection are high 
performance liquid chromatography (HPLC), mass spectrometry (MS) or nuclear 
magnetic resonance (NMR)4,5. The disadvantage of these methods is their extended 
sample preparation: samples have to be grinded and often diluted in organic 
solvents, and additionally, highly trained analysts are necessary to interpret the 
results.   
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The use of Raman spectroscopy can avoid these problems. Its non-destructive 
character and high speed of analysis make Raman spectroscopy well suited for the 
detection of counterfeit drugs. This spectroscopic method can be used on samples 
without any preparation, it can measure through blister packages, and small particles 
can as well be analysed. Within a few seconds, the Raman spectrum can tell if the 
drug is counterfeit, based on the absence of the declared active ingredient.  
 
In cases where the active ingredient is present, the focus is moved to the excipients 
that are used in the drugs. If declared excipients are lacking, or if additional 
excipients are present which are not used in the genuine drug, the drug is considered 
a counterfeit. For this qualitative analysis, a highly trained analyst is required to 
analyse the Raman spectrum, but if the spectrometer is equipped with an elaborate 
database and a spectral searching algorithm is implemented, a semi-trained 
professional could use this technique. This way, Raman spectroscopy could not only 
be useful for rich countries, but could also provide a method to reduce the amount of 
counterfeit drugs in developing countries.  
 
Until now, Raman spectroscopy has been used mainly for the qualitative 
identification of ecstasy tablets and cocaine8,9,10,11. Since the production of these 
drugs is highly illegal, research was focussed on identifying the producers. Based on 
excipients used in these ecstasy tablets, it was possible to trace the producer8,9. The 
same is valid for cocaine.  
 
Cocaine is frequently adulterated or “cut” in order to increase the profit. The most 
common used cutting agents are baking soda, starch, lactose, dextrose, or 
anaesthetics10,11. These cutting agents in cocaine could also be used to trace the 
producer. So far, Raman spectroscopy has mainly been used the detection of illicit 
drugs, and is not known as a common technique to identify counterfeit 
pharmaceuticals.  
 
The purpose of this research is to develop Raman spectroscopy as a fast and easy 
method to detect counterfeit drugs. The first part of this research is focussed on the 
qualitative analysis. Since lately, counterfeit drugs appear on the international market 
with the correct active ingredient, quantitative analysis becomes necessary as well. 
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This is the base of the second part of this research. Finally, we hope that this project 
can ease the qualitative as well as quantitative detection of counterfeit drugs by using 
Raman spectroscopy. 
  
1.5 Outline of this thesis 
 
As mentioned before, this thesis is focussed on qualitative and quantitative analysis 
of counterfeit drugs with Raman spectroscopy. The first part of this thesis covers the 
general background of this project. In chapter 2, the theoretical background of 
Raman spectroscopy is discussed. During this project, we had the opportunity to 
work with different Raman spectrometers, dispersive as well as Fourier transform 
(FT). The difference between these two Raman spectrometers is discussed in 
chapter 3, together with several pharmaceutical applications of dispersive and        
FT-Raman spectroscopy.  In chapter 4, the problem of counterfeit drugs is described, 
not only the magnitude of the problem is mentioned, but also different analytical 
techniques that have been used so far.  
 
The next three chapters cover the qualitative investigation of counterfeit drugs with 
Raman spectroscopy. Chapter 5 describes the analyses of single cases of counterfeit 
drugs, that were seized in Belgium. Chapter 6 focuses on the qualitative detection of 
counterfeit antimalarial drugs seized in Southeast Asia while chapter 7 focuses on 
Viagra tablets from different origins. Since many of these counterfeits could be 
detected based on excipients that were present and/or lacking in the drugs, a 
database of the most commonly used excipients was made which is described in 
chapter 8.  
 
Counterfeiters are becoming more and more sophisticated, so quantitative analysis is 
necessary as well. Chapter 9 elaborates on the quantitative analysis of different 
drugs. For the quantitative calculations, different methods were used, including 
chemometrics (PCA and PCR) which are summarised in the appendix. Finally, a 
conclusion and summary of this entire project is given in the final chapter.  
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2 Theory of the Raman effect 
 
2.1 Discovery of the Raman effect 
 
The Raman effect was first predicted by Adolf Smekal (1895 - 1959)1 in 1923. But it 
was for the first time observed in 1928 by sir Chandrasekhara Venkata Raman        
(1888 - 1970) along with Kariamanikam Srinivasa Krishnan (1898 – 1961)1,2. In 1922 
his work on the “Molecular diffraction of light” was published which was the start of a 
series of investigations which led to the discovery of the Raman effect. Six years 
later, in 1928, his work was published in Nature were he described the changes in 
wavelength of scattered light3. He was awarded the Nobel Prize of Physics for his 
work on the scattering of light and for the discovery of the effect that was named after 
him in 19301. 
 
2.2 Theoretical approach of the Raman effect 
 
When monochromatic light is aimed at a sample, the light is transmitted, reflected or 
even scattered4. The easiest way to describe this effect is via an energy level 
diagram, which is shown in figure 2.14.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.1 Overview of the different energy states involved in Raman spectroscopy.    
anti - Stokes 
Vibrational ground state 
Rayleigh Stokes  
Virtual energy level 
  
First exited vibrational state 
v = 0 
v = 1 
h ν 0 h( ν 0 - ν v ) h ν 0 h ν 0 h ν 0 h( ν 0 + ν v ) 
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The majority of the scattered light has the same energy as the incident light. In this 
case (fig. 2.1), a molecule is excited from the vibrational ground state to a virtual 
energy level. Since this virtual energy level is not a stable energy state of the 
molecule, the molecule relaxes back to the original vibrational ground state while 
emitting light. The energy of the incident light is similar to the energy of the scattered 
light: this situation is called Rayleigh scattering4,5.  
 
The origin of Raman spectroscopy is the inelastic scattering effect, which is caused 
by a very small portion of the molecules in the sample (approximately 10-6 to 10-8)5. 
This results in a difference in energy between the incident light and the scattered 
light5. In the second example (fig. 2.1), the molecule is excited from the vibrational 
ground state to a virtual energy level. Instead of relaxing to the original vibrational 
ground state, it relaxes to the 1st excited vibrational state. The energy of the incident 
light (E = hν0) is therefore larger then the emitted light (E = h(ν0 – νv)): this is called 
Stokes scattering, which is the basis of Raman spectroscopy5. The third option, the 
anti-Stokes scattering, consists of molecules leaving from the first exited state and 
relaxing to the vibrational ground state. In this case (fig. 2.1), the energy of the 
incident light (E = hν0) is smaller than the emitted light (E = h(ν0 + νv)). The number of 
molecules in any excited vibrational state is always far less than that of the 
vibrational ground state. That is the reason why Stokes scattering is normally used 
for molecular characterization5.  
 
2.3 The Raman spectrum 
 
For Raman spectroscopy, a vibrational mode is only Raman-active when there is a 
change in polarizability during the vibration5. As vibrational energy levels are product 
specific, the different position(s) of the Raman band(s) can give us information about 
the product analysed. These Raman band(s) are characteristic for functional groups.  
So, different regions in a Raman spectrum correspond with different types of 
functional groups. The position of the Raman band in the Raman spectrum, is 
determined by the energy difference between the vibrational ground state and the 
first excited vibrational state and expressed as a Raman shift (cm-1). The intensity of 
the Raman Stokes scattered light is proportional to the number of molecules, which is 
the basis for the use of Raman spectroscopy as a quantitative method of analysis.  
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At thermal equilibrium, the fraction of molecules in one vibrational energy level, 
relative to another, can be given by the Boltzmann distribution (Eq. 2.1)2: 
 
( ) ]/[
0
1
0
1 kTEe
g
g
N
N ∆−
⋅





=      (Eq. 2.1) 
 
where N1 = number of molecules in a higher vibrational energy level 
 N0 = number of molecules in a lower vibrational energy level 
 g0 = degeneracy of the higher vibrational level 
 g1 = degeneracy of the lower vibrational level 
 ∆E = energy difference between the higher and lower vibrational energy levels 
 k = Boltzmann constant (1,3807 x 10-23 J K-1) 
 T = temperature, K 
 
2.4 Raman spectrometer 
 
During this research project, the majority of the analyses were performed with 
dispersive Raman spectrometers. For the quantitative analysis, a Fourier Transform 
(FT) Raman spectrometer is also used. The differences between these two types of 
Raman spectrometers are described in Chapter 3, which is based on a review article 
published in European Pharmaceutical Review. This article also describes various 
pharmaceutical applications of dispersive and FT Raman spectroscopy.  
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3 Dispersive and Fourier transform (FT) Raman spectroscopy  
 
Based on the paper: de Veij M, Vandenabeele P, Moens L, The rise of Raman, 
European Pharmaceutical Review, Issue 3, 2005, 86 – 89. 
 
The benefits and downsides of dispersive and FT-Raman spectroscopy in the 
field of pharmaceutical applications are described in this chapter. Traditionally, 
analyses in pharmaceutical research and industry are often performed using 
Nuclear Magnetic Resonance (NMR) or Mass Spectrometry (MS). However, 
researchers nowadays are aware that Raman Spectroscopy possesses 
certain advantages in pharmaceutical research.  
 
3.1 Introduction 
 
The Raman effect was first observed in 1928 by Sir C.V. Raman. These early 
experiments were carried out using focussed sunlight and filters and relied on 
visual observations of colour changes in the scattered light1. A few years later, 
with the use of a mercury lamp and a spectrograph, Sir C.V. Raman recorded 
spectra of several liquids, including benzene and CCl41. The first commercial 
Raman instrument was introduced in 1953, making Raman spectroscopy 
available to a wider audience2. The interest in Raman spectroscopy flourished 
even more in the mid-1960’s with the introduction of the first commercial 
reliable continuous wave gas lasers. The introduction of high-quality 
holographic filters (1970’s), diode array detection (1980’s), fibre optics 
(1980’s) and the coupling of microscopes to Raman spectrometers (1980’s) 
expanded the range of the applications3.  
 
3.2 Dispersive versus Fourier Transform Raman spectroscopy 
 
A Raman spectrometer, as shown in figure 3.1, basically consists of a light 
source (A), collection optics (B), a dispersing optical element (C) and a 
detection system (D). Two major technologies are used to collect the Raman 
spectra: dispersive and Fourier Transform (FT) Raman spectroscopy.  
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The major difference between the two techniques is the way Raman 
scattering is detected and analysed4. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.1 Schematic layout of Raman instrument1,2,3. 
 
Typically, the lasers used in dispersive Raman spectroscopy are in the visible 
region and have wavelengths of for instance 785 nm (diode laser), 633 nm 
(He-Ne) or 532 nm (frequency doubled Nd:YAG). In general the lasers used in 
FT-Raman spectroscopy have a wavelength of 1064nm (Nd:YAG)4,5. 
 
The spectral analysis in dispersive Raman spectrometers is done by using a 
grating4. The spectrum is produced by rotating the grating so that the desired 
spectral window is presented to a multi-channel detector (e.g. charge-
coupled-device, CCD)1. FT-Raman spectrometers use interferometric optics 
to collect the light from the sample, allowing to collect all the wavelengths 
simultaneously2,3. 
 
3.3 The advantages and disadvantages of both techniques 
 
The advantages and disadvantages of dispersive and FT-Raman 
spectroscopy are shown in table 3.1. 
Laser (A)
Collection (B)
Detector (D)
Mirror
Filters
Focusing 
Lens
(C)
Filters
Computer
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Topic 
 
dispersive Raman 
spectroscopy 
FT-Raman 
spectroscopy 
Low wavenumbers +  
Spectral window (+) + 
Spectral precision (+) + 
Sensitivity +  
Small spot size +  
Thermal degradation minimal +  
Operating costs +  
Speed of analysis  + 
Fluorescence suppression  + 
 
Table 3.1 Advantages / disadvantages of dispersive and FT-Raman spectroscopy3. 
 
One of the disadvantages of dispersive Raman spectroscopy is that there is a 
low spectral precision caused by motion of the grating (or thermal drift) which 
can degrade precision; when extreme stability is requested an extensive 
calibration may be needed6. The interferometer used with FT-Raman ensures 
high wavelength precision, which allows easy spectral subtraction in order to 
remove background or solvent features3. Another disadvantage of dispersive 
Raman spectroscopy is that the influence from fluorescence is generally 
larger with dispersive Raman than with FT-Raman since the latter uses a 
longer laser wavelength.  
 
A disadvantage of FT-Raman spectroscopy is that the low-frequency region of 
the spectrum is often not available, as well as the cost of running an 
experiment with FT-Raman spectroscopy which is higher than dispersive 
Raman spectroscopy due to the use of liquid nitrogen for the detector. It is 
clear that the choice between dispersive and FT-Raman spectroscopy 
depends on the samples needed to be analysed, since both techniques have 
specific advantages and disadvantages. 
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3.4 Applications in the pharmaceutical research  
 
3.4.1 Drug identification of the active agent and excipients in tablets 
 
A study by Bell et al.7. showed that dispersive Raman spectroscopy (810 nm 
laser wavelength) can be used to distinguish between ecstasy and various 
other phenethylamine ecstasy analogues, commonly seized in the UK. The 
spectra could be used to distinguish between the chemically-similar 
substances such as isomers and polymorphic/hydrated forms. Within an hour 
20 samples could be analysed, showing that Raman spectroscopy could be 
used as a fast and non-destructive method for drug identification. Further 
research on this subject8 showed that the variation in composition of the 
tablets could be identified, which is useful for tracing drug distribution 
networks.  
 
3.4.2 Polymorphism 
 
Polymorphism is important for the pharmaceutical industry since it can affect 
the chemical stability, the behaviour in pharmaceutical formulations, such as 
the tendency to absorb water, the solubility and thus the bioavailability9. The 
majority of the polymorphism experiments are performed by FT-Raman 
spectroscopy. For instance, the quantitative analysis of mannitol polymorphs 
by Roberts et al.10, in which they studied binary mixtures of beta and delta 
mannitol. Different mixtures were studied and the results indicate that levels 
till 2% of beta mannitol could be quantified.  
 
3.4.3 Imaging / Mapping 
 
Raman spectroscopy can be used to analyse and evaluate the content of 
pharmaceutical products as well as the homogeneity of the tablets. There are 
two different methods. Imaging is accomplished by illuminating the sample 
and imaging the scattered light (the so-called wide field illumination)11 onto an 
imaging two-dimensional array detector12. Mapping involves recording a 
spectrum at each point of a grid, for well-defined spatial locations of a 
3. Dispersive and FT-Raman spectroscopy 
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sample12. A chemical image is the spatial distribution of a compound of 
interest, based on its intensity at a uniquely assignable Raman shift11. Before 
starting imaging this Raman shift should be known in advance. One of the 
main advantages of imaging is the fast productions of images.  
 
In a study by Šašić et al.11 a comparison is made between different data 
processing ways for the chemical images of pharmaceuticals. Raman 
spectroscopy with a laser at 782 nm was used to create an image of 
pharmaceutical beads, which consisted of four different layers. Within 60 
seconds, acceptable images were created11, showing the speed of recording 
images of pharmaceuticals. 
 
Mapping can be used to determine the homogeneity of an ingredient in, for 
example, a tablet. Spectra are taken, from the entire surface of the tablet, for 
instance a 10 x 10 map or higher. Specific software allows mapping of the 
chemical composition of the tablet by rationing characteristic band intensities.  
 
An example of the mapping is the distribution of vitamin B12 trough tablets 
(own research) by Raman spectroscopy with a diode laser (785 nm). In this 
case a 8 x 8 map (steps of 1 mm) was created of both sides of the tablets  
(fig. 3.2) and the colour of the map corresponds with the band intensity, 
corresponding with the concentration. 
 
  
 
Figure 3.2 Mapping of Vitamin B12 tablets, side a (left) and side b (right). 
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3.4.4 Industrial applications  
 
One of the advantages of Raman spectroscopy is that measurements can 
take place through, for instance, blister packages or drug vials. This is a major 
benefit for the use of Raman spectroscopy in industry. A dispersive Raman 
spectrometer (laser wavelength 488 nm) was used for a study by Powell on 
sealed drug vials, for a quick headspace analysis14. Drug vials with 
pharmaceuticals that decompose when in contact with oxygen are packaged 
under nitrogen atmosphere. Raman spectroscopy was able to detect the 
presence of oxygen in the headspace of the vial.  
 
Raman spectroscopy has been used to measure the concentration of 
bucindolol in gel capsules15 inside the blister packages with dispersive (micro) 
Raman spectroscopy (785 nm laser wavelength). FT-Raman spectroscopy 
has also been used for the in-line monitoring of a pharmaceutical blending 
process16. The blending process of diltiazem hydrochloride pellets and 
paraffin wax beads was monitored and the results of these experiments were 
confirmed by HPLC16. These three experiments demonstrate the potential of 
Raman spectroscopy in the pharmaceutical industry. 
 
3.4.5 Quantitative analysis  
 
In the last few years, increasingly more papers are published on quantitative 
analysis of the active ingredient in tablets. For example, a study performed by 
Izolani et al.17, describes the quantitative determination by using FT-Raman of 
Dipyrone (an antipyretic drug) in different tablets. A drawback of this study 
was that the tablets had to be grinded, homogenized and pressed again to 
make tablets of 250 mg, disregarding the absence of sample preparation that 
Raman spectroscopy usually requires. A similar approach was also used for 
the determination of Ciprofloxacin in pharmaceuticals18 in which different 
concentrations of Ciprofloxacin were mixed with maize starch and pressed 
into tablets to be used as standards. The commercial tablets were grinded as 
well and pressed into 300 mg discs.  
3. Dispersive and FT-Raman spectroscopy 
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Many more articles20-23 are available about the quantitative measurements of 
pharmaceuticals with the use of FT-Raman spectroscopy. The majority of the 
quantitative analysis has been established by FT-Raman spectroscopy. 
However, some quantitative studies have been performed by dispersive 
Raman spectrometry. For instance in the study by Fauilloux et al.24 a laser 
with a wavelength of 514 nm was used for the quantitative measurement of 
the degradation of retinol (vitamin A). These results were compared with 
HPLC results and differed only 8 %. Quantification with dispersive Raman 
spectroscopy generally needs more time than FT-Raman spectroscopy, since 
the spectra have to be calibrated against standards, which for this research 
was done with the 992 cm-1 Raman band of benzene24.  
 
3.5 Conclusion 
 
This review gives an overview on pharmaceutical applications of Raman 
spectroscopy. It shows that Raman spectroscopy is a well established method 
for quantitative as well as qualitative measurements. Gradually, Raman 
spectroscopy becomes a more commonly used research method in 
pharmaceutical studies. In this review, the use of dispersive and FT-Raman 
spectroscopy is described for different pharmaceutical applications. Both 
techniques have their advantages and disadvantages: the choice between the 
two techniques mainly depends on the specific research question.  
 
3.6 Notes on this publication 
 
This article illustrates the differences between dispersive and FT-Raman 
spectroscopy, and their specific pharmaceutical applications. In this research 
project, dispersive Raman spectroscopy is used for the qualitative analysis of 
the counterfeit drugs. For the quantitative analysis of counterfeit Viagra 
drugs, dispersive Raman spectroscopy is compared with FT-Raman, which is 
described in chapter 9.  
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4 Counterfeit drugs 
 
The previous two chapters discussed the theory of Raman spectroscopy and the  
pharmaceutical applications of this technique. This research project is focussed on 
the detection of counterfeit drugs with Raman spectroscopy. Chapter 4 elaborates on 
the definition of counterfeit drugs, the magnitude of the problem and the benefits of 
Raman spectroscopy as a fast and easy method to detect these counterfeit drugs. 
   
The production of counterfeit drugs is a significant problem that contributes to 
morbidity, mortality, drug resistance and lost of confidence in the health-care 
systems1. During the last decade the amount of counterfeit drugs on the worldwide 
market has rapidly increased. It is difficult to determine the exact scale of this 
problem, since not all counterfeit drugs are reported or even detected. The 
International Federation of Pharmaceutical Manufacturers Associations (IFPMA) has 
estimated that 10% of the drugs sold worldwide are counterfeits2. The value of this 
trade is more than 30 billion US$ and it is expected to reach 75 billion US$ in 20103.   
 
4.1 What are counterfeit drugs? 
 
Counterfeit drugs are part of substandard pharmaceuticals, which are drugs that are 
manufactured below established standards of quality3. Definitions of substandard and 
counterfeit drugs according to the World Health Organization (WHO) are3: 
 
 
 
 
 
 
 
 
 
 
 
A counterfeit drug is one which is deliberately and fraudulently mislabelled with 
respect to identity and/or source. Counterfeiting can apply to both branded and 
generic products and counterfeit products may include products with the 
correct ingredients or with the wrong ingredients, without active ingredients, 
with insufficient active ingredient or fake packaging. 
A substandard drug is a genuine drug product that does not meet the quality 
specifications set for the specific drug. 
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At the Conference of Experts on the Rational Use of Drugs in Nairobi (Kenya) in 
1985, the problem of counterfeit drugs was first adressed4. Three years later, in 
1988, the World Health Assembly adopted a resolution which requested for the 
prevention and detection of export, import and smuggling of counterfeit 
pharmaceutical products4. The first international meeting on counterfeit drugs was 
organised by the WHO and the IFPMA in 1992. Since then the awareness on the 
harmful effects of counterfeit drugs has grown slowly at international level4. 
 
In order to create more awareness to this 
increasing problem of counterfeit drugs, the 
IMPACT (International Medicinal Products Anti-
Counterfeiting Taskforce) was created in 
February 2006. The IMPACT is comprised of all 
193 WHO member states and consists of 
international organizations, national drug 
regulatory authorities, enforcement agencies, 
customs, policy organizations, associations 
representing pharmaceutical manufactures, non-
governmental organizations, wholesalers, health 
professionals, and patient groups3.  
 
 
       Figure 4.1 poster from WHO to   
         increase public awareness 
 
Figure 4.1 represents a poster used by the WHO to warn the public against the 
harmful effects of counterfeit drugs. Since IMPACT has only started less than two 
years ago, it is too early to indicate the effect of this program. 
 
4.2 How big is the problem of counterfeit drugs?  
 
Any kind of drugs ranging from expensive lifestyle drugs up to drugs to treat life-
threatening illnesses like HIV/Aids are counterfeited. The drugs that are often 
counterfeited can be divided into two groups, depending on the region where they 
are brought on the market: developing or developed countries.  
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• In wealthier countries, expensive lifestyle drugs are frequently counterfeited, such 
as Lipitor (a cholesterol lowering drug), Viagra and Cialis (drugs to treat 
erectile dysfunctions) and steroids3,5.  
 
• In developing countries drugs for treatment of life-treating diseases such as 
malaria, tuberculosis and HIV/AIDS are frequently counterfeited3,5.  
 
The number of counterfeit drugs has been increasing rapidly during the last decade. 
Since it is difficult to show this in statistical proven research, it will be demonstrated 
by the number of counterfeit drug cases annually opened by the U.S.A. Food and 
Drug Administration (FDA) which is presented in figure 4.2.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.2 Number of counterfeit drug cases opened by the FDA per year6. 
 
In figure 4.2 the number of drug cases from 1997 until 2005 is presented. This is an 
estimation from the FDA which are preliminary data depending on ongoing 
investigation7. A decline in counterfeited drug cases investigated by the FDA  can be 
seen in 2005, with only 32 cases. This decline covers only the number of counterfeit 
cases investigated by the FDA and does not indicate the amount of drugs involved.  
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It could be possible that the number of cases decreased but that the total amount of 
counterfeit drugs seized increased. In order to get  a clear idea of this problem, the 
quantity of counterfeit drugs found in each counterfeit drug case is necessary.  
 
The regular use of counterfeit drugs can lead to therapeutic failure or drug 
resistance. In some cases, it can even lead to death as can been seen in these 
examples of incidents with counterfeit drugs, showing the scope of this 
problem2,3,8,9,10: 
 
• The consumption of paracetamol cough syrup prepared with diethylene glycol (a 
toxic chemical used in antifreeze), instead of propylene glycol, lead to the death 
of 109 children in Nigeria in 1990, 59 children in Haiti in 1996 and 30 children in 
India in 1998.  
 
• In Niger, between 1995 and 1996 over 50.000 people were inoculated with fake 
vaccines against meningitis (the vaccines consisted only of water). These were 
donated by a country which thought it was safe but it resulted in the death of at 
least 2.500 people.  
 
• In 2000, 6 million ampoules of counterfeit Voltaren (painkiller) were seized in 
Colombia.  
 
• 240.000 packs of counterfeit drugs and 2 ton of raw materials, worth                     
1 million US$, were seized in 2000 in Italy. 
 
• In a single counterfeiting factory in India, 660 kg of counterfeit drugs, 1000 kg of 
raw materials and boxes bearing the logo of another company were found in 
2001. 
 
• In 2003, 200.000 bottles of Lipitor were recalled in the USA. Lipitor is used 
together with lifestyle changes (diet, weight-loss, exercise) to reduce the amount 
of cholesterol and other fatty substances in the blood.  
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• In December 2003, approximately 5 million capsules of assorted counterfeit drugs 
including amoxicillin, ampicillin, cloxacillin, ampiclox and other products were 
seized in Myanmar. 
 
As shown by these examples, the problem does not only exist in developing 
countries, but has reached the western world as well. The production of these 
counterfeit drugs does not necessary need to happen in large infrastructures or 
facilities. The majority of these drugs are produced in ordinary households, small 
cottage industries or just in peoples backyard3.  
 
An additional problem that has contributed to the increase of counterfeit drugs on the 
market, is the sale of drugs through the internet11. For instance in the U.S.A., it is 
very common to order prescription drugs online. Recently, the FDA released a 
warning about the risk involved in buying drugs online, and issued a warning against 
24 websites, which sold counterfeit drugs11.  
 
The National Association of Boards of Pharmacy released a specified list of 
susceptible products in 2004. This list includes 32 prescription drugs which are to be 
susceptible to adulteration, counterfeiting or diversion and posing therefore the 
potential for a greater public health risk12. From these 32 drugs, 16 are used of the 
treat HIV/ AIDS: Combivir, Crixivan, Epivir, Gamimune, Gammagard, Immune 
globulin, Panglobulin, Retrovir, Sustiva, Trizivir, Venoglobulin, Videx, 
Viracept, Viramune, Zerit and Ziagen.  
 
On this list are also drugs to treat infections (Diflucan, Lamisil, Rocephin), to treat 
anaemia (Epogen and Procrit), to lower cholesterol levels (Lipitor and Zocor), to 
treat different symptoms of cancer (Lupron, Zofran and Zoladex), and to help 
against schizophrenia (Risperdal and Zyprexa). Also on the list are Neupogen, to 
increase the level of white blood cells, Viagra, to treat erectile dysfunction, Nutropin 
AQ and Serostim, which are both hormones to enhance growth12,13,14.  
  
34 
4.3 Actions taken against counterfeiters 
 
Countries need appropriate legislation in order to combat manufacturing and 
distribution of counterfeit drugs. So far, there is no specific legislation on international 
level and strangely enough, there is apparently, no emphasis by the industry to 
enforce legislation. Pharmaceutical companies have spent a large amount of money 
to develop a single new drug (approximately 500-800 million dollar per drug). If this 
drug is counterfeited the pharmaceutical companies are, on one hand afraid for loss 
in revenues and, on the other hand, anxious to face damage of brand integrity, which 
can destroy a companies reputation2.  
 
Counterfeit drugs can also damage the confidence that people have in their national 
health care system; additionally, the government has less tax revenues, while there 
is an increase in the cost of monitoring the efficacy and safety of pharmaceuticals2. 
Particularly in the U.S.A., the emphasis is not only focussed on the improvement of 
technology to protect the drug supply but also to improve the nation’s prescription 
drug distribution system2. So far, it seems that the priority of the governments and the 
pharmaceutical industry is to avoid that customers suspect their drugs to be 
counterfeited. This could explain why emphasis on legislation in the western world is 
limited.  
 
Currently in the U.S.A., the penalty for counterfeiting a drug label is 10 years 
imprisonment, while the penalty for counterfeiting the actual drug is only 3 years6. 
However, this might change since in the U.S.A., in the beginning of 2007, a new bill 
has been introduced in the House of Representatives to increase the penalties for 
drug counterfeiting (the counterfeit drug prevention act of 2007, HR 780). It is 
suggested that the penalties for counterfeiting drugs should be increased to an 
imprisonment for at least 20 years. If the counterfeit drug is the proximate cause of a 
consumers death, the penalty can be increased to life improsenment15.  
 
On the contrary, in the developing world, emphasis is on legislation and the penalties 
are therefore much higher. In the Philippines offenders can face penalties from 6 
months to life imprisonment along with a hefty fine of 1 million peso (circa $ 25,000)1.  
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While in India, under the Indian Drugs Act, a counterfeit drugs manufacturer can face 
an imprisonment of at least 3 years and 5000 Rupees (circa $ 1,000) fine. Recently 
the government of India discussed the death penalty as a sentence for 
counterfeiters1. In May 2007, the former head of China’s Food and Drug safety 
agency was sentenced to death, after pleading guilty to corruption and accepting 
bribes ($ 850.000) for approving drug-production licenses16. Over the last few years, 
the governments have become aware of the fact that the penalties for counterfeiters 
have to be increased in order to tackle the problem of counterfeit drugs. 
 
Besides increasing the penalties for counterfeiters, steps have been taken to make it 
more difficult for the counterfeiters to sell the drugs on the market or to add the drugs 
to the legal supply chain. One of these steps is the use of tracking or trace detection 
systems by legal pharmaceutical manufactures. There are two authentication 
features that can be used: optical variable coatings and holograms. These security 
features are apparent and visible and, therefore do not require any instruments to 
detect them2.  
 
The use of holograms has grown rapidly over the last decade: these are generated 
from the interference patterns obtained through the interaction of laser beams2. 
Advantages of these holograms are that they are recognizable to the customer and 
relatively cheap.  
 
Newton et all.17 started a large project on the distribution of counterfeit antimalarial 
tablets in Southeast Asia. Based on the hologram used by Guilin Pharma, the 
counterfeit tablets could be easily detected (100% accurate) in the first survey 
(1999/2000)17. However, experience is required to identify the counterfeits and due to 
increased counterfeiter sophistication, this method was less accurate in a second 
survey (2002/2003)18. In figure 4.3 the genuine hologram attached to the blisterpack 
of Guilin Pharma is shown (A) with two kinds of fake holograms (B and C): it is 
difficult to distinguish the fake holograms from the genuine one.   
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Figure 4.3 Genuine (A) and fake (B and C) Guilin Pharma artesunate blister pack holograms 
found in mainland Southeast Asia19. The red circles highlight the differences of the fake 
holograms (B and C) compared to the genuine one (A).  
 
Apparently, the counterfeiters have no trouble in duplicating the holograms. 
Holograms that are being used by at least two pharmaceutical companies in Asia, 
were conventional holograms and are known to be duplicated by counterfeiters within 
a month after product launch20. 
 
Another measure taken against counterfeiting is adding features that are hidden and 
not immediately apparent. These features can be easily identified with the use of a 
simple instrument, like for instance a UV lamp or a microscope1. These chemical of 
physical markers (taggants) can be added on the product and/or packaging. Four 
different types of taggants are available, namely spectroscopic, biological, chemical 
and physical.  For spectroscopic taggants, inks are used that are UV absorbers while 
biological taggants may include ink with strands of a specific DNA. This DNA-
embedded ink is very difficult to replicate. Chemical taggants can include materials 
that can only be detected with IR spectroscopy or X-ray fluorescence. The last group 
are physical taggants, which are for instance microscopic plastic particles and are 
only visible with the use of a microscope1. These  four different taggants allows rapid  
identification of the counterfeits.  
 
The manufactures and distributors are forced to improve technologies against 
counterfeiters, since the criminals, that introduce counterfeit drugs, are becoming 
increasingly more sophisticated. One of these new developed methods is the track-
and-trace technology which, with the use of radio frequency chips, can track the 
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products from the point of manufacturing to the point of dispensing2,21. The key to this 
track-and-trace technology is the use of a unique serial number for each and every 
prescription drug. By using radio frequency identification (RFID), these serial 
numbers can be automatically read by sensors over short distances21. RFID varies in 
cost, ranging from a few cents to several dollars per package, depending on data 
capacity, range and read/write capability2. The downside of this method, at this 
moment, is that it is affordable for developed countries but too expensive to use to 
combat the problem of counterfeit drugs in developing countries.  
 
4.4 Analytical techniques used to detect counterfeit drugs  
 
The first step in detecting counterfeit drugs, is the careful visual inspection of the 
package and label, since even the smallest modifications may indicate a potential 
counterfeit. But since the counterfeiters become more sophisticated, additional 
analytical techniques are necessary to detect the counterfeits from the genuine 
drugs. So far, several analytical techniques have been used to detect counterfeit 
drugs.  
 
Chromatography is one of the most commonly used techniques, for instance, high 
performance chromatography (HPLC) to detect counterfeit antimalarial drugs. Green 
et al22 investigated drugs containing artesunate, chloroquine phosphate (tablets and 
injectables), quinine sulfate capsules and sulfadoxine / pyrimethamine tablets from 
Laos. The samples were dissolved in organic solvents and diluted before analysis 
with the HPLC. The accuracy of the method is ± 8%22. A second example of the use 
of HPLC to detect counterfeit is the research performed by Atemnkeng et al. which 
focused on the detection of artemisinin-derivatives (including artesunate) from Kenya 
and DR Congo23. The tablets for this research were weighed, crushed and dissolved 
in the appropriate solvents. The correct active ingredient was present in each case, 
the dosage however was is some cases substandard23.  Additional to these two 
investigations, HPLC has proven to be an accurate analytical technique for the 
detection of counterfeit homeopathic medicinal products24, determination of 
oseltamivir phosphate in tamiflu25 and detection of counterfeit anti-diabetic drugs26 as 
well.  
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For the detection of counterfeit antimalarial medicines, reversed-phase liquid 
chromatography (LC) can also be used. Gaudiano et all. demonstrated the use of this 
technique on antimalarial drugs (chloroquine, quinine and mefloquine) purchased 
from markets in Congo, Burundi and Angola27. The drugs analysed in this study, 
contained less then 90% of required active ingredient. Additionally, the level of 
impurities in these drugs, was much higher then tablets sold on the Italian market27.  
 
Another method is the use of thin layer chromatography (TLC) for the detection of 
counterfeit drugs. TLC is much cheaper than HPLC or LC. Laserson et al. 
demonstrated the use of TLC for tuberculosis drugs28. With this method, 10 % of the 
samples analysed, contained less then 85% of the required active ingredient28. The 
downside of all these chromatographic methods is the extended sample preparation, 
since the tablets have to be grinded, dissolved, diluted and analysed.  
 
Some methods require hardly any sample preparation. The first one is X-ray powder 
diffraction (XRD), where the only sample preparation is the removal of the coating 
(ca. 2mm x 14mm) before analysis29. In case of analyzing Viagra, the diffraction 
pattern of a genuine tablet, containing 100 mg active ingredient,  is compared to the 
diffraction patterns of the six counterfeit ones.  By using this method, the presence of 
the active ingredient sildenafil citrate could be determined as well as some excipients 
used in the tablet, for instance the cellulose and anhydrous calcium hydrogen 
phosphate. This method could easily distinguish the counterfeit from the genuine 
based on the visual examination of the diffraction patterns. The conclusion of this 
investigation has to be used very carefully since the results are based on the analysis 
of six Viagra tablets.   
 
Counterfeit Viagra tablets have also been analysed by using near-infrared 
spectroscopy (NIRS), another method which requires no sample treatment30. Since 
NIRS spectrum reflects both chemical and physical properties, the spectrum could be 
used to detect counterfeit drugs. In total 103 samples were analysed, and with the 
use of wavelength correlation and principal component analysis (PCA), the 
counterfeits could be distinguished from the genuine samples. From the 103 samples 
screened, 99 were correctly analysed with the use of NIRS. Additionally, other 
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substances present in the Viagra tablets were detected, for instance quinine and 
amphetamine30. A downside of these analytical techniques is, that they require 
trained analysts for analysis and data interpretation. Moreover, the cost of the 
equipment can be quite high.  
 
Colorimetry is a cheap and easy to use method, where the intensity of the positive 
colour reaction is proportional to the concentration of the active ingredient2. This 
method was proven to be effective for the detection of counterfeit antimalarial tablets 
by Green et al22. By simply adding diazonium fast red TR salt (C7H9Cl2N) to a small 
amount of powder from the tablet, it could be demonstrated whether the antimalarial 
tablet contained the active ingredient artesunate22. A downside of this method is that 
for each drug a new colorimetric agent has to be developed. Moreover, no 
information about excipients present in the drugs is presented with this method.   
 
4.5 History of Raman spectroscopy as a detection method of counterfeit drugs 
 
The use of Raman spectroscopy in the pharmaceutical field has been increasing for 
the last few years. Raman spectroscopy has some specific benefits, which are very 
useful for the detection of counterfeit drugs: a Raman spectrum can be recorded 
rapidly without any sample preparation. Moreover, this technique provides not only 
information about the active ingredient present in the drug, but a Raman spectrum 
contains also information on the concentration of the active ingredient, identification 
of excipients present in the drug2.  
 
This technique has been used for the detection of different kinds of illicit drugs, such 
as cocaine, heroin and ecstasy31,32. Bell et al. used Raman spectroscopy for the 
analysis of ecstasy tablets and other phenethylamine ecstasy analogues. By 
determining the excipients used, links between the seized tablets could also be 
established33,34.  
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4.6 Conclusion 
 
So far, Raman spectroscopy has been used for the detection of illicit drugs but not for 
counterfeit drugs. This PhD thesis will demonstrate the use of Raman spectroscopy 
as a fast and easy detection method of counterfeit drugs. In this thesis the focus is 
not only on the analysis of the active ingredient in the drugs (qualitative and 
quantitative), but also on the excipients used. To ease the detection of excipients in 
counterfeit drugs, an elaborate database is presented in chapter 8 with the most 
frequently used excipients in the pharmaceutical field. Chapter 5, 6, and 7 will cover 
the qualitative analysis of counterfeit drugs while in chapter 9 the quantitative 
determination of these counterfeit drugs will be discussed.  
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5 Qualitative analysis of counterfeit drugs 
 
As mentioned in the previous chapter, numerous techniques can, and have been 
used, to detect counterfeit drugs. Raman spectroscopy has certain benefits that the 
other techniques lack. There is no sample preparation necessary, the sample can be 
measured through glass or the blister package, and above all, this technique is non-
destructive.  
 
In order to verify if Raman spectroscopy can be useful for qualitative detection of 
counterfeit drugs, different kinds of possible counterfeit drugs are analysed. This 
chapter describes the qualitative analysis of tablets, gels, syringes and capsules. 
These drugs are, either seized at customs at Brussels airport, at raids in different 
houses, buildings or companies in Belgium by the FAGG (Federal Agency for 
Medicines and Health Products), or received anonymously. 
 
This chapter describes the analyses of different possible counterfeit drugs. Firstly, 
erectile dysfunction drugs are analysed. Three different genuine erectile dysfunction 
drugs are available, namely Viagra, Cialis and Levitra. Viagra is still the most 
commonly counterfeited erectile dysfunction drug, but the amount of counterfeit Cialis 
has rapidly increased over the last few years1. The Raman spectra of these genuine 
drugs are compared with the Raman spectra of possible counterfeits. The group of 
possible counterfeits consists of two Viagra tablets, a gel containing the same active 
ingredient as Viagra and two tablets claiming to contain the same active ingredient 
as Cialis.  
 
Secondly, possible counterfeit Noromectin, which is an oral paste used to cure 
horses from different kinds of parasites, is analysed. Noromectin is sold in a  blue 
and white plastic syringe, which was sold illegally on the Belgium market in 2005. 
With Raman spectroscopy, not only the content is analysed, but the plastics of the 
syringe and the inks used on the label are analysed as well. These Raman spectra 
are compared to the corresponding Raman spectra of the genuine Noromectin 
sample.  
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Finally, two examples of possible counterfeited Amoxil are analysed and compared 
to a genuine sample. Amoxil contains the active ingredient amoxicillin and is an 
antibiotic (penicillin). It is used for treating numerous infections of the chest, tonsils, 
ears, sinuses and the urinary tract. Amoxil can also be used to treat gonorrhoea. 
These examples will demonstrate the use of Raman spectroscopy as a fast and easy 
qualitative method of detection2.  
 
5.1 Experimental 
 
Two dispersive Raman spectrometers (MArtA and Renishaw System-1000 
instrument) are used for the qualitative analysis and are described below: 
 
MArtA3,4: 
 
The core of the mobile art analyser (MartA) is a modified portable Raman imaging 
microscope (PRIM) (Spectracode, West Lafayette, Ind. USA), which is based on a 
SpectraPro-150i 150-mm spectrometer and a thermo-electrically cooled, charge-
coupled device detector (Roper Scientific / Prince Instruments). The system is 
equipped with a 785 nm diode laser (Process Instruments, Salt Lake City, Ut., USA) 
for excitation, with a power of ca. 70 mW at the sample. A 6x objective lens is used 
which creates a spot size of ca. 25 µm. All spectra are recorded in the spectral 
window of 0 to 2500 cm-1. The analysis time and number of accumulations differ 
between the samples analysed. The standard deviation on the position of a Raman 
band ranges from 4 – 8 cm-1.  
 
Renishaw5:  
 
The Renishaw System-1000 spectrometer (Wotton-under-Edge, UK)  is connected to 
a Olympus BH-2 microscope. The diode laser has a power of 50 mW at the source 
and a wavelength of 785 nm (DL 100, TuiOptics GmbH, Martinsried/Munich, 
Germany). A 5x objective lens (Olympus MDPlan5, 0.10 NA, Omnilabo, Aartselaar, 
Belgium) is used and the collected Raman radiation is dispersed with a                
1200 lines mm-1 grating (focal length 250 mm) and focussed on a Peltier-cooled CCD 
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detector, allowing to obtain a spectral resolution of ca. 1 cm-1. All spectra are 
recorded in the spectral window of 200 to 1800 cm-1. The analysis time and number 
of accumulations differ between the samples analysed. The standard deviation on 
the position of a Raman band is circa 1 cm-1. The recorded spectra are averaged 
(three per sample) and baseline-corrected with  ACD/Specmanager (version 9.13, 
Advanced Chemistry Development, inc. Toronto, Canada) to eliminate the influence 
of broadband fluorescence.  
 
5.2 Analysis of erectile dysfunction drugs 
 
5.2.1 Functioning of erectile dysfunction drugs  
 
During sexual stimulation, nitric oxide (NO) is released from the nerve endings and 
endothelial cells in the corpus cavernosum. NO activates the enzyme guanylate 
cyclase, which results in an increased level of cyclic guanosine monophosphate 
(cGMP), allowing inflow of blood which causes the erection. Phosphodiesterase   
type 5 (PDE5) is responsible for the degradation of the cGMP level in the corpus 
cavernosum6,7,8. The three most common drugs against erectile dysfunction are 
Viagra, Cialis, and Levitra. These oral drugs inhibit PDE5, therefore increasing 
the amount of cGMP, which is responsible for the erection6,7,8. Since the introduction 
of these drugs, the amount that is available through Internet, legally as well as 
illegally, has increased.  
 
5.2.2 Content of the three erectile dysfunction drugs  
 
The active ingredients of these three oral drugs, and excipients present in the tablets, 
are described below: 
 
Viagra6: 
 
The active ingredient of Viagra is sildenafil citrate. Sildenafil citrate is designated 
chemically as 1-[[3-(6,7-dihydro-1-methyl-7-oxo-3-propyl-1H-pyrazolo[4,3-d]pyrimidin-
5-yl)-4-ethoxyphenyl1]sulfonyl]-4-methylpiperazine citrate. The structural formula and 
picture of a genuine Viagra tablet are shown in figure 5.16. 
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Figure 5.1 Left: structural formula of sildenafil citrate; right: both sides of a genuine Viagra 
tablet6. 
 
The tablets made for oral administration are blue, diamond shaped and are sold in 
three different doses of respectively 25, 50 and 100 mg sildenafil citrate. Viagra also 
consists of the following excipients: microcrystalline cellulose, anhydrous dibasic 
calcium phosphate, croscarmellose sodium, magnesium stearate, hypromellose, 
titanium dioxide, lactose, triacetin and FD&C Blue 2 aluminum lake6.  
 
Cialis7: 
 
The active ingredient of Cialis is tadalafil. Tadalafil is designated chemically as 
pyrazino[1’,2’:1,6] pyrido[3,4-b] indole-1,4-dione,6-(1,3-benzodioxol-5-yl) -2,3,6,7,12, 
12a -hexahydro-2-methyl-,(6R,12aR)-. The structural formula  and a picture of a 
genuine Cialis tablet are presented in figure 5.27. 
 
 
  
Figure 5.2 Left: structural formula of tadalafil; right: both sides of a genuine Cialis tablet7. 
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The tablets, made for oral administration, are yellow, almond shaped  and sold in 
three different dosages of 5, 10 and 20 mg active ingredient. Cialis also consists, 
besides the active ingredient, of the following excipients: croscarmellose sodium, 
hydroxypropyl cellulose, hypromellose, iron oxide, lactose monohydrate, magnesium 
stearate, microcrystalline cellulose, sodium lauryl sulfate, talc, titanium dioxide and 
triacetin7.  
 
Levitra8: 
 
The active ingredient of Levitra is vardenafil HCl. Vardenafil HCl is designated 
chemically as piperazine,1-[[3-(1,4-dihydro-5-methyl-4-oxo-7-propylimidazo[5,1-f] 
[1,2,4]triazin-2-yl)-4-ethoxyphenyl]sulfonyl]-4-ethyl-,monohydrochloride. The formula 
and figure of a genuine Levitra tablet are presented in figure 5.38. 
 
 
 
  
 
 
Figure 5.3 Left: the structural formula of vardenafil; right: a genuine Levitra tablet8. 
 
The tablets, made for oral administration, are orange, round shaped tablets and have 
2.5, 5, 10 or 20 mg active ingredient. Levitra also consists, besides the active 
ingredient, of the following excipients: microcrystalline cellulose, crospovidone, 
colloidal silicon dioxide, magnesium stearate, hypromellose, polyethylene glycol, 
titanium dioxide, yellow ferric oxide, and red ferric oxide8.  
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The first step of the analysis of counterfeit drugs is recording of the Raman spectra of 
the genuine drugs, which can be used as a reference. Figure 5.4 shows the Raman 
spectra of genuine Viagra, Cialis and Levitra tablets.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.4 Raman spectra of erectile dysfunction drugs, all analysed with the Renishaw 
System-1000 instrument  with a 5x objective (25 acc. x 30 s):  (A) genuine Viagra tablet (50 
mg), (B) genuine Cialis tablet (20 mg) and (C) genuine Levitra tablet (20 mg). Raman 
bands marked with * can be assigned to anatase titanium dioxide.  
 
All three tablets against erectile dysfunctions show strong Raman bands at ca. 395, 
513 and 636 cm-1, which can be assigned to anatase TiO2 (chapter 8, figure 7C). To 
avoid these strong Raman bands, the spectral window, presented in figure 5.5 is 
reduced to the range of 700 to 1800 cm-1. This emphasizes the Raman bands of the 
active ingredients. 
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Figure 5.5 Raman spectra of erectile dysfunction drugs (range 700 till 1800 cm-1) all analysed 
with the Renishaw System-1000 instrument with a 5x objective (25 acc. x 30 s): (A) genuine 
Viagra tablet, (B) genuine Cialis tablet and (C) genuine Levitra tablet.  
 
The Raman bands in the spectra of the genuine erectile dysfunction drugs are used 
as reference to detect the counterfeit drugs discussed in the following paragraphs 
(5.2.3 - 5.2.5).  
 
5.2.3 Viagra tablets 
 
Two anonymously received tablets, possible Viagra counterfeits, are analysed with 
the use of the Renishaw System-1000 spectrometer, and compared to a genuine 
Viagra tablet. Figure 5.6 shows the tablets analysed, while figure 5.7 shows the 
Raman spectrum of the two possible counterfeits (B and C) in a range of               
200 - 1800 cm-1 compared with genuine Viagra (A). 
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Figure 5.6 Genuine Viagra (A) and two possible counterfeit Viagra tablets (B and C).   
 
Visual inspection shows that the first possible counterfeit tablet (B) is not significantly 
different  from the genuine Viagra (A). However, the second possible counterfeit 
tablet (C) shows clear differences with the genuine one: the Pfizer logo is lacking and 
the amount of active ingredient is mentioned as “50 mg” in stead of  “VGR 50”. Figure 
5.7 shows the Raman spectrum of these two possible counterfeits and the spectrum 
of the genuine Viagra as a reference.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.7 Raman spectra of genuine Viagra tablet (A) and two possible counterfeit Viagra 
tablets (B and C), all analysed with the Renishaw System-1000 instrument (5 acc. x 30 s). 
Raman bands marked with *, # and + can be assigned to respectively anatase TiO2, barium 
sulfate and sildenafil citrate.  
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Figure 5.7 shows the spectral range of 200 till 1800 cm-1. In all the spectra the three 
Raman bands of anatase titanium dioxide (TiO2), at ca. 394, 513 and 634 cm-1 are  
present (chapter 8, fig. 8.7C). When the spectrum of the genuine Viagra (fig. 5.7A)  
is compared to the two spectra of the possible counterfeits (fig. 5.7B and C), 
differences can be noted.  
 
• Firstly, when looking at the intensities of the Raman band of TiO2 at ca. 634 
cm-1 and of the active ingredient at ca. 1576 cm-1 in the genuine Viagra (fig. 
5.7A), the ratio of these two intensities is approximately 3:1. However, for 
tablet B this ratio is circa 2:1, and for tablet C this ratio is circa 5:1, this could 
be an indication that these two tablets are possibly counterfeited.  
 
• Secondly, both possible counterfeit tablets show an additional Raman band 
around 982 cm-1, which can be assigned to barium sulfate (BaSO4, chapter 7, 
fig. 7.6A).  
 
Based on these differences, the two tablets can be considered as counterfeited. 
 
5.2.4 Gel containing the active ingredient of Viagra 
 
At Brussels airport, Seyagra gel sachets 
(fig. 5.8) containing the active ingredient 
of Viagra, namely sildenafil citrate, were 
seized. According to the manufacturer, it 
is a gel which is not only “fast acting” but 
also “great tasting”. In figure 5.9, the 
Raman spectrum of this gel is shown (B), 
next to the Raman spectrum of the active 
ingredient of genuine Viagra: sildenafil 
citrate (A). 
 
 
 
Figure 5.8 Seyagra gel 
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Figure 5.9 Raman spectrum of sildenafil citrate (A: 10 acc. x 30 s) and Seyagra gel             
(B: 20 acc. x 30 s) both analysed with the Renishaw System-1000 instrument. 
 
The Raman bands of sildenafil citrate could be easily recognized, but some 
additional bands, not caused by the active ingredient, are present as well. These 
Raman bands, at 1390, 1017, 837, 705, three bands around 660 cm-1, and several 
bands between 500 and 200 cm-1 have so far been unidentified.  
 
5.2.5 Tablets containing the active ingredient of Cialis  
 
At Brussels airport, on two different occasions, tablets were seized, claiming to 
contain  the active ingredient of Cialis (fig. 5. 10). 
  
A  
 
  B   C 
 
 
  
Figure 5.10 Genuine Cialis (A) and two tablets claiming to contain tadalafil (B and C). 
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Visual inspection of the tablets shows a clear difference in appearance compared to 
genuine Cialis. The appearance of the tablets show more similarity with the Levitra 
tablet, shown in figure 5.3. In figure 5.11 the Raman spectrum of genuine Cialis is 
compared to the Raman spectra of the seized tadalafil tablets.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.11 Raman Spectra of genuine Cialis (A) and the two seized tablets (B and C) 
analysed with the Renishaw System-1000 instrument  (25 acc. x 30 s). Raman bands 
marked with *, #, “, ~, and + can be assigned to respectively anatase TiO2, barium sulfate, 
starch, lactose and tadalafil. 
 
When the spectrum of genuine Cialis is compared to the two spectra of the possible 
counterfeits (fig. 5.11B and C), the following differences can be noticed: 
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• The three Raman bands of titanium dioxide (TiO2, ca. 396, 515 and 634 cm-1) 
are only present in the first two spectra. However, as seen in the analysis of 
counterfeit Viagra (paragraph 5.2.3), the ratio of the intensities of the active 
ingredient (ca. 1593 cm-1) and TiO2 differs significantly. In the genuine Cialis 
(fig. 5.11A) the ratio is circa 1:25 while in tablet B the ratio is circa 1:7 which is 
an indication that less TiO2 is used, compared to the active ingredient.  
 
• Secondly, all Raman spectra show the Raman bands of lactose at ca.         
353 cm-1 and ca. 474 cm-1 (chapter 8, fig. 8.1D). However, the ratio between 
these two Raman bands differs significantly in both counterfeits. The ratio in 
the genuine Cialis is approximately 2:1 while in the counterfeits these ratios 
are 1:1 (B) or 1:3 (C). The increase of the relative intensity of the Raman band 
ca. 474 cm-1 can be attributed to starch (chapter 8, fig. 3A). 
 
• In the second counterfeit tablet the Raman band at ca. 985 cm-1, can be 
assigned to barium sulfate (BaSO4, chapter 7, fig. 6A).  
 
Since the active ingredient, tadalafil, was not available for analysis it can not be 
guaranteed that the active ingredient is present in the tablets. However, based on the 
detected Raman bands, it can be stated that these tablets contain additional 
excipients that are not commonly used in genuine Cialis tablets.  
 
5.3 Analysis of Noromectin 
 
5.3.1 Introduction of Noromectin 
 
In January 2005, a Dutchman was arrested for selling 1500 plastic syringes with the 
brand logo of Noromectin. Noromectin is an oral paste which is used for the 
treatment of gastrointestinal roundworms, lungworms, grubs, hornflies, sucking and 
biting lice and sarcoptic mange mites in  horses. The active ingredient in the paste is 
Ivermectin (22,23-dihydroavermectin). Besides 1,87% w/w active ingredient, the 
paste consists of the following excipients: hydroxypropyl cellulose, hydrogenated 
castor oil, titanium dioxide and propylene glycol9,10.  
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5.3.2 Analysis of packaging 
 
First a visual inspection of the syringes is 
executed and secondly, the content, the 
packaging, and labeling, are analysed with 
Raman spectroscopy. Based on their 
appearance (figure 5.12), small differences 
between the two syringes can be noted. 
Both logos show a blue label with a picture 
of a white horse, but in different formats. 
 
 
 
Figure 5.12 Genuine (A) and counterfeit 
(B) Noromectin syringe. 
 
 
But whether the syringe is counterfeit or whether it just has a new and improved 
packaging, it is difficult to say. So, it is necessary to analyze not only the content of 
both syringes with Raman spectroscopy, but the package as well. The Raman 
spectrum and chemical structure of the active ingredient Ivermectin, is shown in 
figure 5.13. Figure 5.14 shows the results of the first step in the investigation, which 
is the analysis of the white and blue plastics used for the syringes. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.13 Raman spectrum of pure Ivermectin recorded with the Renishaw System-1000 
spectrometer (5 acc. x 30 s) and its chemical structure9. 
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Figure 5.14 Raman spectra of white (A1) and blue (A2) plastic packaging of the genuine 
Noromectin and white (B1) and blue (B2) plastic of the counterfeit Noromectin analysed 
with the Renishaw System-1000 spectrometer (10 acc. x 30 s).  Raman bands marked with *, 
#
 and “ can be assigned to respectively rutile TiO2, polyethylene and ultramarine. 
  
All four spectra shown in figure 5.14 reveal similar Raman bands between 1060 and 
1460 cm-1. These Raman bands can be attributed to polyethylene11. The Raman 
bands at ca. 1062 and 1128 cm-1 are due to ν(C-C) stretching vibrations, the δ(CH) 
twisting vibration is situated at ca. 1294 cm-1, while the Raman bands between 1400 
and 1460 cm-1 can be assigned to δ(CH) bending vibrations11. Figure 5.14 A1 and 
B1, the white plastics from the syringe, show three Raman bands at ca. 232, 448 and 
607 cm-1. These can be assigned to the rutile form of titanium dioxide (chapter 8, fig. 
8.7D). The blue caps shown in figure 5.14 A2 and B2 have just one additional band 
at ca. 547 cm-1 which is caused by the blue color (ultramarine blue, approximately  
Na8[Al6Si6O24]Sn) added to the polyethylene12,13. This Raman band can be assigned 
to the symmetric stretching vibration (ν3) of ultramarine blue14.  
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Based on the spectra of the plastic syringes, the counterfeit could not be 
distinguished from genuine Noromectin. Therefore, the next step is to focus on the 
colours used in the label of the two syringes (fig. 5.15). The colours showed similar 
Raman spectra, except the spectra of the two small blue dots on the bottom of each 
label (fig. 5.16). 
 
A  B  
 
Figure 5.15 A represents the label of the genuine Noromectin and B the counterfeit label. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.16 Raman spectra of the blue dots on the labels from the (A) genuine Noromectin  
syringe (Renishaw System-1000, 5x obj., 10 acc. x 30 s) and the (B) counterfeit Noromectin  
syringe (MArtA, 6x obj., 30 acc. x 30 s). 
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The Raman spectra of the genuine and counterfeit can be easily distinguished from 
each other. All Raman bands in the spectrum of the genuine Noromectin syringe, 
can be assigned to the blue pigment copper phthalocyanine15, while these Raman 
bands could not be identified in the Raman spectrum of the counterfeit sample.  
 
5.3.3 Analysis of the content of the syringes 
 
Based on the Raman spectra of these two small blue dots on the labels, the 
counterfeit Noromectin  syringe could be differentiated from the genuine. In order to 
analyse the content of these syringes, the blue cap was removed and by using the 
mobile Raman spectrometer (MArtA), the laser beam is aimed in the syringe. These 
Raman spectra are shown in figure 5.17.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.17 Raman spectra of the content of genuine (A) and counterfeit (B) Noromectin 
syringes (MArtA, genuine sample: 5 acc. x 30 s, counterfeit sample: 30 acc. x 60 s). Raman 
bands marked with *, # and + can be assigned to respectively anatase TiO2, propylene glycol 
and Ivermectin. 
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As can be seen in figure 5.17 the counterfeit Noromectin (B) is not Raman active. 
The genuine product (A) shows the three intense bands of anatase titanium dioxide 
at ca. 395, 519 and 637 cm-1 (chapter 8, fig. 8.7C). The Raman bands between 800 
and 1460 cm-1 can be assigned to propylene glycol (chapter 8, fig. 8.4A). The Raman 
bands at 804 and 841 cm-1 can be assigned to the in-phase ν(CCO) stretching 
vibration while Raman bands between 925 and 1137 cm-1can be attributed to the  
out-of-phase ν(CCO) stretching vibration.  
 
Since the active ingredient (fig. 5.13) is only present in a very small amount (1,87% 
w/w), the Raman band at 1675 cm-1 is small, but distinguishable in figure 5.17. Based 
on the Raman spectra of the content and the label of the syringe, the counterfeit 
Noromectin sample could be distinguished from the genuine.  
 
5.4 Analysis of Amoxil 
 
Amoxil is an antibiotic that is used to treat a wide range of infections and is 
produced by GlaxoSmithKline (GSK). It belongs to a group of antibiotics, called 
“penicillin”. The capsule contains the active ingredient amoxicillin, in either 250 mg or 
500 mg. Amoxicillin is designated chemically as: (2S,5R,6R)-6-[(R)-(-)-2-amino-2-(p-
hydroxyphenyl) acetamido] -3,3- dimethyl -7-oxo-4-thia-1-azabicyclo [3.2.0] heptane-
2-carboxylic acid trihydrate2.  
 
The medicine, made for oral administration, is a red and yellow capsule, consisting of 
250 or 500 mg active ingredient and magnesium stearate as excipient. The capsule 
is made from gelatin, erythrosine, indigo carmine, iron oxides and titanium dioxide2.   
 
The first step in the evaluation is the visual analysis of the capsules. Figure 5.18 
shows the pictures of the genuine Amoxil capsule and two possible counterfeits, 
seized by the FAGG (B) and customs at Brussels airport (C). 
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A  
 
B C 
 
 
 
 
Figure 5.18 Genuine Amoxil (A) and two possible counterfeit Amoxil (B and C) capsules. 
 
Based on visual examination, no obvious differences can be noted between the 
genuine capsule and the two possible counterfeits (B and C). With Raman 
spectroscopy, the Raman spectrum of the active ingredient amoxicillin (fig. 5.19) is 
compared to the Raman spectra of the content of these three capsules (fig. 5.20).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.19 Raman spectrum of pure amoxycillin with the Renishaw System-1000 instrument 
(10 acc. x 30 s) and its chemical structure9.  
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Figure 5.20 Raman spectra of content of genuine (A) and two possible counterfeits Amoxil® 
(B and C) with the Renishaw System-1000 instrument (5 acc. x 30s).  
 
The three spectra of the Amoxil capsules in figure 5.20 show all the distinctive 
Raman bands of the active ingredient amoxicillin (figure 5.19). The content of a 
genuine Amoxil capsule consists of the active ingredient and magnesium stearate 
(chapter 8, fig. 5C). No additional Raman bands in these spectra could be assigned 
to this excipient.  
 
Based on these Raman bands, no difference can be noted between the genuine 
sample (A) and two possible counterfeits (B and C). In order to visualize differences 
between the genuine Amoxil® and two possible counterfeits, a difference spectrum is 
calculated between the active ingredient, amoxicillin, and the content of the three 
capsules (A, B and C) with the use of ACD Specmanager. The three difference 
spectra are shown in figure 5.21.  
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Figure 5.21 Difference spectra between content of Amoxil capsules (genuine (A) and two 
possible counterfeits (B and C)) and active ingredient amoxicillin. Raman bands marked with 
* and # can be assigned to respectively magnesium stearate and starch.  
 
The difference can now be noted between the genuine Amoxil capsule (A) and the 
two possible counterfeits (B and C). The differences spectrum of sample B shows 
several additional bands due to magnesium stearate (chapter 8, fig. 5C) and starch     
(chapter 8, fig. 3A). Raman bands at 1061, 1125 and 1294 cm-1 can be assigned to 
magnesium stearate while the Raman bands at 476, 940 and 1082 cm-1 are due to 
starch. Based on the presence of an additional excipient, the Amoxil® capsule seized 
by the FAGG can be considered as counterfeit.  
 
1618
1396
12
94
*
1257
1197
1177
11
25
*
10
82
#
10
61
*
1050 985
94
0
#
852
804
636
585
507
47
6
#
447 358
229
1619
1396 1257
1195 1177
1051
985
852
804
636
585
507
447
360
229
1619
1397 1255
1195
1176
1049
985
850 802
634
585
505 443 355
229
1800 1700 1600 1500 1400 1300 1200 1100 1000 900 800 700 600 500 400 300 200
A
B
C
Wavenumber (cm-1)
R
am
an
 
in
te
ns
ity
 
(ar
bi
tra
ry
 
u
n
its
)
1618
1396
12
94
*
1257
1197
1177
11
25
*
10
82
#
10
61
*
1050 985
94
0
#
852
804
636
585
507
47
6
#
447 358
229
1618
1396
12
94
*
1257
1197
1177
11
25
*
10
82
#
10
61
*
1050 985
94
0
#
852
804
636
585
507
47
6
#
447 358
229
1619
1396 1257
1195 1177
1051
985
852
804
636
585
507
447
360
229
1619
1396 1257
1195 1177
1051
985
852
804
636
585
507
447
360
229
1619
1397 1255
1195
1176
1049
985
850 802
634
585
505 443 355
229
1619
1397 1255
1195
1176
1049
985
850 802
634
585
505 443 355
229
R
am
an
 
in
te
ns
ity
 
(ar
bi
tra
ry
 
u
n
its
)
5. Qualitative analysis 
 
65 
The difference spectrum of sample C in figure 5.21 shows no additional Raman 
bands compared with the difference spectrum of the genuine sample. However, 
when using the same subtraction factor, the negative Raman bands of the active 
ingredient in sample C are more prominent than for the genuine sample, indicating 
possibly a lower level of active ingredient in the capsule.  
 
5.5 Conclusion  
 
By using Raman spectroscopy, differences between genuine and possible counterfeit 
samples could be detected. This chapter described the qualitative analysis of tablets, 
gels, syringes and capsules. Based on a simple visual examination of the drugs, not 
all counterfeits could be detected, which illustrates that counterfeiters are becoming 
highly sophisticated. With Raman spectroscopy, based on the presence or absence 
of Raman bands (active ingredient and/or excipients) the counterfeits could be 
differentiated from the genuine samples.  
 
This chapter, however, is only based on one or two counterfeits per example. The 
next two chapters, describe the use of Raman spectroscopy to qualitatively detect 
larger groups of possible counterfeits. Chapter 6 describes the analysis of 50        
anti-malarial tablets while chapter 7 describes the analysis of 18 Viagra tablets.        
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Based on the paper: de Veij M, Vandenabeele P, Alter Hall K, Fernandez FM, Green 
MD, White NJ, Dondorp AM, Newton PN, Moens L, Fast detection and identification 
of counterfeit antimalarial tablets by Raman spectroscopy, Journal of Raman 
Spectroscopy, 38, 2007, 181-187. 
 
Malaria is an infectious disease, affecting people worldwide. There are four 
principal species of the genus Plasmodium which can cause Malaria, namely: 
P. falciparum, P. vivax, P. malariae, and P. ovale. Plasmodium falciparum is 
by far the most common and deadly type of malaria infection1,2,3.  According to 
the World Health Organization, each year more than 500 million people 
become severely ill with malaria3. The number of different types of antimalarial 
drugs is small; predominately chloroquine is used, despite its decreasing 
efficiency2. One of the most efficient antimalarial drugs momentarily, is 
artesunate, which is an artemisinin derivative2. These derivatives were 
discovered in the early 1970s by Chinese scientists and since then this drug is 
used extensively in Southeast Asia2. This chapter is focused on detection of 
counterfeit antimalarial drugs with the use of Raman spectroscopy.  
 
Abstract 
 
During the last decade there has been an apparent increase in the prevalence 
of counterfeit medicines in developing as well as developed countries. The 
pivotal antimalarial artesunate has been counterfeited on a large scale in SE 
Asia. In this work, the possibilities of Raman spectroscopy are explored as a 
fast and reliable screening method for the detection of counterfeit artesunate 
tablets. In this study 50 “artesunate tablets”, purchased in South-east Asia, 
were examined.  
 
This spectroscopic method was able to distinguish between genuine and 
counterfeit artesunate and to identify the composition of the counterfeit 
tablets. These contained no detectable levels of artesunate, but consisted 
mostly of starch, calcite (CaCO3), and paracetamol (4-acetamidophenol).  
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In one particular case an admixture of rutile (TiO2) and artesunate was 
detected. The results of the investigation by Raman spectroscopy were in 
agreement with these of the artesunate colorimetric test and of liquid 
chromatography mass spectrometry.  
 
Moreover, principal components analysis (PCA) was combined with 
hierarchical cluster analysis to establish an automated approach for the 
discrimination between different groups of counterfeits and genuine 
artesunate tablets.  
 
These results demonstrate that Raman spectroscopy combined with 
multivariate analysis is a promising and reliable methodology for the fast 
characterization of genuine and counterfeit artesunate antimalarial tablets.  
 
6.1 Introduction 
 
Counterfeit medicines happen to be a problem, not only for many developing 
nations but for developed countries as well4. The United States Food and 
Drug Administration (FDA) estimates that counterfeits make up of more than 
10% of the global medicines market5. In 2004, FDA's Office of Criminal 
Investigations initiated 58 counterfeit drug cases in the United States 
compared to 9 cases in 1997, which shows that counterfeit drugs is an 
increasing problem6. 
  
Counterfeit medicines include drugs without sufficient active ingredient, 
without any active ingredients or with fake packaging4,5. In wealthier countries 
new and expensive medicines, such as hormones, corticosteroids, and cancer 
drugs, are frequently counterfeited7. Amongst the most well-known counterfeit 
drugs in wealthier countries are Viagra® and Cialis® which are used against 
erectile dysfunction4,8. In developing countries, the most counterfeited 
medicines are those used to threat widespread infectious diseases, such as 
tuberculosis and malaria7. 
 
6. Analysis of counterfeit antimalarial tablets 
71 
Until recently, analytical controls in the drug distribution system were 
considered to be supplementary9 to the Quality Control at the production unit. 
Counterfeit drug detection is often a complex process. Careful visual 
inspection of the product’s packaging and labelling is the first step of defence, 
since modifications may indicate a potential counterfeit.  
 
Visual inspection is followed by chemical analysis, often using high 
performance liquid chromatography (HPLC)10. HPLC is considered to be the 
golden standard analytical method in drug analysis, since it allows active 
components as well as impurities to be determined quantitatively10. In the last 
few years more methods4,8,11,1213 have been developed for the quality control 
of drugs, such as thin layer chromatography (TLC), UV/VIS-spectroscopy, 
near-infrared (NIR) spectroscopy, and liquid-chromatography mass 
spectrometry (LC-MS).  
 
This paper describes the fast analysis of genuine and counterfeit ‘artesunate 
tablets’ by Raman spectroscopy.  Artesunate is a key drug in the treatment of 
multi-drug resistant Plasmodium falciparum malaria in Southeast Asia14. As 
counterfeit antimalarials usually contain insufficient or no active ingredient, the 
unwitting patient is at substantial risk of developing severe malaria and even 
dying due to lack of treatment15.  
 
According to the World Health Organisation (WHO), one million deaths per 
year occur due to malaria and as many as 200.000 deaths could be avoided if 
the medicines available were of good quality5. In two surveys14,15 conducted in 
2000-2001 and 2002-2003 ‘artesunate’ bought in mainland Southeast Asia 
(Burma (Myanmar), Lao PDR, Vietnam, Cambodia and on the Thai/Burma 
border) the prevalence of counterfeit artesunate increased from 38 % in the 
first study to 53 % in the following years. 
 
Counterfeit artesunate tablets may be detected using several methods, relying 
on visual inspection, chemical assays and instrumental analysis15. First 
counterfeits can be classified qualitatively as genuine or counterfeit, based on 
the characteristics of the hologram, blisterpack and packaging.  
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Although this is an inexpensive approach, it has been found to be 100% 
accurate in recognizing counterfeits tablets in the first survey of counterfeit 
artesunate tablets in SE Asia14. However, experience is required to identify 
the counterfeits and with increased counterfeiter sophistication, this method 
was not as accurate in the second survey15.  
 
The simplest chemical assay is a coloured-based dye test, based on the 
reaction between an alkali decomposition product of artesunate and a 
diazonium fast red Tr salt16. This is a simple and inexpensive test, but it does 
not give information regarding the chemical composition of the counterfeit 
tablets or regarding substandard amounts of artesunate16.  
 
Moreover, this approach is limited to the identification of artesunate; the 
investigation of other counterfeit drugs requires the development of another 
dye test. The reference method to determine quantitatively the amount of 
artesunate in tablets is high-performance-liquid-chromatography (HPLC), 
which has been used to confirm the results of the first two tests during the 
2002-2003 surveys14-16. Although HPLC is very sensitive and provides 
comprehensive information about the sample, the sample preparation and 
analysis is time-consuming and requires trained chemists for the analysis as 
well as for the interpretation of the results.  
 
Therefore, we have investigated the potential use of Raman spectroscopy for 
the detection of counterfeit artesunate, since the technique does not require 
any sample preparation and if needed the tablet components can even be 
analyzed through the blister package. It’s non-destructive character and high 
speed of analysis make Raman spectroscopy well-suited for investigating 
possible counterfeit drugs.  Moreover, since mobile fibre optics spectrometers 
are becoming increasingly available, small instruments can be deployed for in 
situ analysis. By using chemometric techniques to compare the recorded 
spectra with those in a reference library, instrument operation and spectral 
interpretation can be automated in order to give a pragmatic answer to non-
specialist operators in the field.  
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Pharmaceutical analysis by Raman spectroscopy is becoming a commonly 
accepted approach, as illustrated by the rising number of research papers that 
are published in this field. Raman spectroscopy has been used for the 
identification of active substances in pharmaceuticals17,18, their qualitative19 
and quantitative analysis20, the characterization of different crystalline 
forms21,22 and even for on-line monitoring of pharmaceutical blending 
process23.  
 
Moreover, the identification of illicit drugs (cocaine, heroin and MDMA) which 
are contaminated with one or more cutting agents24,25 has been presented. 
Raman spectroscopy is also used for the identification of seized ecstasy 
tablets18,26. These results show that Raman spectroscopy can be used to 
distinguish between ecstasy and various other phenethylamine ecstasy 
analogues.  
 
So far, no research papers have been published on the use of Raman 
spectroscopy for the identification of counterfeit pharmaceuticals. The first aim 
of this study is to evaluate the ability of Raman spectroscopy to rapidly 
discriminate between genuine and counterfeit artesunate tablets. Second, an  
attempt is undertaken to classify the different counterfeit tablets, since this 
could be of help, in combination with other analytical techniques, to pinpoint 
the relationships (between location of sample sale, sample production source 
and distribution routes) in different forgery cases.  
 
Finally, possibilities for the application of Raman spectroscopy in counterfeit 
drug detection are examined, by developing a basic chemometrics algorithm 
and automated classification procedure.  
 
6.2 Experimental 
 
The analyses were carried out with a Renishaw System-1000 spectrometer 
(Wotton-under-Edge, UK) connected to a Olympus BH-2 microscope. The 
diode laser has a power of 50 mW at the source and a wavelength of 785 nm 
(DL 100, TuiOptics GmbH, Martinsried/Munich, Germany).  
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By using a 20x objective lens (Olympus MDPlan20, 0.20 NA, Omnilabo, 
Aartselaar, Belgium) spectra of particles with a diameter down to ca. 5 µm can 
be recorded. The collected Raman radiation was dispersed with a             
1200 lines mm-1 grating (focal length 250 mm) and focussed on a Peltier-
cooled CCD detector allowing to obtain a spectral resolution of ca. 1 cm-1. All 
spectra were recorded in the spectral window of 200 to 1800 cm-1, with           
5 accumulations of 30s each. Spectra were baseline-corrected before 
presentation, to eliminate the influence of broadband fluorescence.   
 
The artesunate samples, including both genuine artesunate and counterfeit 
tablets were collected in Vietnam, Cambodia, Lao PDR (Laos), the Thai  
Burma border, Burma and Hong Kong15. Pure artesunate (Apin Chemicals, 
UK) was used as a reference.  
 
Since Raman analysis of these samples was preceded by colorimetric test16 
and liquid chromatography mass spectrometry (LC-MS) analyses27, tablets 
had been previously ground with a mortar and pestle. Reference samples of 
excipients, such as calcite (CaCO3, UCB Belgium), starch (starch, soluble 
reagent, UCB Belgium) and 4-acetamidophenol (Acros, Belgium) were also 
analyzed by Raman spectroscopy.  
 
Liquid chromatography-mass spectrometry (LC-MS) experiments were 
performed on an AccuTOF orthogonal time-of-flight mass spectrometer 
(JEOL, Peabody, MA, USA) coupled to an Agilent 1100 HPLC system (Palo 
Alto, CA USA) via an electrospray ionization interface. A Zorbax 300Å 300 
Extend-C18 column (2.1mm ID and 150mm long, Agilent, Palo Alto, CA USA) 
was used in all of the experiments.   
 
The LC was operated at a flow rate of 200 µL min-1, with an injection volume 
of 20 µL. The binary pump used HPLC grade water with 0.01% acetonitrile as 
mobile phase A and mobile phase B was acetonitrile. The gradient started at 
5% B and ramped to 45% B until 7 minutes, it increased to 100% B from 7 to 
8 minutes and it was held at 100% B until 12 minutes. 
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Data processing was done with Matlab 6.5 (The MathWorks Inc. Natick, MA, 
U.S.A.) and the PLS toolbox, version 3.0 (Eigenvector Research Inc., 
Manson, Washington). For display, a manual baseline correction was 
performed by using Grams/AI(7.01) (Thermo Galactic, Waltham, MA, U.S.A.). 
 
6.3 Results and Discussion 
 
6.3.1 Spectral Interpretation 
 
In order to classify the samples into genuine artesunate and counterfeit 
tablets, a spectrum of pure artesunate was recorded (fig. 6.1). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.1 Raman spectrum of artesunate analysed with the Renishaw System-1000 
spectrometer (5 acc. x 30 s) and its molecular structure. 
 
The Raman bands in the spectrum could be assigned to the corresponding 
functional groups, including the endoperoxide function, the epoxy rings and 
the carboxylic groups, which are reflected in the Raman bands at 833, 728 
and 1757 cm-1, respectively28. Raman bands assignments for the spectrum of 
artesunate are summarized in table 6.1.  
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Wavelength Assignments 
1757 cm-1 ν(C=O) 
1452 cm-1  δ(CH3), δ(CH2) scissoring 
1438 cm-1 δ(CH2) Cyclo-alkane  
1397 cm-1 ν(CO2) 
1356 cm-1 δ(CH), δ(CH3) symmetric 
1309 cm-1 CH2 in phase twist 
1174 – 1309 cm-1 CH2 twist and rock, CH2 in-phase 
1045 cm-1 Anti-symmetric ν(COCOC) 
977 – 1164 cm-1 ν(CC) 
908 cm-1 Symmetric ν(COC) 
881 cm-1 ν(CC) skeletal stretch 
858 – 881 cm-1 νs(COC) 
833 cm-1 ν(O-O) 
728 cm-1 Ring vibration (epoxy rings) 
526 cm-1 δ(OOCOC) 
422 – 483 cm-1 δ(COC) 
308 – 434 cm-1 Chain expansion n-alkanes 
347 cm-1 δ(COCOC) 
 
Table 6.1 Raman band assignments for artesunate28. 
 
In our first approach, the presence or absence of these Raman bands was 
used to distinguish between genuine and counterfeit artesunate samples. A 
total of fifty samples were analysed under identical conditions                            
(5 accumulations of 30 s).  According to their spectra, the fifty samples could 
be divided into four different groups.  
 
Figure 6.2 shows representative spectra of these four types of samples which 
were labelled group A - D.  
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Figure 6.2 Overview of the four classes of antimalarial samples analysed with the 
Renishaw system-1000 spectrometer: A: Genuine samples; B: Calcite-containing; C: 
Starch-containing; D: Paracetamol-containing. (5 acc. x 30 s). 
 
Group A consists of the genuine artesunate tablets (fig. 6.2, top trace). The 
spectra of these samples are highly similar to the spectrum of the artesunate 
standard. For instance the ν(C=O) stretching vibration at 1757 cm-1, the 
Raman band of the ν(O-O) stretch at 833 cm-1 and the ring vibration at       
728 cm-1 are present in their spectra.  
 
The other Raman bands of artesunate were also present in the spectrum of 
these samples, which coincides with positive results from the artesunate 
colorimetric test and with the detection of the [M+Na]+ (m/z=407)and 
[2M+Na]+ (m/z=791) artesunate ions at a retention time of 18.1 ± 0.4 min by 
LC-MS. Therefore, Group A can be safely considered as genuine tablets 
containing artesunate.  
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Group B (fig. 6.2, second trace) samples showed very simple spectra, with 
only two prominent Raman bands. The Raman bands at 1086 and 712 cm-1 
are consistent with the Raman spectrum of calcite (CaCO3)29 which was 
confirmed by a spectrum taken of pure CaCO3.  
 
Because samples were extracted with acetonitrile before LC-MS analysis, no 
signals that could be attributed to calcium carbonate-related species were 
detected in the mass spectra of Group B samples. 
 
Group C samples show spectra which are easily distinguished from the 
genuine tablets and which are very similar to the spectrum of starch30. For 
instance the glycoside chain expansion vibration at 475 cm-1, the symmetric 
ν(COC) vibration at 940 cm-1 and the ν(COC) vibration at 868 cm-1 of starch 
are present in the spectra of group C samples.  
 
Unmodified starch was as well detected by LC-MS as a series of equally 
spaced peaks at m/z=365, 527, 689, 851, 1013, and 1175 with a 162 Da 
separation consistent with the formula [(C6H10O5)n + Na]+ for n = 1 to 7. 
Interestingly, one  additional Raman band is present in the samples, which is 
not consistent with the spectrum of starch. This is the Raman band at         
675 cm-1 indicating the presence of another compound in the sample, which 
coincides with two intense MS signals at m/z=438 and 493. The identity of this 
compound is yet to be determined. 
 
The fourth group (D), consisted of compounds with spectra different to those 
of the previous groups; group D spectra show strong Raman bands at 857, 
1167, 1235 and 1322 cm-1. These spectra are consistent with the spectrum of 
4-acetaminophenol (paracetamol)31. This was confirmed by a Raman 
spectrum taken of pure 4-acetaminophenol and by the LC-MS results which 
revealed a peak at m/z=152. There are two additional Raman bands present 
in the spectra, at 1086 and 712 cm-1, which are consistent with the Raman 
spectrum of calcite (CaCO3)29.  
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Of the 50 samples analysed, 26 samples contained artesunate, 10 samples 
consisted of starch and an unknown compound, 10 samples consisted of 
calcite and 4 samples consisted of paracetamol mixed with calcite. The results 
of these groups are consistent with the results obtained by the colorimetric 
test for artesunate16 and by (LC-MS)27.  
 
6.3.2 Chemometrical classification of counterfeit drug samples 
 
When designing an automated system, to be used in the field by non-
specialist operators, it is necessary to provide an automated spectral 
interpretation or classification algorithm. In this exploratory chemometrical 
approach, principal components analysis (PCA), followed by unsupervised 
hierarchical cluster analysis (HCA) was performed.  
 
Before analysis, a data matrix was constructed, consisting of 50 rows          
(50 samples) and 1467 columns (1467 data points, between 400 and 
1800 cm-1). To take sample inhomogeneity (since the lateral resolution in the 
current Raman set-up was ca. 5 µm) into account, triplicate spectra for each 
sample were obtained and averaged.  
 
In order to correct for non-specific fluorescence, which causes a sloping 
spectral background, the first derivative of the spectra was used (Savitsky-
Golay algorithm32, 2nd degree polynomial, 13 data points window). Each first 
derivative spectrum was scaled to zero mean and unit variance (SNV). 
Subsequently the PCA algorithm was run on the data matrix, without any 
further preprocessing.  
 
The resulting Scree plot, loading plots (shifted for better visualization) and 
score plots are given in figure 6.3. 
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Figure 6.3 Principal components analysis of the Raman spectra of 50 drug samples. 
Preprocessing performed: Savitsky Golay 1st derivative and SNV. No scaling was 
used. Scree plot is given, along with the loadings plot for the first 4 principal 
components (loadings are shifted for visualisation). Labels in the biplots correspond 
with the groupings as observed after visual inspection (fig. 6.2). Each case is the 
average spectrum of 3 spectra (5 acc. x 30 s) with no baseline correction. 
 
Scores on PC 2 and PC 3 seem to be highly discriminative for the spectra of 
group D, while the score on PC 4 accounts for the differentiation of group C. 
By using the scores of the first 4 principal components as the input for a 
simple K means clustering algorithm, HCA was performed on the data set. 
Clustering was thus based on the Euclidean distances (fig. 6.4). Although the 
Scree plot seems to suggest including more than five principal components, 
there were no improvements in the sample clustering. Therefore, to avoid over 
fitting, the number of principal components included, was limited to four  
(99,57 % variance captured in total). In figure 6.4, four different groups can be 
clearly distinguished from each other. 
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Figure 6.4 Dendrogram as obtained by hierarchical cluster analysis of the first 4 
principal components of 50 drug samples. Labels are according to the groups 
obtained after visual inspection (fig. 6.2). The asterisk (*) refers to a specific case, as 
explained in the text. Each case is the average spectrum of 3 spectra, recorded 
under the same conditions as in figure 6.2 (no baseline correction). 
 
These groups are in agreement with the visual inspection of the Raman 
spectra. In the group of genuine artesunate samples, one spectrum seems to 
be significantly different from the others (marked with an asterisk (*) in the 
dendrogram shown in fig. 6.4). The spectrum of this artesunate sample had 
some prominent Raman bands in the low wavenumbers region (fig. 6.5) which 
distinguished this sample from the other genuine tablets. These bands are 
caused by the presence of rutile33, one of the polymorphs of TiO2, a product 
that is used as a whitener. Despite this interference, this simple classification 
algorithm still classifies this sample in the proper group.  
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Figure 6.5 Raman spectrum of an artesunate sample, analysed with the Renishaw 
System-1000 spectrometer (5 acc. x 30 s), that shows intense Raman bands of rutile 
(TiO2) (case marked with an * in fig. 6.4).  
 
Within the A-branch of the dendrogram, a small group of 4 artesunate 
samples is separated from the rest of the group: these spectra showed 
Raman bands that were slightly broader than the Raman bands of the other 
artesunate samples. This may indicate a lower degree of crystallinity.  
 
It has to be considered that, when the database of reference products and 
possible counterfeits becomes more complex (i.e. more entries as well as an 
increasing number of classes to distinguish), more advanced chemometric 
techniques, such as linear discriminant analysis (LDA) or artificial neural 
networks (ANNs) may be required. Until now the spectral analysis was 
focused towards the qualitative composition of these tablets, but in future 
work, quantitative aspects will also be investigated. 
 
6.4 Conclusion 
 
This research shows that Raman spectroscopy has a great potential for the 
fast detection of counterfeit artesunate tablets, one of the most widely 
counterfeited antimalarial drugs. Spectra of genuine artesunate and three 
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different groups of counterfeits could be differentiated by careful spectroscopic 
interpretation, as well as by an automatic approach (principal components  
and hierarchical clustering algorithms). These results suggest that Raman 
spectroscopy, in combination with chemometry, is not only able to 
discriminate between genuine and counterfeit tablets, but also to produce a 
“chemical fingerprint” of different types of counterfeits, which is helpful in 
determining the relationships between different samples. The combination of 
Raman spectroscopy and multivariate clustering can thus assist in the 
forensic investigation of the sources and trade routes of these drugs. These 
protocols may also be implemented in mobile Raman spectrometers, which 
could potentially allow customs officers, law-enforcement personnel and drug 
regulatory authorities to conveniently and rapidly  analyse suspect tablets in 
the field. 
  
6.5 Notes on this publication 
 
The work presented in this publication has also been used by KA Hall et al. for 
comparing the analysis of these 50 artesunate tablets with Liquid 
Chromatography – Mass Spectrometry (LC-MS)27, which not only focuses on 
qualitative but as well on quantitative analysis. The qualitative results of that 
investigation were compared with results of the Fast Red TR colorimetric 
method and Raman spectroscopy. Additionally, counterfeits were detected by 
focusing on the holograms on the blisterpack14. All methods confirmed our 
results with Raman spectroscopy, and could also detect the counterfeits from 
the genuine artesunate samples.  
 
However, since the counterfeiters are becoming increasingly sophisticated, 
quantitative analysis becomes increasingly important. Group A are considered 
genuine artesunate tablets, but so far, it is not proven that the amount of 
active ingredient is identical to the amount stated on the package. Therefore, 
quantitative analysis has to be performed on the tablets as well. Results of the 
quantitative analysis of antimalarial tablets will be described in Chapter 9. In 
the next chapter, however, we will focus on the analysis of another type of 
drug that is often counterfeited in the western world, namely Viagra. 
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7 Analysis of counterfeit Viagra® tablets  
 
Based on the paper: de Veij M, Deneckere A, Vandenabeele P, de Kaste D, Moens 
L, Detection of counterfeit Viagra® with Raman spectroscopy, Journal of 
Pharmaceutical and Biomedical analysis, 2008; 46: 303-309. 
 
In the previous chapter, it is demonstrated that Raman spectroscopy can be 
used to qualitatively detect counterfeit antimalarial drugs in developing 
countries. This chapter focuses on one of the most counterfeited drugs in 
developed countries, namely is Viagra®. Initially, Pfizer developed Viagra® as  
 
 
 
Fig.7.1 Chinese advert for Viagra® 
a treatment against angina and high blood 
pressure. During the clinical trials, some 
positive side effects were found. Since 
1996, the FDA has approved Viagra as 
the first drug to treat erectile dysfunction. 
Pfizer earns approximately 1 billion US$ 
each year with the production of Viagra1. 
At this moment, it is the most used drug 
against erectile dysfunction worldwide, 
even in China (fig. 7.1), and the most 
counterfeited as well.  
 
Abstract 
 
During the last few years, counterfeiters have become increasingly 
sophisticated by falsifying drugs and making them look identical to genuine 
tablets. In this paper, Raman spectroscopy is proposed as a fast and reliable 
method for the detection of counterfeit Viagra® tablets. This technique can 
easily detect genuine from counterfeit tablets without the need of sample 
preparation. In total 18 tablets were analysed which all contained the active 
ingredient sildenafil, but different excipients were used, as could be observed 
in the Raman spectra between 1150 and 700 cm-1. So, the spectra could be 
divided into genuine or counterfeit.  
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Additionally, principal component analysis (PCA), combined with hierarchical 
cluster analysis (HCA), was used to establish an automated approach for the 
discrimination of counterfeit from genuine Viagra® tablets. Raman 
spectroscopy, combined with principal components analysis, could be used in 
the future by customs or in the field to identify counterfeit tablets on the spot 
without involvement of trained chemists.  
 
7.1 Introduction  
 
Since the introduction of Viagra® for erectile dysfunction by Pfizer in 19981, 
numerous websites have been appearing, where people easily and 
anonymously can purchase Viagra® tablets. Viagra® has been falsified 
numerous times2 and has been put on the National Specified List of 
Susceptible Products by the National Association of Boards of Pharmacy3 in 
the U.S.A. The products on this list are popular among counterfeiters and 
could therefore pose a potential risk for public health.  
 
According to the World Health Organization (WHO) a counterfeit medicine is 
one which is deliberately and fraudulently mislabelled, with respect to its 
identity and/or source4. This includes products with correct ingredients or with 
the wrong ingredients, without active ingredients, with insufficient active 
ingredient or with fake packaging4.  
 
So far, different methods have been used for the analysis of sildenafil in 
Viagra® tablets. These methods include capillary gas chromatography5, 
polymer membrane sensors6, NMR (1H, 13C, 15N)7, UV-VIS8,9, infrared 
spectroscopy9,10, micellar electrokinetic capillary chromatography11, high-
performance liquid chromatography with diode-array detection9,12,13, liquid 
chromatography coupled with mass spectrometry (LC-DAD-MS9,                 
LC-ECI-MS/MS12 and LC-MS/MS14) and thin-layer chromatograpy9,13. The 
disadvantage of many non-spectroscopic methods is their need for sample 
preparation, e.g. by pulverizing the tablet and dissolving it.    
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Until now, in literature only two methods have been used, specifically to detect 
counterfeit Viagra®, namely X-ray powder diffraction analysis15 and near-
infrared spectroscopy (NIRS)9. With X-ray diffraction only six Viagra® tablets 
were investigated and compared with a genuine Viagra® tablet. Based on the 
information it could predict if the active ingredient and/or particular excipients 
were present, so the analysis with X-ray diffraction is only qualitative15. A 
downside of this method is that the coating of the Viagra® tablet had to be 
removed before analysis and the technique requires a trained analyst operator 
as well. For the analysis of the Viagra® with NIRS, a total of 103 samples were 
analysed. The method can be used to check homogeneity of a batch, 
distinguish counterfeits and imitations from authentic Viagra® and screen for 
the presence of sildenafil citrate9. NIRS can therefore give an indication if 
sildenafil citrate is present in the tablet but for definitive confirmation LC-MS 
analysis are necessary9.  
 
Lately, it has become very difficult to distinguish counterfeit from genuine 
drugs, based on their appearance16. So it is necessary to develop a fast and 
easy method, in order to identify these counterfeit drugs in the field.  In this 
paper, we propose a Raman spectroscopic method for the detection of 
counterfeit Viagra® tablets.  
 
Pharmaceutical analysis by Raman spectroscopy is becoming a commonly 
accepted approach as illustrated by the rising number of research papers that 
are published in this field17. Raman spectroscopy has been used for drug 
identification of active ingredients as well as excipients18, polymorphism19, 
imaging of tablets20, quality control21, industrial applications22. This technique 
requires no sample preparation; tablets can even be analysed through their 
coating, while non-destructive character and high speed of analysis make 
Raman spectroscopy well-suited for investigating possible counterfeit 
drugs23,24. Moreover, by using chemometric techniques to compare the 
recorded spectra with those in a reference library, instrument operation and 
spectral interpretation can be automated, in order to give a pragmatic answer.  
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7.2 Experimental 
 
The analyses of the Viagra® tablets were carried out with a Renishaw System-
1000 spectrometer (Wotton-under-Edge, UK) which is connected to an 
Olympus BH-2 microscope. The laser used is a diode laser with a wavelength 
of 785 nm and a power of 50 mW (DL 100, TuiOptics GmbH, 
Martinsried/Munich, Germany). A 5x objective lens (Olympus MDPlan5,      
0.10 NA, Omnilabo, Aartselaar, Belgium) was used to focus the laser light on 
the sample and to collect the scattered light. The collected Raman radiation 
was dispersed with a 1200 lines mm-1 grating (focal length 250 mm) and 
focussed on a Peltier-cooled CCD detector, allowing to obtain a spectral 
resolution of ca. 1 cm-1.  
 
18 tablets were recorded in the spectral window of 700 to 1800 cm-1, with 10 
accumulations of 30 s each. Besides the 18 tablets, an genuine Viagra® tablet 
(provided by a pharmacy, Ghent, Belgium), the active ingredient (provided by 
the National Institute for Public Health and the Environment, RIVM, Bilthoven, 
the Netherlands) and inactive components of a genuine Viagra® tablet were 
analysed as well. These are: microcrystalline cellulose (Sigma-Aldrich, 
Belgium), calcium hydrogenphosphate (Sigma-Aldrich, Belgium), 
croscarmellose (Certa, Belgium), magnesium stearate (Sigma-Aldrich, 
Belgium), hypromellose (Shin Etsu, Japan), lactose (DMV international, the 
Netherlands), triacetin (Sigma-Aldrich, Belgium) and indigo carmine (Fluka, 
Belgium).  
 
Additionally, several reference products were analysed, namely: barium 
sulphate (UCB, Belgium), calcium sulphate (Fluka, Switzerland), calcium 
carbonate (Merck, Belgium), mannitol (Cerestar, Belgium) and sucrose 
(Merck, Belgium).  
 
Three spectra were recorded, averaged and baseline-corrected before 
presentation, to eliminate the influence of broadband fluorescence.   
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18 “Viagra” tablets (fig. 7.2) were purchased in local pharmacies in China 
(tablet 1 & 3 from Shanghai, tablet 2 from Beijing and tablet 4, 5, 6, 17 & 18 
from Suzhou) and Mexico (tablet 7 from Cancun). Other “Viagra” tablets were 
donated by Public Health and Environment in the Netherlands (tablet 8, 9, 10, 
11, 12 & 13), customs at Brussels Airport (tablet 14 & 16) and by the Federal 
Agency for Medicines and Health Products in Belgium (tablet 15).  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7.2 Picture of the 18 tablets used in this research. In some cases, tablets are 
broken, for reason of differentiation of the coating and the bulk of these tablets. 
 
Data processing was performed with Matlab 6.5 (The MathWorks Inc. Natick, 
MA, U.S.A.) and the PLS toolbox, version 3.0 (Eigenvector Research Inc., 
Wenatchee, WA, U.S.A.). The average of the three or five spectra (depending 
on tablet or pure substance) and a manual baseline correction was performed 
by using ACD/Specmanager (version 9.13, Advanced Chemistry 
Development, Inc. Toronto, Canada). 
 
7.3 Results and discussion 
 
7.3.1 Visual inspection of the tablets 
 
The first step in detecting counterfeit drugs is based on the appearance of the 
tablet. Viagra® is known for its distinct blue diamond shape, with on one side 
1 2 3 4 5 6
7 8 9 10 11 12
13 14 15 16 17 18
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the Pfizer-logo and on the other side the abbreviation “VGR” plus the amount 
of sildenafil in mg (25, 50 or 100).  Based on this information the tablets 16, 17 
and 18 can be eliminated as genuine Viagra® tablet, since tablet 16 lacks the 
blue colour,  tablet 17 has different names pressed in the tablet and tablet 18 
has a different shape. Tablet 1 till 15, based on their appearance, look similar 
to genuine Viagra® tablet and for these tablets Raman analysis is necessary.  
 
7.3.2 Visual inspection of the Raman spectra 
 
To be able to differ the 18 tablets based on their Raman spectrum, a Raman 
spectrum of a genuine Viagra® tablet is necessary. Figure 7.3 shows the 
spectrum of pure sildenafil (A), its chemical structure and the spectrum of 
genuine Viagra® (B). The majority of the Raman bands in the genuine Viagra® 
spectrum (fig. 7.3B) can be assigned to the  corresponding functional groups25 
of the active ingredient (fig. 7.3A). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7.3 Raman spectrum of sildenafil and its molecular structure (A) and the 
genuine Viagra® tablet (B) analysed with the Renishaw System-1000 spectrometer 
(10 acc. x 30 s).  
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A Raman band at the far end of the spectrum at 1699 cm-1 can be assigned to 
the stretching vibration of the C=O group, additionally the doublet at          
1580 / 1562 cm-1 is attributed by the C=C bond. Raman bands at              
1528 cm-1 (ν(N-C=N), 1238 and 1272 cm-1 (ν(C=N)) and the Raman band at 
927 cm-1 (ν(C-N)) are attributed to nitrogen containing bonds. The Raman 
bands at 1170 and 1057 cm-1 can be assigned to the symmetric ν(SO2) and 
the asymmetric ν(SO2) vibrations, respectively.  
 
There are some additional Raman bands present in the spectrum of genuine 
Viagra® which can not be attributed to the active ingredient, but can be 
assigned to one of the excipients (769, 847, 873, 1117, 1294 and 1352 cm-1, 
weakly, not always visible in fig. 7.3B).   
 
A Viagra® tablet consists of a white core and a blue coating. The core of the 
tablet consists of sildenafil citrate, microcrystalline cellulose, calcium hydrogen 
phosphate, croscarmellose and magnesium stearate. The coating of the tablet 
consists of hypromellose, lactose, triacetin, titanium dioxide and indigo 
carmine for its distinct blue colour26.  
 
The Raman spectra of these excipients are shown in figure 7.4, the spectrum 
of titanium dioxide is not presented, since this spectrum only consist of three 
very strong Raman bands below 700 cm-1 (394, 514 and 635 cm-1)27. 
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Figure 7.4 Raman spectrum of excipients used in a Viagra® tablet analysed with the 
Renishaw System-1000 spectrometer, A: microcrystalline cellulose (10 acc. x 30 s), 
B: calcium hydrogen phosphate (5 acc. x 30 s), C: croscarmellose (50 acc. x 60 s), 
D: magnesium stearaat (5 acc. x 30 s), E: hypromellose (15 acc. x 60 s), F: lactose 
(5 acc. x 30 s), G: triacetin (5 acc. x 30 s) and H: indigo carmine (40 acc. x 30 s). 
 
Based on these spectra, the additional bands in the spectrum (fig. 7.3B) of the 
genuine Viagra® tablet can be assigned to microcrystalline cellulose (1352 
and 1117 cm-1)28, magnesium stearate (1294 and 769 cm-1) and lactose (873 
and 847 cm-1)28. The spectrum of genuine Viagra® (fig. 7.3B) is compared to 
the Raman spectra of the 18 tablets in figure 7.5. 
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Figure 7.5 Raman spectra of the 18 tablets analysed with the Renishaw System-
1000 spectrometer (10 acc. x 30 s). 
 
The Raman bands at 1699 cm-1 (ν(C=O) stretch vibration), 1580 and        
1562 cm-1 (ν(C=C) doublet), 1528 cm-1 (ν(C=N) stretch)  and at 1238 cm-1 
(ν(C-N) stretch), which are grey highlighted in figure 7.5, were used to check 
for the presence of the active ingredient. It can be concluded that all 18 tablets 
contain the active ingredient.  
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However, when focussing on the Raman bands between 1150 and 700 cm-1, 
differences between these tablets can be noticed:   
 
• Tablet 1 till 8 and tablet 13 show the same spectrum as the genuine 
Viagra®, including the Raman band of microcrystalline cellulose at          
1117 cm-1 (fig. 7.4A). This Raman band is clearly lacking in the tablets    
9 till 12 and 14 till 18, which therefore can be considered as counterfeits. 
These 9 tablets (9 - 12 and 14 - 18)  do not show certain Raman bands 
which are present in the spectrum of genuine Viagra® and/or have 
additional Raman bands of other excipients.  
 
• Five tablets have extra Raman bands which are attributed by different 
excipients not present in genuine Viagra®.  
 
- Tablet 9 has an additional Raman band at 985 cm-1 which can be 
assigned to barium sulphate (fig 7.6A)29 whereas tablet 10 has an 
extra Raman band at 1005 cm-1 attributed by calcium sulphate       
(fig. 7.6B)29.  
 
- Raman bands at 711 and 1084 cm-1 which are specific for calcium 
carbonate (fig. 7.6C)30 can be observed in the spectrum of tablet 15. 
Mannitol (fig. 7.6D)31 is present in tablet 16 according to the three 
Raman bands at 782, 872 and 1034 cm-1.  
 
- Tablet 18 shows three additional Raman bands at 846, 921 and   
1123 cm-1 which can be assigned to sucrose (fig. 7.6E)31. 
 
• The three tablets 11, 12 and 14 lack the Raman band at 1117 cm-1, as 
do all 9 counterfeits, but show no obvious Raman bands of other 
excipients besides the excipients used in genuine Viagra®.  
 
• Finally, besides the Raman bands of sildenafil (fig. 7.3A) no other 
Raman bands can be observed in the Raman spectrum of tablet 17, not 
even Raman bands from the excipients used in the genuine Viagra®. 
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Figure 7.6 Raman spectra excipients found in the analysed “Viagra” tablets with use 
of the Renishaw System-1000 spectrometer, A: barium sulphate (1 acc. x 30 s),         
B: calcium sulphate (20 acc. x 30 s), C: calcium carbonate (1 acc. x 30 s), D: 
mannitol (5 acc. x 120 s) and E: sucrose (20 acc. x 30 s). 
 
In stead of using Raman bands of the active ingredient as distinction between 
genuine and counterfeit Viagra®, the tablets could be divided into these two 
categories based on the excipients used.  
 
7.3.3 Chemometrical analyses 
 
When considering an analytical technique for routine or screening 
investigations, this technique has to fulfil several requirements. These include, 
amongst others, a high speed of analysis, easiness to operate and the 
technique should be quite robust. It is clear that the accuracy of the applied 
method is also critical. Raman spectroscopy seems to meet many of these 
conditions. However, if this technique has to be operated by non-specialist 
users (e.g. at customs), there is need for an automated spectral interpretation. 
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Here a chemometrical approach combined with an elaborated database with 
Raman spectra of genuine pharmaceutical products has to be considered.  
Here, in an exploratory approach, we use a combination of principal 
components analysis (PCA) and hierarchical cluster analysis (HCA). However, 
it is not the aim of this work to select the most appropriate chemometrical 
technique for this discrimination.  
 
The dataset, consisting of the Raman spectra of 19 Viagra tablets is 
arranged in a 19 by 1205 data matrix (1205 data points, between 700 and 
1800 cm-1). In order to avoid contributions from the broad-featured 
fluorescence background, the 2nd derivative of all spectra was taken by using 
the Savitsky-Golay algorithm32. A 13 - point window-function and the use of a 
3rd order polynomial happened to yield the best results. The mean-centered 
dataset was reduced, retaining the first 8 principal components. Subsequently, 
K-means clustering was applied, by using the nearest group clustering 
algorithm and Euclidean distance in the 8-dimensional principal component 
space. The resulting Dendrogram is presented in figure 7.7.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7.7 Dendrogram of the 18 Viagra tablets and genuine Viagra tablet. 
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In this dataset, a clear cluster is observed containing the spectra of               
tablets 1– 8, tablet 13 and the genuine tablet. This group contains Raman 
spectra of the genuine Viagra tablets. The other tablets are on a distinct 
distance from this group, showing that chemometrical methods are able to 
discriminate genuine from counterfeit Viagra tablets. Amongst the counterfeit 
spectra, the dendrogram seems to show some tailing effects which is a 
consequence from the minute differences that are observed between these 
falsifications. Most of these counterfeits are different from each other. Only 
tablets 11, 12 and 14 resemble in the sense that they all lack the cellulose 
additive, which is present in genuine Viagra. Apparently, from the cluster 
diagram tablets 11 and 12 seem to be more closely related than 14. Although, 
large-scale research is needed before final conclusions can be drawn, 
indication of relationships between the counterfeit tablets might contain useful 
information in forensics in order to track down the origin of these products.  
 
7.4 Conclusion 
 
Raman spectroscopy has been proposed as a fast and reliable qualitative 
technique for the detection of counterfeit Viagra tablets. In this work, 18 
tablets were examined. From visual inspection, 3 tablets (16 - 18) could be 
assigned as counterfeit, whereas Raman spectroscopy was able to detect an 
additional 9 counterfeit tablets (9 – 12 and 14 - 15) from our test set. Although 
these tablets contain the active ingredient sildenafil citrate, they can be 
considered as counterfeit, since they contain less or other inactive 
compounds. In the spectra of counterfeit Viagra tablets, Raman bands of 
barium sulphate, calcium sulphate, calcium carbonate, mannitol and sucrose 
could be detected. The other tablets (1 – 8 and 13) show an identical Raman 
spectrum compared to the Raman spectrum of the genuine Viagra. By using 
a combined approach of principal components analysis (PCA) and 
hierarchical cluster analysis (HCA), with Raman spectroscopy it was possible 
to design an automated approach to distinguish between genuine and 
counterfeit tablets. The lather turns out to be useful when considering this 
technique for screening by non-specialist operators, for instance at customs.    
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7.5 Notes on this publication 
 
Counterfeit Viagra has, so far, been analysed with different analytical methods 
such as GC5, NMR7, UV-VIS8,9, HPLC9,12,13 and LC-MS/MS14. Compared to 
these techniques, Raman spectroscopy has the advantage for being a fast 
and easy technique. This project shows that, even if all the tablets have, 
qualitatively speaking, the correct active ingredient as the genuine Viagra®, it 
was possible to distinguish the counterfeits based on the excipients used. This 
shows the importance of establishing a database with reference spectra of 
commonly used excipients (chapter 8). Since the counterfeiters are becoming 
so sophisticated, quantitative analysis is required as well. The possibilities of 
quantitative analysis with Raman spectroscopy is discussed in Chapter 9.  
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8 Database of Raman spectra of commonly used excipients 
 
Based on the paper: de Veij M, Vandenabeele P, De Beer TRM, Remon JP,          
Moens L, Reference database of Raman spectra of pharmaceutical excipients,        
to be submitted.  
 
Another way of distinguishing counterfeit drugs is the analysis of excipients 
used. This requires an extensive database of commonly used excipients. 
Since access to commercially available databases is quite expensive, a 
database focusing on only excipients has been established. Based on the 
research of the most commonly used drugs, a list of excipients has been 
established. The Raman spectra of these excipients are presented and 
discussed in this chapter.  
 
Abstract 
 
Raman spectroscopy has evolved to an important technique in 
pharmaceutical analysis. Usually, the focus in this field concentrates mainly 
on the numerous active ingredients and not on the excipients used. A 
collection of Raman spectra of pharmaceutical excipients is presented in this 
paper, which can serve as a reference for the interpretation of Raman spectra. 
The 43 analysed excipients can be classified in seven categories, namely: 
mono- and disaccharides (dextrose, lactitol, maltitol, lactose and sucrose), 
polysaccharides (microcrystalline cellulose, methylcellulose, carboxy-
methylcellulose, hydroxypropyl cellulose, hydroxypropyl methylcellulose, 
wheat starch, maltodextrin, primojel, tragacanth and pectin), polyalcohols 
(propylene glycol, erythritol, xylitol, mannitol and sorbitol), carboxylic acids 
and salts (alginic acid, glycine, magnesium stearate, sodium acetate, sodium 
benzoate), esters (arachis oil, lubritab, dibutyl sebacate, triacetin, eudragit 
E100 and RL100), inorganic compounds (calcium phosphate, talc, anatase 
and rutile (TiO2), calcium carbonate, magnesium carbonate, sodium 
bicarbonate and calcium sulfate) and some unclassified products (gelatin, 
macrogol 4000 (PEG),  polyvinyl pyrrolidone and sodium laurisulfas).  
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8.1 Introduction 
 
The most widely used spectroscopic techniques in pharmaceutical research 
include nuclear magnetic resonance (NMR) and mass spectrometry (MS)1. 
Lately, Raman spectroscopy is becoming increasingly more accepted as a 
powerful tool in this field, mainly since this approach has some major benefits 
compared to the well established ones1. When using Raman spectroscopy, no 
sample preparation is necessary, the microscope allows us to study very 
small particles (down to 1 µm) and it is even possible to measure through 
blister packages2.  
 
Raman spectroscopy has been used as an important research tool for 
different domains in the pharmaceutical world, quantitative as well as 
qualitative analysis3. In the past, this technique has been used for the 
identification of active ingredients and their different polymorphic crystalline 
forms4,5,6.  
 
Another domain is the production of pharmaceuticals where this technique 
can be used for process monitoring during the manufacturing of 
pharmaceuticals or as a quality control method7, 8. Raman spectroscopy can 
also be used for the identification of counterfeit drugs, as has been shown by 
the identification of counterfeit antimalarial9 and Viagra tablets10.  
 
The majority of the articles in pharmaceutical research focuses on active 
ingredients but hardly pay any attention to the excipients present in these 
drugs. Pharmaceutical dosage forms contain both active ingredient(s) and 
excipients added to aid the formulation and manufacture of the subsequent 
dosage form11.   
 
In general, different types of application of excipients can be distinguished, 
such as diluents, binders, lubricants, disintegrants, colours and sweeteners11. 
Diluents are added to increase the size of the tablet or the amount of powder 
present in a capsule. Binders are added to improve the cohesiveness of 
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powders in order for the powder to form granulates which are necessary to 
form tablets. To reduce the friction between the granulation and the wall 
during compression and ejection of the tablets, lubricants are added. 
Disintegrants are added to facilitate the break-up of tablets after 
administration while colours and sweeteners are added to improve the look 
appearance and the taste of the drug11.  
 
There are many active ingredients on the market, especially compared to the 
number of excipients which have hardly changed over the last years1. 
Databases of pharmaceutical ingredients are commercially available but the 
downside of these databases is that they are generally relatively expensive 
and that they are usually not always available for Raman spectroscopy 
combined with a diode laser.  
 
Additionally, these databases usually only show the Raman spectrum of the 
excipient and do not include any interpretation of the Raman bands and/or 
references for the excipient. In this paper, we study the Raman spectra of the 
most commonly used excipients in pharmaceutical preparations. These 
spectra can serve as a reference to simplify the interpretation of Raman 
spectra of different drug formulations.  
 
8.2 Experimental 
 
Raman analyses were carried out with a Renishaw System-1000 
spectrometer (Wotton-under-Edge, UK)  connected to an Olympus BH-2 
microscope with a 5x objective lens (Olympus MDPlan5, 0.10 NA, Omnilabo, 
Aartselaar, Belgium). The diode laser of 785 nm has a power of 50 mW at the 
source (DL 100, TuiOptics GmbH, Martinsried/Munich, Germany). The 
collected Raman radiation was dispersed with a 1200 lines mm-1 grating (focal 
length 250 mm) and focussed on a Peltier-cooled CCD detector allowing to 
obtain a spectral resolution of ca. 1 cm-1. All spectra were recorded in the 
spectral window of 200 to 1800 cm-1.  
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The analysis time and number of accumulations to obtain a well-resolved 
Raman spectrum vary, depending on the excipient. An average of 3 Raman 
spectra per excipient were used for the database in order to check sample 
homogeneity.  
 
For display, spikes were removed and a manual baseline correction was 
performed by using ACD/Specmanager (version 9.13, Advanced Chemistry 
Development, inc. Toronto, Canada). The Raman bands were assigned with 
the use of ACD/Specmanager and the Raman intensities are described as      
weak (w), medium (m), strong (s) and very strong (vs).   
 
The 43 excipients analysed for this database are listed in table I, including the 
supplier and the function of this excipient in the pharmaceutical process. The 
figure in which the specific excipient is presented is also mentioned. These    
43 excipients were selected based on their presence in articles about 
pharmaceuticals. 
 
8.3 Results and Discussion 
 
Table 8.1 gives an overview of the excipients that were used in this study, 
their suppliers and their main use. However, often one excipient can have 
different uses in drug formulation. For instance, maltodextrin can be added as 
a coating agent but can also be added as a tablet and capsule diluent.  
 
Therefore, in this paper, we preferred to classify the excipients according to 
their chemical composition. The following classification was used: 1) mono- 
and disaccharides, 2) polysaccharides, 3) polyalcohols, 4) carboxylic acids 
and salts, 5) esters, 6) inorganic substances and 7) others.   
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Table 8.1 Suppliers of the 43 excipients and functional categories of each excipient. 
Name Company Functional category1 Fig. 
Dextrose Vel Tablet and capsule diluent, therapeutic agent 1a 
Lactitol Danisco  Sweetening agent, tablet and capsule diluent 1b 
Maltitol Roquette  Coating agent, diluent 1c 
Lactose DMV International  
Binding agent, directly compressible tableting 
excipient 1d 
Sucrose Merck Coating agent, granulating agent 1e 
Microcrystalline cellulose Sigma-Aldrich Absorbent, suspending agent  2a 
Methylcellulose Fluka Coating agent, emulsifying agent 2b 
Carboxymethylcellulose  Sigma-Aldrich Stabilizing agent, suspending agent 2c 
Hydroxypropyl cellulose Klucel Coating agent, emulsifying agent 2d 
Hydroxypropyl methylcellulose  Shin-Etsu Suspending agent, viscosity-increasing agent 2e 
Wheat starch Alpha Pharma Glidant, tablet and capsule diluent 3a 
Maltodextrin Roquette  Coating agent, tablet and capsule diluent 3b 
Primojel Avebe Tablet and capsule disintegrant 3c 
Tragacanth Sigma-Aldrich Suspending agent, viscosity-increasing agent 3d 
Pectin Federa Absorbent, emulsifying agent 3e 
Propylene glycol Merck Antimicrobial preservative, disinfectant 4a 
Erythritol Cerestar  Sweetening agent, tablet and capsule diluent 4b 
Xylitol Roquette  Antimicrobial preservative, coating agent 4c 
Mannitol Cerestar  Diluent, sweetening agent 4d 
Sorbitol Cerestar  Humectant, plasticizer 4e 
Alginic acid Sigma-Aldrich Stabilizing agent, suspending agent 5a 
Glycine Acros bulking agent in freeze-dried formulations2 5b 
Magnesium stearate Sigma-Aldrich Tablet and capsule lubricant 5c 
Sodium acetate Federa Antimicrobial preservative, buffering agent 5d 
Sodium benzoate Sigma-Aldrich Antimicrobial preservative, tablet and capsule lubricant 5e 
Arachis oil Delhaize Oleaginous vehicle, solvent 6a 
Lubritab Mendell Tablet and capsule lubricant, tablet binder 6b 
Dibutyl sebacate BASF Plasticizer 6c 
Triacetin Sigma-Aldrich Humectant, plasticizer 6d 
Eudragit E 100 Rohm Pharma Film former, tablet binder  6e 
Eudragit RL 100 Rohm Pharma Film former, tablet binder 6f 
Calcium phosphate Sigma-Aldrich Tablet and capsule diluent 7a 
Talc Pleuger Anticaking agent, glidant 7b 
Anatase (TiO2) Sennlier Paris Coating agent, pigment 7c 
Rutile (TiO2) UCB Coating agent, pigment 7d 
Calcium carbonate Merck Buffering agent, coating agent 8a 
Magnesium carbonate Riedel-de-Haen Absorbent, antacid 8b 
Sodium bicarbonate RPL Alkalising agent, therapeutic agent 8c 
Calcium sulfate Fluka Tablet and capsule diluent 8d 
Gelatin Merck Coating agent, film-former 9a 
Macrogol 4000  Fagron Ointment base, plasticizer 9b 
Polyvinyl pyrrolidone Sigma-Aldrich Disintegrants, dissolution aid 9c 
Sodium lauryl sulfate Alpha Pharma Anionic surfactant, detergent 9d 
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8.3.1 Mono- and disaccharides 
 
The first group of excipients consists of mono- and disaccharides (structures 
are given in the appendix), namely: dextrose, lactitol, maltitol, lactose, and 
sucrose. Dextrose is commonly used as a sweetening agent, but is also used 
as a direct-compression tablet diluent and binder, primarily in chewable 
tablets11. Another sweetener used in pharmaceutical preparations is lactitol,  
4-Ο-β-D-galactopyranosyl-D-glucitol, which can also be used as a diluent in 
solid dosage forms11,12. Maltitol is a disaccharide consisting of a glucose unit 
linked with a sorbitol unit11 while lactose consists of galactose and glucose. 
Lactose is a natural disaccharide which exists as two anomeric forms, α and 
β, which are normally handled as the monohydrate and the anhydrous 
material, respectively. In the pharmaceutical industry, lactose is widely used 
as a filler or diluent in capsules and tablets13. Maltitol is made from maltose 
and it is almost as sweet as sucrose and can therefore be used as its 
replacement. Sucrose is obtained from sugar cane, sugar beet or other 
sources and is widely used in oral pharmaceutical formulations.  
 
The spectra of the three monomers (dextrose, lactitol and maltitol)  and the 
two dimers (lactose and sucrose) are highly similar as can be seen in      
figure 8.1. The Raman spectra can be distinguished14,15,16 from each other, 
based on the δ(CC) and δ(CO) bending vibrations in the region, between 800 
and 900 cm-1. Differences between the spectra can also be seen in the 
regions between 730 and 960 cm-1 and between 1200 and 1460 cm-1 which 
contain δ(CH) deformations and in the region between 1430 and 1480 cm-1 
(plus Raman bands around 830 cm-1) which contain δ(CH2) deformations13,15.  
Since these monomers and dimers lack any C=O or C=C bonds in their 
structure (see paragraph 8.5), there are no Raman bands present above           
1500 cm-1. When comparing the Raman spectra of the monomers (dextrose 
(fig. 8.1A), lactitol (fig. 8.1B) and maltitol (fig. 8.1C)) with dimers (lactose      
(fig. 8.1D) and sucrose (fig. 8.1E)), it can be noted that Raman bands of the 
dimers are much broader than those of the monomers11. 
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Figure 8.1 Raman spectra of mono- and disaccharides with the Renishaw System-
1000 spectrometer, A: dextrose (3 acc. x 30 s), B: lactitol (5 acc. x 120 s), C: maltitol        
(5 acc. x 60 s), D: lactose (5 acc. x 120 s) and E: sucrose (20 acc. x 30 s).  
 
8.3.2 Polysaccharides 
 
Raman spectra of 10 polysaccharides are presented in figures 8.2 and 8.3. 
Polysaccharides are mainly used in tablet formulations as a binder 
(microcrystalline cellulose, methylcellulose (MC), carboxymethylcellulose 
(CMC), hydroxypropyl cellulose (HPC), hydroxypropyl methylcellulose 
(HPMC), starch and maltodextrin), diluent (microcrystalline cellulose, 
carboxymethylcellulose (CMC), starch and maltodextrin) and disintegrant 
(carboxymethylcellulose (CMC), starch and primojel) in both direct-
compression and wet-granulation11. The function of two polysaccharides 
(tragacanth and pectin) is different from the rest of  this group. Pectin is not 
only used as a binding agent, but predominately as part of controlled-release 
matrix tablet formulations17. Finally, tragacanth gum is used as an emulsifying 
and suspending agent in a variety of pharmaceutical formulations, such as 
creams, gels and emulsions11.  
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Figure 8.2 represents the Raman spectra of excipients that consist of 
cellulose while figure 8.3 contains spectra of the other polysaccharides.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 8.2 Raman spectra of polysaccharides with the Renishaw System-1000 
spectrometer, A: microcrystalline cellulose (10 acc. x 30 s), B: methylcellulose (15 
acc. x 60 s), C: carboxymethylcellulose (15 acc. x 60 s), D: hydroxypropyl cellulose 
(15 acc. x 60 s), E: hydroxypropyl methylcellulose (15 acc. x 60 s).  
 
The general appearance of the Raman spectra of the polysaccharides is quite 
similar in the region between 850 and 1500 cm-1, where ν(C-O) and ν(C-C) 
stretching vibrations and δ(CH2) deformations20,21,22,23,24 can be observed. 
However, in the Raman spectra of microcrystalline cellulose (fig. 8.2A) an 
additional Raman band at 1093 cm-1 is present, which is  characteristic of 
unsubstituted cellulose rings20. In the region between 300 and 700 cm-1, there 
are clear differences between the Raman spectra of the polysaccharides and 
based on these Raman bands, the spectra can be distinguished from each 
other. For instance, microcrystalline cellulose (fig. 8.2A) has additional bands 
between 380 and 460 cm-1 which can be assigned to δ(CCC), δ(CO), δ(CCO) 
bending vibrations and ring deformations18.  
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Figure 8.3 Raman spectra of polysaccharides with the Renishaw System-1000 
spectrometer, A: wheat starch (15 acc. x 60 s), B: maltodextrin (20 acc. x 60 s),         
C: primojel (20 acc. x 30 s), D: tragacanth (30 acc. x 30 s), E: pectin (15 acc. x 60 s). 
 
The strong Raman band around 477 cm-1, which can be assigned to the 
ν(CC) backbone stretch19, is characteristic for substances that contain 
starches (fig. 8.3A, 8.3B and 8.3C). For starch only the Raman spectrum of 
wheat starch (fig. 8.3a) is presented since this spectrum was similar to that of 
pure amylose and different starches (rice, corn and potato). Maltodextrin     
(fig. 8.2B) has two additional bands at 452 and 487 cm-1 which probably arise 
from the δ(C-C=O) deformations14.  
 
The Raman spectra of HPC (fig. 8.2D) and HPMC (fig. 8.2E) are highly 
similar, although there are some differences between the two spectra: mainly 
the relative intensities of Raman bands are different. For instance, when 
comparing the intensity of δ(CH2) deformations at ca. 1360 cm-1 relative to the 
band at ca. 1450 cm-1 it shows a increase when HPC is compared to HPMC20, 
which is consistent with the higher number of –CH3 groups in HPMC. 
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Tragacanth is a gum which has different characteristics in the Raman 
spectrum (fig. 8.3D) compared to the other polysaccharides. The bands below 
400 cm-1 can be assigned to the skeletal breathing modes, bands near       
500 cm-1 are due to the ring deformations, while the strong features between 
800 and 1100 cm-1 and at ca. 1400 cm-1 are characteristic for sugars25.  
 
8.3.3 Polyalcohols 
 
The spectra of five polyalcohols are shown in figure 8.4. These polyols are 
commonly added to foods because of their sweet taste and lower caloric 
content compared to sugar. Erythritol, xylitol, sorbitol and mannitol are mainly 
used as diluents in for instance, chewable tablets11. Propylene glycol is widely 
used as solvent and preservative in pharmaceutical formulations. It is also 
commonly used as plasticizer in aqueous film-coating formulations11.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 8.4 Raman spectra of polyalcohols with the Renishaw System-1000 
spectrometer, A: propylene glycol (5 acc. x 30 s), B: erythritol (5 acc. x 120 s),           
C: xylitol (5 acc. x 60 s), D: mannitol (5 acc. x 120 s), E: sorbitol (5 acc. x 60 s). 
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There is little information available on the Raman spectra of polyalcohols,  
except for the quantitative analysis of mannitol polymorphs by Roberts et al26 
and the mapping of amorphous sorbitol by Ward et al27.   
 
Characteristic for these polyols are the strong Raman band between 430 and 
500 cm-1, bands between 800 and 900 cm-1 and a group of Raman bands in 
the region between 1000 and 1150 cm-1, which are due to the δ(CCO) 
bending vibration, the in-phase ν(CCO) stretching vibration and the out-of-
phase ν(CCO) stretching vibration, respectively25,28. The Raman band position 
of the ν(CCO) stretching vibration increases with increasing chain length and 
number of OH groups (paragraph 8.5):  the band at 838 cm-1 in the spectrum 
of propylene glycol, shifts to 851 cm-1 for xylitol, 872 cm-1 for mannitol and   
878 cm-1 for sorbitol.  
 
Since mannitol is isomeric with sorbitol, their Raman spectra appear to be 
similar, except for small differences in Raman bandwidth or shifts of Raman 
bands. For instance, the δ(CCO) bending vibration for sorbitol consists of a 
single bond (454 cm-1) and a doublet (478 and 499 cm-1) while this vibration 
consists of a triplet for mannitol (473, 490 and 515 cm-1). Another difference 
between mannitol and sorbitol is the out-of-phase ν(CCO) stretching vibration 
which shifts from 1034 cm-1 (mannitol) to 1054 cm-1 (sorbitol).  
 
8.3.4 Carboxylic acids and salts 
 
Figure 8.5 shows the Raman spectra of alginic acid, glycine, magnesium 
stearate, sodium acetate and sodium benzoate. In tablet and capsule 
formulations, alginic acid is used, both as binder and as a disintegrant agent 
but is also used as thickening agent in a variety of pastes, creams and gels11. 
There are three polymorphic forms of anhydrous glycine, namely α-, β- and   
γ-glycine. When cooling aqueous glycine solutions, it results in the 
crystallization of β-glycine. Glycine is commonly used as bulking agent in 
freeze-dried formulations29. Magnesium stearate is a very fine, white powder 
which is primarily used as a lubricant in capsule and tablet manufacturing.  
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The last two substances of this group are sodium acetate and sodium 
benzoate, which are both used as antimicrobial preservative.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 8.5 Raman spectra of carboxylic acids and salts with the Renishaw System-
1000 spectrometer, A: alginic acid (15 acc. x 60 s), B: glycine (15 acc. x 30 s),           
C: magnesium stearate (5 acc. x 50 s), D: sodium acetate (5 acc. x 30 s),                   
E: sodium benzoate (10 acc. x 30 s). 
 
The first Raman spectrum is of alginic acid (fig. 8.5A) which shows three 
Raman bands between 810 and 960 cm-1, which can be assigned to a 
combination of ν(CO) ring breathing, ν(CC) stretch and ν(COC) ring 
vibrations. Furthermore, the δ(CH) deformations cause multiple broad bands 
in the region between 1300 and 1450 cm-1.  
 
The spectra of glycine, magnesium stearate, sodium acetate en sodium 
benzoate have several strong Raman bands, including ν(CC) stretching 
vibrations. These give rise to strong Raman band(s) at 890 cm-1 for glycine30, 
two Raman bands at 1060 and 1128 cm-1 for magnesium stearate31, at       
928 cm-1 for sodium acetate32 and finally at 1434 cm-1 for sodium benzoate33.  
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For glycine, magnesium stearate and sodium acetate the δ(CH2) and 
respectively δ(CH3), are found between 1400 and 1460 cm-1 30,31,32. The 
spectrum of sodium benzoate shows an additional strong Raman band at 
1003 cm-1 which can be assigned to ring breathing of the benzene ring.  
 
8.3.5 Esters 
 
In total, 6 excipients were used for the database with an ester structure. The 
first excipient is peanut oil (arachis oil), which is mainly used as a solvent for 
intramuscular injections11. The second oil in this group is lubritab which is a 
hydrogenated vegetable oil consisting of a mixture of triglycerides of fatty 
acids and is used as a lubricant in tablet and capsule formulations11. The four 
other excipients (dibutyl sebacate, triacetin, Eudragit  E100 and RL 100) are 
used in pharmaceutical preparations as film coating agents of capsules, 
tablets, beads or granules. The applications of these coating agents are 
different from each other, for instance Eudragit E100 is used as a film former 
and is soluble in gastric fluid while RL 100 is used to form water-insoluble film 
coatings for sustained-release products11.  
 
The spectra of these six esters are shown in figure 8.6. In the lower region at 
ca. 600 cm-1 the Raman spectra of triacetin and Eudragit (E100 and RL100) 
show an intense Raman band. This band in the spectrum of triacetin can be 
assigned to δ(CO) deformation14,28  while this band in the spectra of Eudragit 
is due to the ν(CN) stretching vibration14,28.  
 
The spectra all show Raman bands assigned to the ν(CC) stretching vibration 
between 800 and 900 cm-1. Triacetin also has an additional band at 890 cm-1 
due to the ν(COC) symmetric stretch14,28. The ν(C-CO-C) vibration can be 
seen in the spectrum of dibutyl sebacate in between 800 and 900 cm-1 and 
between 1000 and 1150 cm-1: symmetric and asymmetric stretching 
vibrations, respectively14,28. 
 
  
120 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 8.6 Raman spectra of esters with the Renishaw System-1000 spectrometer,   
A: arachis oil (20 acc. x 60 s), B: lubritab (15 acc. x 60 s), C: dibutyl sebacate           
(20 acc. x 30 s), D: triacetin (5 acc. x 30 s), E: eudragit E100 (20 acc. x 30 s) and             
F: eudragit RL100 (20 acc. x 30 s). 
 
Since Eudragit E100 and Eudragit RL100 have a predominatly similar 
chemical structure, the spectra will differ only slightly. Comparing the intensity 
of the ν(CN) stretching vibration at ca. 600 cm-1 to the ν(CC) stretching 
vibration at ca. 810 cm-1, it shows that for Eudragit E100 the relative 
intensities are very similar, while Eudragit RL 100 shows a large difference 
between the intensity of these two Raman bands14,28. In the Raman spectra of 
all 6 excipients, δ(CH2) and δ(CH3) deformations are observed in the region 
between 1400 and 1500 cm-1 14,34,35. Some differences can be noted between 
the spectra of these excipients in the region between 1600 and 1800 cm-1. 
Arachis oil (fig. 8.6A), for instance, has a distinct intense Raman band at         
1653 cm-1, which can be assigned to the ν(C=C) stretching vibration due to 
the oleic acid present in the oil28. Arachis oil, triacetin and eudragit E100 and 
RL100 also contains a Raman band at ca. 1730 cm-1 that can be assigned to 
the ν(C=O) stretching vibration which is typical for esters14,24. 
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8.3.6 Inorganic substances  
 
In figures 8.7 and 8.8 the Raman spectra of 8 inorganic substances are 
shown. Half of these organic substances (calcium phosphate, calcium- and 
magnesium carbonate and calcium sulfate) are used as diluents in 
pharmaceutical preparations, mainly in solid-dosage forms11. Sodium 
bicarbonate is widely used to produce or maintain an alkaline pH in a 
preparation11. Talc was once widely used in oral solid dosage formulations as 
a lubricant and diluent; however, today it is less commonly used11. Titanium 
dioxide can occur in three distinct polymorphs: rutile, anatase and brookite36 
but only rutile and anatase are used in pharmaceutical formulations as a 
whitener. Rutile is used more frequently than anatase since most production 
techniques yield TiO2 in the rutile phase11,36.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 8.7 Raman spectra of inorganic substances with the Renishaw System-1000 
spectrometer, A: calcium phosphate (5 acc. x 30 s), B: talc (50 acc. x 60 s), C: 
anatase (TiO2, 1 acc. x 30 s) and D: rutile (TiO2, 1 acc. x 30 s). 
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The Raman spectra of these inorganic substances (fig. 8.7 and 8.8) show a 
few strong Raman bands, which are due to the fact that these substances 
only have a few vibration modes. The first spectrum shown is the Raman 
spectrum of calcium phosphate (Ca3(PO4)2) and has several intense Raman 
bands. The two Raman bands around ca. 400 cm-1 can be assigned to δ(PO) 
deformations while the two bands at 896 and 983 cm-1 are due to the ν(PO) 
stretching vibration37. The second spectrum of talc (3 MgO · 4 SiO2 · H2O) in 
figure 8.7 has two distinguished Raman bands at 361 cm-1 and 675 cm-1 
which can be assigned to the asymmetric and symmetric ν(SiO4) stretching 
vibrations, respectively38. The last two spectra in figure 8.7 are from two 
different forms of TiO2 namely anatase (fig. 8.7C) and rutile (fig. 8.7D). Both 
excipients are used as a whitener in coatings of pharmaceuticals but can 
easily be distinguished by their Raman spectra, as has been described by 
Rigby et al39. The Raman bands are caused by the δ(TiO2) bending vibration 
(636 cm-1 for anatase and 446 cm-1 for rutile) and the symmetric ν(TiO2) 
stretching vibration (513 cm-1 for anatase and 609 cm-1 for rutile)39.  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 8.8 Raman spectra of inorganic substances with the Renishaw System-1000 
spectrometer, A: calcium carbonate (1 acc. x 30 s), B: magnesium carbonate (3 acc. 
x 30 s), C: sodium bicarbonate (10 acc. x 30 s) and D: calcium sulfate (20 acc. x 30 s). 
1800 1700 1600 1500 1400 1300 1200 1100 1000 900 800 700 600 500 400 300 200
Wavenumber (cm-1)
R
am
an
 
in
te
ns
ity
 
(ar
bi
tra
ry
 
u
ni
ts
)
A
B
C
D
R
am
an
 
in
te
ns
ity
 
(ar
bi
tra
ry
 
u
ni
ts
)
R
am
an
 
in
te
ns
ity
 
(ar
bi
tra
ry
 
u
ni
ts
)
8. Database of excipients 
123 
The inorganic substances, calcium carbonate (CaCO3), magnesium carbonate 
(MgCO3), sodium bicarbonate (NaHCO3) and calcium sulfate (CaSO4), all 
have one or two intense Raman band(s). The first three spectra contain 
carbonate or a bicarbonate group. The Raman band between 600 and       
700 cm-1 can be assigned to the ν4 symmetric stretch while the intense 
Raman band between 1000 and 1100 cm-1 can be assigned to the ν1 
symmetric stretch28,40,41. 
 
8.3.7 Others 
 
Figure 8.9 presents 4 excipients, which are also commonly used in 
pharmaceutical formulations. Gelatine is widely used in a variety of 
pharmaceutical formulations, although it is most frequently used to form either 
hard or soft gelatine capsules. These capsules are unit-dosage forms that are 
filled with an active drug and are generally designed for oral administration11.  
 
Macrogol is a polyethylene glycol (PEG) which is an polymer of ethylene oxide 
and water and exists with different molecular weights (200 till 6000 g/mol), for 
this database macrogol with a molecular mass of 4000 was used. These 
PEGs can be used as ointment base, suppository base, suspending agent or 
act as an emulsion stabilizer11.  
 
Another excipient that can be used in a variety of pharmaceutical formulations 
is povidone (polyvinylpyrrolidone, PVP), namely as binder, solubilizer, coating 
agent, suspending agent, stabilizing agent or as a viscosity-increasing 
agent11.  
 
Sodium lauryl sulfate (also known as dodecyl sodium sulfate) is an anionic 
surfactant which is applied in a wide range of pharmaceutical formulations. 
The spectra of these four substances are presented in figure 8.9.  
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Figure 8.9 Raman spectra of other substances with the Renishaw System-1000 
spectrometer, A: gelatin (40 acc. x 30 s), B: macrogel 4000 (10 acc. x 30 s),              
C: polyvinyl pyrrolidone (20 acc. x 30 s) and D: sodium laurisulfas (10 acc. x 30 s). 
 
In the spectrum of gelatine (fig. 8.9A) the Raman bands between 800 and         
950 cm-1 can be assigned to the ν(COC) stretching vibrations while the 
Raman bands between 1000 and 1100 cm-1 can be assigned to the δ(CH2) 
deformations, ν(CC) and ν(CO) stretching vibrations. Two Raman bands at 
1246 cm-1 and 1663 cm-1 can also be assigned to the amide III and the    
amide I bond, respectively24,42.  
 
Macrogol 4000 (fig. 8.9B) is a polyethylene glycol and this spectrum shows 
multiple strong Raman bands at 858 cm-1, between 1050 and 1130 cm-1 and 
at 1444 cm-1, which can be assigned to the symmetric ν(COC) stretch, the 
ν(CC) stretch and to δ(CH) deformations, respectively34. This product is a 
polymer and the Raman bands are rather broad28. The distinct Raman band in 
the spectrum of polyvinyl pyrrolidone (fig. 8.9C) at ca. 1660 cm-1 is 
characteristic for the ν(C=O) stretching vibrations, while the bands in the area 
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between 1400 and 1500 cm-1 can be assigned to ν(CC) stretching vibrations 
and ν(CN) in-plane vibrations. The ring vibration causes a very strong Raman 
band at 932 cm-1 with next to it two bands (850 and 892 cm-1) due to the 
ν(CNC) stretching modes14. The last excipient of this database is sodium 
lauryl sulfate which has intense Raman bands related to the ν(CC) stretching 
vibration in the region between 1000 and 1150 cm-1, a band at 1294 cm-1 
related ν(SO4) stretch and at 1433 cm-1 δ(CH2) deformations28.  
 
8.4 Table with Raman bands of the 43 excipients 
 
Name Raman bands (cm-1) Acc. & 
Time1 
Fig. 
Dextrose 
232(w), 288(w), 363(w), 396(m), 404(s), 422(w), 439(w), 
539(vs), 653(w), 770(w), 841(m), 913(w), 1020(w), 
1053(w), 1073(m), 1106(w), 1119(w), 1147(w), 1272(w), 
1331(w), 1343(w), 1458(w) 
3 x 30s 1a 
Lactitol 
249(m), 299(w), 327(w), 356(vs), 405(w), 426(w), 
475(vs), 544(w), 614(w), 857(w), 878(m), 895(m), 
929(m), 945(w), 1010(m), 1025(m), 1045(w), 1062(m), 
1087(m), 1121(m), 1145(w), 1236(w), 1271(w) 
5 x 120s 1b 
Maltitol 
239(w), 302(m), 318(w), 373(s), 397(w), 414(s), 431(vs), 
474(w), 507(vs), 541(m), 574(s), 635(w), 709(w), 743(w), 
784(w), 844(m), 872(s), 900(s), 910(vs), 929(m), 969(w), 
986(s), 1017(m), 1039(s), 1071(s), 1097(m), 1123(s), 
1147(m), 1206(w), 1251(w), 1298(w), 1332(m), 1340(m), 
1365(m), 1399(w), 1433(w), 1458(m) 
5 x 60s 1c 
Lactose 
256(w), 353(vs), 374(s), 395(m), 474(m), 551(w), 
629(w), 847(m), 873(m), 912(w), 950(w), 1015(w), 
1037(w), 1049(w), 1083(m), 1117(w), 1139(w), 1258(w), 
1323(w), 1344(w), 1377(w) 
5 x 120s 1d 
Sucrose 
283(w), 314(w), 363(m), 400(vs), 441(m), 473(w), 
495(w), 523(m), 553(m), 582(w), 639(m), 847(s), 867(w), 
908(w), 920(w), 940(w), 1011(w), 1035(w), 1102(w), 
1122(w), 1160(w), 1237(w), 1259(w), 1460(w) 
20 x 30s 1e 
Microcrystalline cellulose 
343(w), 378(s), 435(m), 457(m), 517(m), 894(w), 
1093(vs), 1120(s), 1152(m), 1335(m), 1378(m), 1473(w) 10 x 30s 2a 
Methylcellulose 
890(m), 943(s), 1024(m), 1118(vs), 1149(s), 1265(w), 
1363(s), 1450(s) 15 x 60s 2b 
Carboxymethylcellulose 
719(m), 804(w), 911(s), 1098(vs), 1265(m), 1325(s), 
1372(s), 1408(s) 15 x 60s 2c 
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Hydroxypropyl cellulose  
848(vs), 923(m), 1086(s), 1124(s), 1249(m), 1361(s), 
1454(vs) 15 x 60s 2d 
Hydroxypropyl 
methylcellulose  
495(w), 637(w), 709(w), 829(m), 907(m), 944(m), 
1008(m), 1119(s), 1152(m), 1208(w), 1263(w), 1366(vs), 
1452(s), 1739(w) 
15 x 60s 2e 
Wheat starch 
302(w), 359(w), 409(w), 439(w), 477(vs), 576(w), 
867(w), 940(m), 1050(w), 1081(m), 1126(m), 1261(w), 
1338(w), 1379(w), 1458(w) 
15 x 60s 3a 
Maltodextrin 
319(w), 355(w), 402(w), 438(m), 477(vs), 575(w), 
849(m), 938(m), 1040(m), 1079(m), 1119(m), 1259(w), 
1333(m), 1381(m), 1456(w) 
20 x 60s 3b 
Primojel 
229(w), 303(w), 355(w), 439(w), 476(vs), 574(w), 
864(m), 940(m), 1053(m), 1077(m), 1122(m), 1260(w), 
1339(m), 1378(m), 1456(w) 
20 x 30s 3c 
Tragacanth 
260(w), 336(w), 368(m), 419(vs), 510(s), 561(m), 
589(w), 770(w), 854(m), 913(m), 923(m), 1020(w), 
1055(w), 1071(m), 1096(w), 1124(m), 1157(w), 1226(w), 
1249(w), 1327(m), 1358(w), 1384(w), 1423(w), 1452(w) 
30 x 30s 3d 
Pectin 
452(m), 487(w), 550(w), 719(w), 836(m), 876(m), 
972(w), 1073(s), 1261(m), 1355(vs), 1454(m) 15 x 60s 3e 
Propylene glycol 
383(w), 522(m), 802(m), 838(vs), 921(w), 1045(w), 
1079(w), 1457(w) 5 x 30s 4a 
Erythritol 
246(w), 265(w), 384(w), 487(m), 698(vs), 862(m), 
874(s), 918(s), 1029(w), 1040(w), 1107(m), 1125(m), 
1236(w), 1414(w), 1468(w) 
5 x 120s 4b 
Xylitol 
238(w), 318(w), 353(vs), 424(m), 459(w), 851(s), 
882(m), 913(w), 1000(w), 1056(m), 1069(m), 1089(m), 
1105(m), 1276(w), 1313(w), 1330(w), 1459(m) 
5 x 60s 4c 
Mannitol 
240(w), 284(w), 365(w), 473(m), 490(w), 515(w), 644(w), 
784(w), 872(vs), 1034(m), 1114(w), 1130(w), 1228(w), 
1360(w), 1456(w) 
5 x 120 s 4d 
Sorbitol 
246(w), 263(w), 342(w), 415(w), 478(w), 499(w), 642(w), 
773(w), 876(vs), 936(w), 1054(m), 1091(w), 1129(w), 
1250(w), 1325(w), 1369(w), 1446(w) 
5 x 60s 4e 
Alginic acid 813(s), 890(m), 956(m), 1093(m), 1346(vs), 1409(vs) 15 x 60s 5a 
Glycine 
357(w), 500(w), 599(w), 695(w), 890(vs), 1032(w), 
1322(m), 1406(w), 1436(w) 15 x 30s 5b 
Magnesium stearate 
888(w), 945(w), 1061(s), 1102(w), 1128(s), 1294(vs), 
1437(s), 1458(m) 5 x 50s 5c 
Sodium acetate 656(w), 928(vs), 1414(w) 5 x 30s 5d 
Sodium benzoate 
 
612(w), 676(w), 843(m), 1003(vs), 1028(w), 1156(w), 
1180(w), 1434(w), 1601(w) 
 
10 x 30s 
 
 
5e 
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Arachis oil 
401(w), 477(w), 722(w), 844(m), 867(m), 908(w), 
968(w), 1061(m), 1079(m), 1117(w), 1261(m), 1298(m), 
1436(vs), 1653(vs), 1743(w) 
20 x 60s 6a 
Lubritab 
888(w), 1059(s), 1102(w), 1126(s), 1172(w), 1294(vs), 
1415(w), 1438(m), 1461(m) 15 x 60s 6b 
Dibutyl sebacate 
275(w), 527(w), 804(vs), 837(vs), 883(s), 1057(m), 
1130(s), 1239(m), 1280(vs), 1387(m), 1468(vs) 20 x 30s 6c 
Triacetin 
230(m), 425(w), 628(vs), 832(m), 858(m), 890(s), 
991(w), 1013(w), 1053(w), 1098(w), 1312(w), 1366(w), 
1437(w), 1736(m) 
5 x 30s 6d 
Eudragit E 100 
234(w), 361(w), 482(w), 555(w), 601(vs), 778(w), 817(s), 
878(w), 963(m), 1121(w), 1153(w), 1231(w), 1444(m), 
1723(w) 
20 x 30s 6e 
Eudragit RL 100 
362(m), 483(w), 552(w), 598(m), 715(m), 809(vs), 
852(m), 962(w), 985(w), 1112(w), 1450(w), 1726(w) 20 x 30s 6f 
Calcium phosphate 
390(m), 416(s), 557(m), 571(m), 587(m), 896(m), 
983(vs), 1090(w), 1128(w) 5 x 30s 7a 
Talc 
361(s), 466(w), 550(m), 675(vs), 1050(w), 1229(m), 
1260(m), 1385(w), 1412(w) 50 x 60s 7b 
Anatase (TiO2) 395(m), 513(m), 636(vs) 1 x 30s 7c 
Rutile (TiO2) 234(w), 446(vs), 609(s) 1 x 30s 7d 
Calcium carbonate 281(m), 711(w), 1084(vs) 1 x 30s 8a 
Magnesium carbonate 1117(vs) 3 x 30s 8b 
Sodium bicarbonate 224(w), 683(w), 1043(vs), 1264(w) 10 x 30s 8c 
Calcium sulfate 1133 (w), 1005(vs) 20 x 30s 8d 
Gelatin 
318(vs), 809(w), 854(m), 915(m), 998(m), 1029(w), 
1098(w), 1246(m), 1338(s), 1384(s), 1448(s), 1663(m) 40 x 30s 9a 
Macrogol 4000  
277(m), 360(m), 533(w), 579(w), 842(vs), 858(m), 
1060(m), 1123(w), 1138(m), 1228(m), 1277(s), 1393(w), 
1444(w), 1476(m) 
10 x 30s 9b 
Polyvinyl pyrrolidone 
362(w), 553(m), 606(w), 645(w), 753(s), 850(m), 892(m), 
932(vs), 999(w), 1022(w), 1073(w), 1109(w), 1225(m), 
1272(w), 1307(w), 1340(w), 1369(m), 1423(s), 1454(m), 
1490(w), 1662(w) 
20 x 30s 9c 
Sodium lauryl sulfate 
404(w), 418(w), 595(w), 633(w), 833(m), 867(w), 
887(m), 1060(s), 1082(vs), 1126(s), 1294(s), 1368(w), 
1433(s), 1449(m) 
10 x 30s 9d 
 
Table 8.2, Raman bands and intensities for each reference product (very weak bands 
are not listed). Abbreviations: w, weak; m, medium; s, strong; mw, medium weak; vs, 
very strong.  
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8.5 Chemical structures of the 43 excipients 
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carboxylic acids and salts 
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inorganic substances 
 
 
 
 
others 
 
 
 
 
 
 
 
 
 
 
8.6 Conclusion 
 
In the field of pharmaceutical analysis, the focus is on the active ingredient 
and hardly any attention is paid to the excipients present. In this work, the 
Raman spectra of 43 commonly used excipients in pharmaceutical 
formulations are presented and Raman bands are identified (table 8.2). Since 
the excipients usually have several purposes in the pharmaceutical process, 
the excipients were divided based on their chemical structure into seven 
different groups. The recorded spectra of these excipients show clear 
differences and specific Raman bands and could be of help when a excipient 
needs to be identified. This database will also be of great help for the 
identification of excipients present in genuine and counterfeit drugs or for 
instance illicit drugs based on their Raman spectrum.   
talc: 3 MgO ⋅ 4 SiO2 ⋅ H2O
titanium dioxide: TiO2
calcium carbonate: CaCO3
calcium phosphate: Ca3(PO4)2
calcium sulphate: CaSO4
magnesium carbonate:         MgCO3
sodium bicarbonate: NaCHO3
NH2
O
OH
R
R = H   glycine
R = CH3 alanine
R = CH(CH3)2 leucine
gelatin: glycine, alanine and leucine 
(CH2)10 CH2CH3 O S
O-
O-
O-
Na+ H(OCH2CH2)nOH
macrogol 4000sodium lauryl sulfate
CHCH2
N
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n
polyvinyl pyrrolidone
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8.7 Notes on publication 
 
This database shows the 43 most commonly used excipients present in 
pharmaceutical dosages. These Raman spectra can help with the detection of 
excipients present and lacking in counterfeit drugs as described in the three 
previous chapters. It has to be noted that identification of excipients should 
not be based on one single Raman band. Excipients often do present similar 
Raman bands, like for instance lactose (figure 8.1.D) and starch (figure 8.1.E) 
which both present a Raman band at 847 cm-1. Based on this Raman band no 
conclusions can be formed whether lactose or starch is present in the drug. 
However, lactose shows a strong Raman band at 374 cm-1 while sucrose has 
a very strong Raman band at 400 cm-1, which makes it possible to distinguish 
these two excipients. In order to make conclusions about the presence of an 
excipient in the drug, more Raman bands should be investigated.  
 
Chapter 8 and the three previous chapters are focusing on the qualitative 
analysis of counterfeit drugs. Since these counterfeiters are becoming more 
sophisticated, quantitative analyses will be necessary as well. This subject is 
discussed in the next chapter, chapter 9.  
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9 Quantitative analysis of drugs with Raman spectroscopy 
 
9.1 Introduction 
 
The benefits of Raman spectroscopy as a fast qualitative analysis method to 
detect counterfeit drugs, have been described in chapters 5, 6 and 7. Since 
the counterfeiters are becoming increasingly sophisticated, quantitative 
analysis is necessary as well. Raman spectroscopy can be used for 
quantitative analysis, since the intensity of the vibrational bands is directly 
proportional to the concentration of the species (chapter 2.3)1. Different 
examples of quantitative analysis with Raman spectroscopy in other research 
fields have been shown in chapter 3.4.5.  
 
In general, a calibration curve is generated, using different mixtures of known 
composition1. The accuracy of the calibration curve can be significantly 
influenced by the homogeneity of the tablets used1. The first step in this 
quantitative analysis process, is to develop homogenized calibration tablets. 
Secondly, by rotating the tablet during analyses the precision between 
analyses, is decreased1. These two subjects are discussed in paragraphs 
9.3.1 and 9.3.2. and describe the steps that have to be undertaken before the 
start of the quantitative analysis of the counterfeit drugs.  
 
Some of the counterfeit drugs used for the qualitative analysis (antimalarial 
and Viagra® tablets, as described in chapters 6 and 7), are used for the 
quantitative study. The quantitative results of the antimalarial tablets with 
Raman spectroscopy are compared with the results of liquid chromatography 
mass spectrometry (LC-MS) analyses, while the Viagra® tablets are compared 
to the results of high performance liquid chromatography with diode-array 
detection (HPLC-DAD) analyses.  
 
The concentration of active ingredient in the possible counterfeits can be 
calculated in different ways. This concentration can be determined by using 
the intensity or the area of individual bands, but also with multivariate methods 
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like principal component regression (PCR). The advantage of these 
multivariate methods is that the whole spectrum is used, rather than an 
individual band. This chapter describes the use of calibration curves based on 
a single band in paragraph 9.4, while the chemometrical approaches are 
described in paragraph 9.5.  
 
The counterfeit Viagra® tablets are analysed with Fourier-Transform (FT) 
Raman spectroscopy (paragraph 9.6) as well. Additionally, the Viagra® tablets 
are grinded and pressed again to see if the coating of the tablets could have a 
negative influence on the quantitative analysis (paragraph 9.7).   
 
9.2 Experimental 
 
Two dispersive Raman spectrometers (MArtA and Renishaw System-1000) 
and a FT-Raman spectrometer (Bruker Equinox 55) were used for the 
quantitative analysis and is described below. 
 
• MArtA: 
 
Details about the MArtA instrument are given in paragraph 5.2.   
 
• Renishaw:  
 
The Renishaw System-1000 instrument is described in paragraph 5.2.  
 
• Bruker Equinox 55S8: 
 
The Bruker Equinox 55S spectrometer with Raman module FRA 106, is a 
hybrid FT-IR/FT-Raman spectrometer fitted with a cooled (77K) germanium 
high sensitivity detector D418-T. The data transfer, collection, and processing 
is automated using the Bruker OPUSTM software. The spectrum recorded 
ranges from -100 to 3500 cm-1 with a spectral resolution of ca. 4 cm-1. The 
laser wavelength used is the 1064 nm line of an air cooled diode pumped 
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neodymium yttrium aluminium garnet laser (Nd:YAG). During analyses the 
power of the laser is set at 35.5 % (max. power of 500 mW). Each sample is 
measured five times with 100 scans during each measurement.  
 
To verify the results obtained with Raman spectroscopy, two analytical 
methods were used. The antimalarial tablets are analysed with LC-MS and 
the Viagra®  tablets with HPLC-DAD. 
 
• LC - MS6:  
 
The liquid chromatography mass spectrometry (LC-MS) instrument is 
described in detail in paragraph 6.2.  
 
• HPLC - DAD7: 
 
High-performance liquid chromatography with diode-array detection (HPLC-
DAD) experiments were performed on an Waters HPLC-DAD combination, 
Alliance 2690 separation module with a DAD detector 99614.  
 
For the homogeneity and rotation experiments, pure paracetamol                 
(4-acetamidophenol, Acros organics) is used. The artesunate samples were 
collected in Cambodia, Lao PDR (Laos), the Thai  Burma border, Burma and 
Hong Kong6. Pure artesunate (Dafra Pharma) is used for the calibration 
tablets. The Viagra®  tablets were donated by the National Institute for Public 
Health and the Environment (RIVM) in the Netherlands, including the pure 
active ingredient, sildenafil citrate, for the production of calibration tablets7.  
 
The calibration tablets for the antimalarial and Viagra® analyses consist of 
different dosages of the active ingredient and the following excipients: 
magnesium stearate (Sigma-Aldrich), microcrystalline cellulose (Sigma-
Aldrich), silica (Sigma-Aldrich), and corn starch (Sigma-Aldrich). The tablets 
were made with the use of the Parr Pellet Press (Parr Instrument Company, 
Moline, IL, U.S.A.) and have a diameter of 1 cm.  
  
140 
In order to calculate the intensity or area of the three Raman bands used, the 
recorded spectra are averaged and baseline-corrected to eliminate the 
influence of broadband fluorescence. Two computer programmes are used, 
ACD/Specmanager (version 9.13, Advanced Chemistry Development, Inc. 
Toronto, Canada) and Grams/AI(7.01) (Thermo Galactic, Waltham, MA, 
U.S.A.). Chemometrical calculations are executed by Matlab 6.5 (The 
MathWorks Inc., Natick, MA, U.S.A.) and the PLS toolbox, version 3.0 
(Eigenvector Research Inc., Manson, WA, U.S.A.). The paired t-test, for 
statistical evaluation, was calculated using Excel. 
 
9.3 Preparation of calibration tablets and analysis conditions 
 
9.3.1 Homogeneity of the calibration tablets  
 
As mentioned before, one of the major errors in quantitative analysis, is the  
lack of homogeneity of the tablets. Calibration tablets are made of a mixture of 
one or more active ingredient(s) and several excipients which had to be 
thoroughly mixed to make sure that the active ingredient is equally distributed 
throughout the entire tablet.  
 
In total, 8 plastic tubes, with the same amount of paracetamol and three 
excipients (magnesium stearate, microcrystalline cellulose and corn starch), 
are placed in a Turbula T2F instrument. After different mixing times  (5 up till 
360 minutes), a plastic tube is removed and a tablet is made using the Parr 
Pellet Press (∅ 1 cm). From these 8 tablets, a 15 x 15 mapping, is made with 
the use of the MArtA instrument (discussed in chapter 3.4.3).  
 
The Raman band at 855 cm-1 of paracetamol, which can be assigned to the 
symmetrical ν(CNC) stretching vibration3, is chosen to calculate the average 
intensity and standard deviation. A Raman spectrum, retrieved during the 
mapping experiment of a paracetamol tablet with the MArtA instrument, is 
shown in figure 9.1. 
 
9. Quantitative analysis 
141 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 9.1 Spectrum of a paracetamol tablet analysed with the MArtA instrument     
(1 acc. x 3 s). 
 
The 15x15 mapping of the paracetamol tablet, rotated for 5 minutes in the 
Turbula T2F instrument, consists of 225 spectra (fig. 9.2).  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 9.2 A 15x15 mapping (steps of 500 µm) of a paracetamol tablet after 5 
minutes homogenization in the Turbula T2F instrument based on the Raman band at 
855 cm-1 (MArtA, 1 acc. x 3 s).  
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Figure 9.2 shows that the active ingredient is not equally dispersed throughout 
the tablet. For the different tablets, the intensity, standard deviation and the 
relative standard deviation (RSD) of  the Raman band at 855 cm-1 is 
calculated and shown in table 9.1 and figure 9.3.  
 
Mixing time (min.) Average intensity* Standard 
deviation* 
RSD (%) 
5 0.404 0.259 64.2 
30 0.353 0.201 56.9 
60 0.225 0.126 56.0 
90 0.663 0.119 18.0 
180 0.489 0.116 23.7 
240 0.629 0.113 17.9 
300 0.486 0.109 22.4 
360 0.505 0.108 21.3 
commercial tablet 0.671 0.115 17.1 
 
Table 9.1 Average intensity, standard deviation and RSD (%) (* arbitrary units) of 
Raman band of paracetamol (855 cm-1) at different shaking times with the       
Turbula T2F instrument.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 9.3 RSD of the Raman band at 855 cm-1 (%) in function of the mixing time in 
the Turbula T2F (min).  
 
0
10
20
30
40
50
60
70
5 30 60 90 180 240 300 360 commercial
tabletMixing time in Turbula T2F (min)
R
SD
 
o
f t
he
 
R
a
m
a
n
 
ba
n
d 
a
t 8
55
 
c
m
-
1  
(%
)
9. Quantitative analysis 
143 
The standard deviation of the 8 tablets, as presented in table 9.1, drops 
significantly after 90 minutes to a range of 0.108 till 0.119. The RSD drops to 
a range of 17.9 to 23.7%. The standard deviation and the RSD of a 
commercial paracetamol tablet (ETOS, the Netherlands) is respectively 0.115 
and 17.1%. This shows that 90 minutes mixing time can be used as a 
minimum for the production of calibration tablets. For the quantitative analysis 
of counterfeit drugs, the calibration tablets were shaken for 360 minutes in 
order to have sufficient margin to obtain homogeneous tablets.   
 
9.3.2 Influence of the rotation of tablets during analysis 
 
Another way to reduce the error during quantitative analysis, is the rotation of 
the tablet during measurement. When rotating the tablet, a larger area is 
measured, as shown in figure 9.4. To rotate the tablet, a small device has 
been developed, and can be positioned under the microscope. The speed of 
this motor can be varied between 12 and 82 rotations per minute.  
 
  
 
Figure 9.4 (A) represents three analyses of a tablet without rotation, while                
(B) represents three analyses of a tablet with rotation. 
 
To establish the influence of rotation on the accuracy of the measurements, 
the paracetamol tablet used in the homogeneity study (tablet 60 min mixing 
time, paragraph 9.3.1) is analysed. The tablet is analysed 30 times with and 
without rotating. For each spectrum, the intensity is calculated and the 
standard deviation of the Raman band at 855 cm-1 is calculated (shown in   
fig. 9.5).   
A B 
  
144 
 
 
 
 
   
 
 
 
 
 
 
 
 
 
 
 
 
Figure 9.5 The lines represent the standard deviation between the intensities of the 
Raman band at 855 cm-1 for each measurement, with and without rotation              
(12 rotations per minute, Renishaw System-1000 spectrometer, 1 acc. x  3s). 
 
The intensities of the Raman band of the analysis without rotation vary 
between 216 and 777 arbitrary units, while the analyses with rotation varies 
between 415 and 519 arbitrary units. Although the average intensity for both 
methods after 30 measurements is 469 arbitrary units, the standard deviation 
of the measurements without rotation is circa 4 times higher than with rotation. 
This shows that, when rotating the sample, less analyses are required and a 
better accuracy is obtained. For the quantitative analyses of the counterfeit 
drugs, discussed in this chapter, an average of 5 measurements with rotation 
(12 rotations per minute) are used, in order to minimize the level of error.  
 
The quantitative analysis in this work is focussed on measuring two 
counterfeit drugs, namely antimalarial tablets and Viagra. The quantitative 
analysis can be executed in two ways. The first is the use of calibration 
curves, which are based on the intensity or area of specific Raman bands 
(paragraph 9.4), whereas the second option is the use of chemometrical 
methods, which are based on the complete Raman spectrum (paragraph 9.5).  
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9.4. Quantitative analysis based on specific Raman bands  
  
With a calibration curve, based on the intensity or area of a specific Raman 
band of the active ingredient, the counterfeit tablets will be analysed. This 
approach is used on the antimalarial tablets as well as on Viagra® tablets.  
 
9.4.1 Analysis based on the intensity of three Raman bands 
 
9.4.1.1  Antimalarial tablets 
 
For this quantitative analysis, 11 tablets of the 50 tablets used in chapter 6 are 
used and the results are compared to liquid chromatography-mass 
spectrometry (LC-MS) results, as performed by Hall et al.6. The first step in 
this research is the production of calibration tablets. The concentration of the 
active ingredient, artesunate, in the 6 calibration tablets varies from 9% w/w 
up to 36% w/w. Since producers of the artesunate tablets from southeast Asia 
did not give any information about excipients used in their tablets, the 
following commonly used excipients were chosen: magnesium stearate      
(2% w/w), microcrystalline cellulose (5% w/w), silica (7% w/w) and corn starch 
(50 - 77% w/w). The ingredients for the calibration tablets are thoroughly 
mixed in the Turbula T2F instrument for 6 hours in total.  
 
For this quantitative analysis, 3 Raman bands were selected, namely the 
bands at 307 cm-1 and at 679 cm-1 due to skeletal modes of the alkenes and 
the ν(C=O) stretching vibration at 1757 cm-1 (see chapter 6, fig. 6.1). These 
Raman bands are selected based on the absence of overlapping Raman 
bands due to excipients. The intensity of these Raman bands are used to 
produce three calibration curves.  
 
With the MArtA instrument, each tablet is analysed and the intensity of the 
three Raman bands at 307, 679 and 1757 cm-1 is determined for all 6 
calibration tablets. The average intensities and standard deviations of these 
three Raman bands are used to establish calibration curves which are shown 
in figure 9.6.  
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Figure 9.6 Average intensity and standard deviation in arbitrary units for 6 calibration 
tablets measured with the MArtA instrument (5 acc. x 120 s).   
 
For each calibration curve the coefficient of determination (R2) is determined 
which can range between 0 and 1 (0 ≤ R2 ≤1)11. The closer the value of R2 is     
to 1, the larger is said to be the degree of linearity between the concentration 
and the Raman intensity11. Although, the calibration curve of 307 cm-1 has the 
highest R2, its standard deviation is high as well.  
 
The function of the three calibration curves are used, in combination with the 
intensities of the corresponding three bands for the 11 tablets from southeast 
Asia. Based on the intensities of these tablets, the concentration in % w/w of 
the active ingredient artesunate is calculated. Table 9.2 shows these results 
and the relative difference in % between the Raman analyses and the LC-MS 
results6.  
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Calculated  active ingredient with Raman spectroscopy 
and relative difference with the LC-MS results (%). 
307 cm-1 679 cm-1 1757 cm-1 
Tablet LC-MS  
(% w/w) 
% w/w % diff. % w/w % diff. % w/w % diff.. 
5 21 17 -17 14 -33 10 -52 
13008 8 15 96 9 23 3 -61 
13009 32 16 -48 10 -67 25 -20 
13013 22 17 -25 11 -50 16 -28 
12064 30 21 -30 19 -37 41 39 
12065 27 22 -20 38 39 43 59 
63001 21 24 12 25 19 7 -67 
artesor 4 30 8 -75 29 -4 35 16 
artesor 7 25 8 -68 15 -41 -8 -131 
artesor 9 24 8 -68 12 -48 24 2 
artesor 10 21 10 -51 30 44 14 -33 
average   54  40  57 
 
Table 9.2 Calculated amount of active ingredient (% w/w) in 11 antimalarial tablets 
from southeast Asia, measured with the MArtA instrument (5 acc. x 120 s) and with 
LC-MS with the relative difference between these two analytical techniques (%). The 
average of all tablets is calculated (square root of the average quadratic value). 
 
The results in table 9.2 are determined with the use of the three calibration 
curves presented in figure 9.6. The difference between the two analytical 
methods (Raman spectroscopy and LC-MS) of these tablets is significant and 
ranges from 2 up to 131%. A positive difference indicates overestimation by 
Raman spectroscopy compared to LC-MS, while negative differences indicate 
an underestimation of the amount of active ingredient. Even the calibration 
curve with the highest R2, 307 cm-1, shows an average difference of 54%.  
 
In addition, a paired t-test is performed on the results (α = 0.05) in order to 
see if there is a significant difference between the results based on Raman 
spectroscopy and LC-MS (P < 0.05).  
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The results based on the Raman band at 307 cm-1 showed a significant 
difference with the LC-MS results (P = 0.004), while the results based on the 
Raman bands at 679 and 1757 cm-1, showed no significant difference           
(P = 0.22 and  P = 0.39).  
 
Next, Viagra® tablets are analysed in a similar way (paragraph 9.3.3.2). 
Additionally, these Viagra® tablets (calibration and counterfeits) are analysed 
using the two dispersive Raman spectrometers, namely the MArtA and 
Renishaw System-1000 instrument.   
 
9.4.1.2  Viagra®  tablets 
 
 
The same quantification process used on the antimalarial tablets is also 
performed on the 6 Viagra® tablets which have been quantitatively analysed 
with HPLC-DAD by RIVM7. The Viagra® tablets are analysed with both the 
MArtA instrument and the Renishaw System-1000 spectrometer.  
 
Original Viagra® tablets contain approximately 16% w/w active ingredient 
(sildenafil citrate). Three different doses are sold, with respectively 25, 50 and 
100 mg sildenafil citrate. The ratio of active ingredient in all three dosages is 
therefore the same, the variation is created by increasing the weight of the 
tablet. The 6 possible counterfeit Viagra® tablets are received from RIVM and 
made up of the three different sizes (1 x 25, 2 x 50 mg and 3 x 100 mg) 
 
The first step in the quantitative analysis is the preparation of calibration 
tablets, made with the active ingredient sildenafil citrate. The chemical 
structure and the Raman spectra of the active ingredient is shown in      
chapter 7 (fig. 7.3). The concentration of the active ingredient in the 7 
calibration tablets varies from 4% w/w up to 30% w/w, were genuine Viagra® 
contains circa 16%. Based on the information of the producer, the following 
excipients were chosen, namely: calcium hydrogen phosphate (4% w/w), 
titanium dioxide (15% w/w), magnesium stearate (4% w/w) and cellulose     
(47 - 77% w/w).  
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The tablets are analysed using the following three Raman bands: the ring 
vibration at 818 cm-1, the ν(C=N) stretching vibration at 1239 cm-1 and the 
ν(C=C) stretching vibration at 1580 cm-1. 
 
• Analysis with the MArtA spectrometer: 
 
Each tablet (calibration and possible counterfeits) are analysed five times. The 
intensities and standard deviation for the three Raman bands, as indicated 
above, results in the following calibration curves (fig. 9.7). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 9.7 Average intensity and standard deviation in arbitrary units for 7 calibration 
tablets, measured with the MArtA instrument (100 acc. x 1 s).   
 
These calibration curves are used to estimate the amount of active ingredient 
in the possible counterfeit Viagra® tablets and are compared to the results of 
the HPLC-DAD analyses. Results are shown in table 9.3 
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Calculated amount active ingredient based on Raman 
spectroscopy and relative difference with the  
HPLC-DAD results. 
818 cm-1 1239 cm-1 1580 cm-1 
Tablet 
 
HPLC       
- DAD 
(% w/w) 
% w/w % diff. % w/w  % diff. % w/w % diff. 
1  16 20 23 21 33 21 30 
2  17 24 45 30 76 29 73 
3  12 15 18 18 50 18 44 
4  15 20 39 22 50 21 47 
5  15 20 38 24 64 23 57 
6  17 22 28 26 56 26 53 
average   33  54  50 
 
Table 9.3 Calculated amount of active ingredient (% w/w) in the 6 Viagra® tablets with 
the MArtA instrument (100 acc. x 1 s) and HPLC-DAD, with the relative difference 
between these two analytical methods (%). The average of the differences of all 6 
tablets is calculated (square root of the average quadratic value). 
 
The average difference between the results of HPLC-DAD and Raman 
spectroscopy of the 6 Viagra® tablets ranges between 33 and 54%. The 
difference for the Viagra® tablets is a bit lower then the difference for the 
artesunate tablets, which ranges between 40 and 57% (paragraph 9.4.1.1).    
 
A paired t-test (α = 0.05) is performed to confirm the results of the analyses 
with the MArtA spectrometer. Based on this test there is a significant 
difference between the HPLC-DAD results and the results based on the three 
Raman bands (P < 0.05).  
 
These same tablets (7 calibration and 6 possible counterfeits) are analysed 
with the Renishaw System-1000 spectrometer, in order to verify if the 
quantitative analysis with the second dispersive Raman spectrometer shows 
improvement in the accuracy.  
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The analyses, so far, are analysed with the mobile Raman spectrometer 
(MArtA). The Renishaw System-1000 spectrometer is a bench top 
spectrometer which could improve the results.  
 
• Analysis with the Renishaw System-1000 spectrometer:  
 
Similar to the analyses with the MArtA instrument, the intensities and standard 
deviations of the three Raman bands of the calibration tablets are used to 
establish calibration curves (fig. 9.8). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 9.8 Average intensity and standard deviation in arbitrary units for 7 calibration 
tablets, measured with the Renishaw System-1000 spectrometer (5 acc. x 30 sec).   
 
The intensities of the three Raman bands of the 6 Viagra® tablets are used to 
estimate the amount of active ingredient, which is compared to the         
HPLC-DAD analyses performed by RIVM.  Results are shown in table 9.4.  
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Calculated amount active ingredient based on Raman 
spectroscopy and relative difference with the  
HPLC-DAD results. 
818 cm-1 1239 cm-1 1580 cm-1 
Tablet 
 
HPLC       
- DAD 
(% w/w) 
% w/w % diff. % w/w  % diff. % w/w % diff. 
1  16 14 -13 9 -42 11 -29 
2  17 27 59 15 -12 22 32 
3  12 18 44 17 38 18 43 
4  15 16 10 14 -3 17 15 
5  15 18 26 16 10 18 23 
6  17 14 -15 9 -45 13 -25 
average   33  30  29 
 
Table 9.4 Calculated amount of active ingredient (% w/w) in the 6 Viagra® tablets with 
the Renishaw System-1000 spectrometer (5 acc. x 30 s) and the HPLC-DAD 
analyses, with the relative difference between these two analytical methods (%). The 
average of all 6 tablets is calculated (square root of the average quadratic value). 
 
The average difference between the results with the HPLC-DAD and Raman 
spectroscopy (Renishaw System-1000) of the 6 Viagra® tablets ranges 
between 29 and 33%, which shows an improvement compared to the results 
with the MArtA spectrometer (table 9.3). To confirm these results, a paired     
t-test (α = 0.05) is performed. According to this test, there is no significant 
difference between the HPLC-DAD analyses and the analyses based on the 
three specific Raman bands (P = 0.21, P = 0.29 and P = 0.49). 
 
The results of the quantification of the antimalarial and Viagra®  tablets based 
on the intensities of three Raman bands, analysed with the MArtA instrument 
and the Renishaw System-1000 spectrometer, are shown below. These 
results represent the minimum and maximum average difference of the 
counterfeit tablets with Raman spectroscopy and LC-MS or HPLC-DAD, 
respectively. 
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• MArtA instrument antimalarial tablets: 40 – 57% 
 Viagra® tablets: 33 – 54% 
• Renishaw System-1000 
spectrometer 
Viagra® tablets: 29 – 33% 
 
It has to be noted that the minimum and maximum difference is an average of 
the 11 antimalarial tablets or 6 Viagra®  tablets. The difference per tablet can 
vary outside of these ranges. When focussing on these results, it can be 
noted that the average difference for the Renishaw System-1000 
spectrometer differs less between the three Raman bands compared to the 
MArtA instrument. This can be due to the fact that the Renishaw System-1000 
is a bench top spectrometer, while the MArtA instrument is a mobile 
spectrometer. Therefore, in the following paragraphs, we will continue to work 
with the Renishaw System-1000 spectrometer.  
 
9.4.2 Analysis based on the area of three Raman bands  
 
In this paragraph, a calibration curve is established, based on the area of the 
three Raman bands rather than this intensity. The area of the Raman band is 
independent of broadening effects and should enhance the results compared 
to the results based on the intensity of a Raman band12. The area of the three 
Raman bands is determined with ACD/ Specmanager (version 9.13). This 
approach is used on the Viagra® tablets analysed with Renishaw System-
1000 spectrometer since these analyses yielded the best results.  
 
The calibration curves are similar to those used for the intensity calculations 
(paragraph 9.4.1) except that these are based on the area of the three Raman 
bands at 818 cm-1, 1239 cm-1 and 1580 cm-1(fig. 9.9). The equations of the 
three calibration curves are used in combination with the areas of these three 
bands of the 6 Viagra® tablets to calculate the amount of active ingredient. 
The amounts of active ingredient are presented in % w/w and are compared 
to those of the HPLC-DAD analyses (difference in %). Results are presented 
in table 9.5.  
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Figure 9.9 Average area and standard deviation in arbitrary units for 7 calibration 
tablets measured with the Renishaw System-1000 spectrometer (5 acc. x 30 s).   
 
Calculated amount active ingredient based on Raman 
spectroscopy and relative difference  
with the HPLC-DAD results. 
818 cm-1 1239 cm-1 1580 cm-1 
Tablet 
 
HPLC       
- DAD 
(% w/w) 
% w/w % diff. % w/w  % diff. % w/w % diff. 
1  16 17 7 10 -37 12 -26 
2  17 30 77 17 -2 21 27 
3  12 19 52 19 56 20 58 
4  15 18 22 17 18 18 24 
5  15 16 8 10 -33 13 -11 
6  17 18 5 15 -13 17 -1 
average   39  32  30 
 
Table 9.5 Calculated amount of active ingredient (% w/w) in the 6 Viagra® tablets with 
the Renishaw System-1000 spectrometer (5 acc. x 30 s) and HPLC-DAD with the 
relative difference between these two analytical methods (%). The average of all 6 
tablets is calculated (square root of the average quadratic value).  
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y = 1766,1x + 8,5097
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For these analyses, a paired t-test is performed as well (α = 0.05). There is no 
significant difference between the analyses with Raman spectroscopy and 
HPLC - DAD based on the area of the three Raman bands (P = 0.08, P = 0.73 
and P = 0.38). The average difference results of the intensity and the area are 
shown below. 
 
• Intensity (paragraph 9.4.1.2): 29 – 33% 
• Area:  30 – 39% 
 
Both calculations are based on the analyses of the 6 possible counterfeit 
Viagra® tablets with the Renishaw System-1000 spectrometer. When 
focussing on the results shown above, it can be noted that the results based 
on the intensity of the Raman bands have a slightly better accuracy then the 
results based on the area of these Raman bands. Although, the opposite 
would be expected, since the band area is independent of broadening 
effects12. When comparing the results with a paired t-test (α = 0.05), no 
significant difference between the results based on the area and the intensity 
of the Raman band can be noted (P = 0.58, P = 0.61 and P = 0.89). The 
calculations presented in paragraph 9.4.1 and 9.4.2 are all based on the 
analyses of a single Raman band. When an excipient has a Raman band at 
the same position, an inaccuracy in the calculations will occur. Therefore, 
chemometrical methods will be used to calculate the amount of active 
ingredient in the Viagra® tablets. With these chemometrical approaches, the 
entire Raman spectrum is used for the calculations.  
 
9.5 Quantitative analysis based on PCR  
 
A commonly used chemometrical approach is PCR, which is a form of factor 
analysis that can be used for quantitative analysis in spectroscopy9. The first 
step in this chemometrical approach is reducing the dataset of all the Raman 
spectra by using principal component analysis (PCA). Secondly, a correlation 
is established between the PCA-scores and the concentration (see Appendix 
for more details). The benefit of chemometrical approaches is that the entire 
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Raman spectrum is considered. Therefore, this method could provide a better 
quantification method since it is less sensitive to interferences as, compared 
to the monovariate approach. The Viagra® tablets analysed with the Renishaw 
system-1000 instrument, are calculated with the use of PCR, to see if this 
improves the quantification process. 
  
Calculations are performed on the raw data retrieved from the Renishaw 
system-1000 spectrometer. Additionally, as a pre-processing method, the 1st 
and 2nd derivative is taken of all spectra, with the use of the Savitsky-Golay 
algorithm10. By using derivatives, the contributions from the broad-featured 
fluorescence background are diminished. The calculations are performed with 
Matlab and the influence of the first 5 principal components (PCs) is 
investigated. With this technique the amount of active ingredient (% w/w) in 
the six Viagra® tablets and the difference (%) with the HPLC-DAD analyses 
are calculated. The differences (%) between the two techniques are presented 
in the next three tables, based on the raw data (table 9.6), 1st derivative   
(table 9.7), and 2nd derivative (table 9.8).  
 
• Analysis with raw data: 
 
Difference between Raman spectroscopy and HPLC-DAD 
analyses in presented in % 
Tablet 
1 PC  2 PCs  3 PCs 4 PCs  5 PCs 
1 -77 32 -87 -91 70 
2 -439 103 -380 -392 135 
3 -76 23 -118 -118 -4 
4 -44 24 -111 -116 51 
5 -92 -8 -129 -136 72 
6 -87 19 -124 -128 63 
average 192 47 187 193 76 
 
Table 9.6 Results of PCR analyses (raw data) with the use of Matlab. Difference (%) 
of calculated amount of active ingredient in the 6 Viagra® tablets between Renishaw 
System-1000 instrument (5 acc. x 30 s) and HPLC-DAD. The average of all 6 tablets 
is calculated (square root of the average quadratic value). 
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• Analysis with 1st derivative of the data: 
 
Difference between Raman spectroscopy and HPLC-DAD 
analyses in (%) 
Tablet 
1 PC  2 PCs  3 PCs 4 PCs  5 PCs 
1 21 34 29 19 18 
2 -13 -1 -9 -21 -21 
3 17 -30 -37 -53 -53 
4 53 -3 -6 -6 -6 
5 3 24 16 -2 -3 
6 23 12 9 -1 -1 
average 26 22 21 24 24 
 
Table 9.7 Results of PCR analyses (1st derivative) with the use of Matlab. Difference  
of calculated amount of active ingredient in the 6 Viagra® tablets  between Renishaw 
System-1000 instrument (5 acc. x 30 s) and HPLC-DAD (%). The average of all 6 
tablets is calculated (square root of the average quadratic value). 
 
• Analysis with 2nd derivative of the data: 
 
Difference between Raman spectroscopy and HPLC-DAD 
analyses in (%) 
Tablet 
1 PC  2 PCs  3 PCs 4 PCs  5 PCs 
1 24 37 34 35 26 
2 -5 7 3 3 -12 
3 6 -25 -32 -36 -44 
4 39 1 -1 -1 -2 
5 9 29 23 22 11 
6 19 15 14 13 7 
average 21 23 22 23 22 
 
Table 9.8 Results of PCR analyses (2nd derivative) with the use of Matlab. Difference 
of calculated amount of active ingredient in the 6 Viagra® tablets between Renishaw 
System-1000 instrument (5 acc. x 30 s) and HPLC-DAD (%). The average of all 6 
tablets is calculated (square root of the average quadratic value). 
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When focussing on the average difference results (%) of the 6 Viagra® tablets 
with the use of chemometrical approaches, it can be noted that the analyses 
of the raw data leads to larger errors. The results of the 1st and 2nd derivative 
show  an improvement with an average difference varying between 21 and 
26%. This can be due to the fact that the coating of the Viagra® tablets can 
cause a broad-featured fluorescence background.  
 
Additionally, a paired t-test ( α = 0.05) is performed in order to see if there is a 
significant difference (P < 0.05) between the PCR on HPLC-DAD analyses. 
 
paired t-test ( α = 0.05) Analyses based 
on PCR results 1 PC  2 PCs  3 PCs 4 PCs  5 PCs 
Raw data 0.07 0.06 0.01 0.01 0.00 
1st derivative 0.19 0.41 0.86 0.30 0.29 
2nd derivative 0.12 0.17 0.32 0.39 0.92 
 
Table 9.9 Statistical evaluation (paired t-test) of the results based on PCR analyses 
(raw data, 1st derivative and 2nd derivative).  
 
Based on the results of the paired t-test, there is a significant difference 
between the PCR results based on the raw data and the HPLC-DAD analyses 
(P < 0.05).  However, this changes when using the 1st or 2nd derivative, when 
there is no significant difference between the two techniques (P > 0.05).  
 
Results based on PCA combined with PCR are compared to the results based 
on the intensity of three Raman bands are shown below: 
 
• PCR: raw data 47 – 193% 
 1st derivative 21 – 26% 
 2nd derivative 21 – 23% 
• Intensity (9.4.1.2):  29 – 33% 
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These results show an improvement compared to results based on a single 
Raman band. This can be expected, since this method incorporates the entire 
Raman spectrum. In order to check if the analyses can be improved, the 
Viagra® tablets are analysed with a FT-Raman spectrometer (Bruker         
Equinox 55S). Commonly, quantitative analysis of drugs is performed more 
often with Fourier transform (FT) Raman spectroscopy than with dispersive 
Raman spectroscopy.  
 
9.6 Analysis with Fourier transform (FT) Raman Spectroscopy  
 
For this analyses, a Bruker Equinox 55S instrument is used in combination 
with the intensity of three Raman bands (similar to paragraph 9.4.1.2) and 
PCR (similar to paragraph 9.5).  
 
9.6.1  Analysis based on the intensity of three Raman bands  
  
The first step in the analyses, is establishing calibration curves, based on the 
intensities of three Raman bands (fig. 9.10). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 9.10 Average intensity and standard deviation in arbitrary units for 7 
calibration tablets with the active ingredient sildenafil citrate analysed with the Bruker 
Equinox 55S spectrometer (100 scans, 178 mW). 
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The determination coefficients (R2) of the calibration curves are lower, 
compared to those obtained with the dispersive Raman spectrometers (fig. 9.7 
and 9.8). With the use of the calibration curves shown in figure 9.10, the 
amount of active ingredient (% w/w) in the counterfeit Viagra® tablets is 
determined. The difference between FT-Raman and the HPLC-DAD is 
calculated and presented in % (table 9.10).  
 
Calculated amount active ingredient based on Raman 
spectroscopy and relative difference  
with the HPLC-DAD results. 
818 cm-1 1239 cm-1 1580 cm-1 
Tablet 
 
HPLC       
- DAD 
(% w/w) 
% w/w % diff. % w/w  % diff. % w/w % diff. 
1  16 4 -74 1 -92 3 -82 
2  17 12 -28 16 -3 17 1 
3  12 13 7 18 46 17 37 
4  15 7 -51 11 -25 11 -24 
5  15 13 -12 22 51 21 45 
6  17 8 -52 13 -21 15 -13 
average   44  49  42 
 
Table 9.10 Calculated amount of active ingredient (% w/w) in the 6 Viagra® tablets 
with the Bruker Equinox 55S spectrometer (100 scans, 178 mW) and HPLC-DAD 
with the relative difference between these two analytical methods (%). The average 
of all 6 tablets is calculated (square root of the average quadratic value).  
 
To confirm these results, a paired t-test (α = 0.05) is performed. The results 
based on the Raman band of 818 cm-1 shows a significant difference            
(P = 0.01) compared to the HPLC-DAD analyses, while the two other Raman 
bands at 1239 and 1580 cm-1 show no significant difference (P = 0.62 and        
P = 0.65). The results presented in table 9.10 are compared to similar 
analyses with the Renishaw System-1000 spectrometer. 
 
• Bruker Equinox 55S instrument:  42 – 49% 
• Renishaw system-1000 spectrometer (9.4.1.2): 29 – 33% 
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Although the opposite is expected, based on the literature, the difference 
between the results of analyses with a FT Raman spectrometer (Bruker 
Equinox 55S) and HPLC-DAD analyses is more significant than compared to 
the dispersive Raman spectrometer (Renishaw system1000).   
 
Based on the results of the paired t-test, the Renishaw System-1000 
spectrometer shows no significant difference with HPLC-DAD for all three 
Raman bands (paragraph 9.4.1.2) while the Bruker Equinox 55S shows no 
significant difference for 2 of the 3 Raman bands.  
 
One of the reasons why the FT Raman spectrometer shows disappointing 
results, can be due to the fact that the tablets were difficult to position in the 
laser beam. With the Renishaw System-1000 spectrometer, the microscope 
enhances focussing of the laser beam on the sample, whereas in the case of 
FT-Raman spectroscopy a standard sample holder is used.  Moreover, when 
using FT-Raman spectroscopy, the tablets could not be rotated. An alternative 
approach is the use of FT-Raman spectroscopy in combination with PCR. 
 
9.6.2 Analysis based on PCR 
 
Calculations with the use of PCR are performed analogous to the calculations 
described in paragraph 9.5 and are presented in table 9.11 till 9.13. Firstly, 
PCA is performed to reduce the data set, secondly PCR is used to establish 
the correlation between the Raman spectra and the concentration.  
 
Calculations are performed with the use of Matlab and the first 5 PCs are 
used. Additionally, the 1st and 2nd derivative is taken of all Raman spectra, 
with the use of the Savitsky-Golay algorithm10 in order to eliminate the 
influence of the possible broad-featured fluorescence background. The 
amount of active ingredient (% w/w) in the six Viagra® tablets is calculated 
and the difference (%) with the HPLC-DAD analyses is established. 
Differences between these techniques are presented in table 9.11, 9.12, and 
9.13, for the raw data, 1st derivative of this data and 2nd derivative of this data, 
respectively.   
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• Analysis with raw data: 
 
Difference between Raman spectroscopy and                      
HPLC-DAD analyses presented in (%) 
Tablet 
1 PC  2 PCs  3 PCs 4 PCs  5 PCs 
1 79 74 74 74 73 
2 45 5 5 4 12 
3 30 -45 -46 -46 -29 
4 59 59 59 59 60 
5 57 7 6 6 2 
6 77 26 25 25 23 
average 60 44 44 44 42 
 
Table 9.11 Results of PCR analyses (raw data) with the use of Matlab.        
Difference (%) of calculated amount of active ingredient in the 6 Viagra® tablets 
between Bruker Equinox 55S instrument (100 scans, 178 mW) and HPLC-DAD. The 
average of 6 tablets is calculated (square root of the average quadratic value). 
 
• Analysis with 1st derivative: 
 
Difference between Raman spectroscopy and                      
HPLC-DAD analyses presented in (%) 
Tablet 
1 PC  2 PCs  3 PCs 4 PCs  5 PCs 
1 98 81 66 69 78 
2 40 33 27 28 32 
3 95 7 -3 3 -6 
4 97 55 48 53 51 
5 94 -11 -24 -16 -26 
6 96 15 8 12 7 
average 89 43 36 38 42 
 
Table 9.12 Results of PCR analyses (1st derivative) with the use of Matlab. Difference 
(%) of calculated amount of active ingredient in the 6 Viagra® tablets between Bruker 
Equinox 55S instrument (100 scans, 178 mW) and HPLC-DAD. The average of 6 
tablets is calculated (square root of the average quadratic value). 
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• Analysis with 2nd derivative: 
  
Difference between Raman spectroscopy and                      
HPLC-DAD analyses presented in (%) 
Tablet 
1 PC  2 PCs  3 PCs 4 PCs  5 PCs 
1 99 81 80 81 64 
2 96 9 8 11 -17 
3 96 7 7 8 -25 
4 69 33 33 34 29 
5 95 -11 -13 -9 -78 
6 96 14 13 15 -16 
average 93 37 37 37 45 
 
Table 9.13 Results of PCR analyses (2nd derivative) with the use of Matlab. 
Difference (%) of calculated amount of active ingredient in the 6 Viagra® tablets 
between Bruker Equinox 55S instrument (100 scans, 178 mW) and HPLC-DAD. The 
average of 6 tablets is calculated (square root of the average quadratic value). 
 
In order to see if there is a significant difference (P < 0.05) between the PCR 
results and results based on HPLC-DAD analyses, a paired t-test ( α = 0.05) 
is performed (table 9.14).  
 
paired t-test ( α = 0.05) Analyses based 
on PCR results 1 PC  2 PCs  3 PCs 4 PCs  5 PCs 
Raw data 0.00 0.14 0.15 0.15 0.09 
1st derivative 0.00 0.08 0.22 0.11 0.24 
2nd derivative 0.00 0.08 0.10 0.07 0.79 
 
Table 9.14 Statistical evaluation (paired t-test) of the results based on PCR analyses 
(raw data, 1st derivative and 2nd derivative).  
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Based on the results of the paired t-test, there is a significant             
difference between the two methods, only when using the first PC. For the 
other four PCs there is no significant difference based on the paired   t-test.  
 
A summary of the results of the chemometrical approach for this FT Raman 
spectrometer (Bruker Equinox 55S) and dispersive Raman spectrometer 
(Renishaw system-1000, paragraph 9.5) are shown below.  
 
 Bruker Equinox 55S Renishaw system-1000 
• Intensity 42 – 49% 29 – 33% 
• raw data 42 – 60% 47 – 193% 
• 1st derivative 36 – 89% 21 – 26% 
• 2nd derivative 37 – 93% 21 – 23% 
 
The results of the PCR analyses show similar results to those based on the 
intensity of the three Raman bands. Additionally, a paired t-test (α = 0.05) is 
performed to see if there is a significant difference (P < 0.05) between the 
results gained by the Bruker Equinox 55S spectrometer and the Renishaw 
System-1000 spectrometer.  
 
The results based on the Raman band at 818 cm-1 between the two 
techniques showed a significant difference (P = 0.006), while the results 
based on the Raman bands at 1238 and 1580 cm-1, showed no significant 
difference (P = 0.95 and  P = 0.43). The results of the paired t-test on the PCR 
results is presented in table 9.15.  
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paired t-test ( α = 0.05) Analyses based 
on PCR results 1 PC  2 PCs  3 PCs 4 PCs  5 PCs 
Raw data 0.02 0.64 0.01 0.01 0.07 
1st derivative 0.00 0.20 0.29 0.05 0.11 
2nd derivative 0.00 0.34 0.26 0.19 0.84 
 
Table 9.15 Statistical evaluation (paired t-test) of the results based on PCR analyses 
(raw data, 1st derivative and 2nd derivative).  
 
Based on the results of the paired t-test, there is significant difference for the 
PCR results based on the first PC, similar to those results presented in table 
9.14. Additionally, the results based on the raw data show a significant 
difference for 3 out of 5 PCs.  
 
Although the average difference with the Bruker Equinox 55S instrument is 
higher than analyses with the Renishaw system-1000 spectrometer, it does 
show that PCR improves the quantitative analysis of counterfeit drugs 
compared to analyses based on the intensity of  single Raman bands.  
 
9.7 Influence of grinding and repressing of tablets 
 
The difference between the Raman analyses and HPLD-DAD analyses might 
be caused by the thickness of the coating, that is used on the Viagra® tablets. 
This blue coating consist of hypromellose, lactose, triacetin, titanium dioxide 
and indigo carmine, which gives the tablet its distinctive colour. In order to 
decrease this influence, the tablets are grinded and repressed.  
 
The six Viagra® tablets received from RIVM were grinded and shaken for    
360 minutes in the Turbula T2F. After mixing the powders thoroughly, the 
tablets were repressed with the use of the Parr Pellet Press into flat round 
tablets with a diameter of 1 cm, similar to the calibration tablets.  
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These tablets were analysed with the Renishaw System-1000 spectrometer 
under the same conditions as described in paragraph 9.4.1.2. Firstly the 
calculations are performed based on the intensity of the three specific Raman 
bands and secondly, the calculations are performed based on PCR.  
 
9.7.1 Analysis based on the intensity of three Raman bands 
 
With the calibration curves, based on the intensity of three Raman bands of 
the active ingredient (818, 1238 and 1580 cm-1), the amount of active 
ingredient in the 6 possible counterfeited Viagra®  tablets is calculated. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 9.11 Average intensity and standard deviation in arbitrary units for 7 
calibration tablets with the active ingredient sildenafil citrate analysed with the 
Renishaw system-1000 spectrometer (5 acc. x 30 s). 
 
The calibration curves shown in figure 9.11 are expected to be similar to those 
presented in figure 9.8, since both are analysed with the Renishaw System-
1000 spectrometer under the same conditions. Unfortunately, the decrease in 
intensity of the calibration curves shows the degradation of the Renishaw 
System-1000 spectrometer over the last two years. Results of the calculations 
using these calibration curves are presented in table 9.16. 
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Calculated amount active ingredient based on Raman 
spectroscopy and relative difference  
with the HPLC-DAD results. 
818 cm-1 1239 cm-1 1580 cm-1 
Tablet 
 
HPLC       
- DAD 
(% w/w) 
% w/w % diff. % w/w  % diff. % w/w % diff. 
1  16 15 -6 13 -21 14 -16 
2  17 24 46 22 33 22 32 
3  12 14 14 16 28 16 29 
4  15 19 31 19 31 19 30 
5  15 29 97 28 93 28 91 
6  17 20 21 21 21 21 21 
average   47  46  44 
 
Table 9.16 Calculated amount of active ingredient (% w/w) in the 6 Viagra® tablets 
with Raman spectroscopy (Renishaw System-1000 spectrometer, 5 acc. x 30 s) and 
HPLC-DAD with the relative difference between the two analytical methods (%). The 
average of all 6 tablets is calculated (square root of the average quadratic value).  
 
For comparison of the methods, a paired t-test is performed (α = 0.05). Based 
on the results of this t-test, there is no significant difference between the 
analyses with the Renishaw System-1000 spectrometer and the HPLC-DAD 
(P = 0.06, P = 0.07 and P = 0.06). It has to be noted that these results are just 
above the required P > 0.05 level.  
 
When grinding the tablets, a decrease in difference would be expected. 
However, when looking at the average differences shown below, the opposite 
has occurred. 
  
• Before grinding (paragraph 9.4.1.2) 29 – 33% 
• After grinding 44 – 47% 
 
  
168 
Based on the results of the paired t-test, there is a significant difference         
(P < 0.05) for the results based on the intensity of the Raman band at        
1239 cm-1 (P = 0.03). The other two Raman bands showed no significant 
difference between the results before and after grinding (P = 0.43 and            
P = 0.22). However, the average difference has increased after the grinding 
compared to results before. This suggest that the coating of the Viagra® 
tablets did not have a negative influence on the results of the quantitative 
analysis.   
 
9.7.2 Analysis based on PCR 
 
The Raman spectra used in paragraph 9.7.1 are used for PCR calculations. 
The difference between the results is based on comparison of the PCR 
calculations and the HPLC-DAD analyses. In table 9.17 till table 9.19, the 
average differences for the six Viagra® tablets for the first 5 PCs is presented. 
The calculations are performed on the raw data and the 1st and 2nd derivative. 
 
• Analysis with raw data: 
 
Difference between Raman spectroscopy and                       
HPLC-DAD analyses in (%) 
Tablet 
1 PC  2 PCs  3 PCs 4 PCs  5 PCs 
1 -68 43 -54 -68 -58 
2 -39 -160 -81 -95 -83 
3 3 -355 -48 -63 -60 
4 -40 -129 -56 -79 -72 
5 1 2 -107 -120 -112 
6 -18 -135 -56 -66 -58 
average 37 177 70 84 76 
 
Table 9.17 Results of PCR analyses (raw data) with the use of Matlab.        
Difference (%) of calculated amount of active ingredient in the 6 Viagra® tablets 
between the Renishaw System-1000 spectrometer (5 acc. x 30 s) and HPLC-DAD. 
The average of 6 tablets is calculated (square root of the average quadratic value). 
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• Analysis with 1st derivative: 
 
Difference between Raman spectroscopy and                  
HPLC-DAD analyses in (%) 
Tablet 
1 PC  2 PCs  3 PCs 4 PCs  5 PCs 
1 78 -60 6 8 8 
2 73 -14 -33 -32 -31 
3 89 -4 -20 -19 -20 
4 81 -9 -33 -33 -33 
5 74 -68 -88 -87 -86 
6 78 -2 -29 -28 -28 
average 79 38 43 42 42 
 
Table 9.18 Results of PCR analyses (1st derivative). Difference (%) of calculated 
amount of active ingredient in the 6 Viagra® tablets between the Renishaw System-
1000 spectrometer (5 acc. x 30 s) and HPLC-DAD analyses. Average of 6 tablets is 
calculated (square root of the average quadratic value). 
 
• Analysis with 2nd derivative: 
  
Difference between Raman spectroscopy and                     
HPLC-DAD analyses in (%) 
Tablet 
 
1 PC  2 PCs  3 PCs 4 PCs  5 PCs 
1 75 32 31 -52 28 
2 46 -15 -17 -17 -19 
3 62 -5 -5 -5 -5 
4 58 -10 -11 -11 -15 
5 26 -68 -70 -70 -75 
6 51 -5 -8 -8 -15 
average 55 32 32 37 35 
 
Table 9.19 Results of PCR analyses (2nd derivative). Difference (%) of calculated 
amount of active ingredient in the 6 Viagra® tablets between the Renishaw System-
1000 spectrometer (5 acc. x 30 s) and HPLC-DAD analyses. Average of 6 tablets is 
calculated (square root of the average quadratic value). 
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A paired t-test ( α = 0.05) is performed in order to see if there is a significant 
difference (P < 0.05) between the PCR results and results based on      
HPLC-DAD analyses (table 9.20). 
 
paired t-test ( α = 0.05) Analyses based 
on PCR results 1 PC  2 PCs  3 PCs 4 PCs  5 PCs 
Raw data 0.10 0.04 0.00 0.00 0.00 
1st derivative 0.00 0.09 0.04 0.04 0.04 
2nd derivative 0.00 0.44 0.39 0.07 0.29 
 
Table 9.20 Statistical evaluation (paired t-test) of the results based on PCR analyses 
(raw data, 1st derivative and 2nd derivative).  
 
Based on the results of the paired t-test, there is a significant difference for the 
majority of the results, based on the analyses of the raw data and 1st 
derivative (P < 0.05). The results based on the 2nd derivative are not 
significantly different from the HPLC-DAD analyses since P > 0.05. Results 
based on analyses of  the Viagra tablets before grinding, show significant 
better results for the t-test (table 9.9).  
 
Below, a short summary is presented where the results of the PCR 
calculations before and after grinding are compared.  
 
 Before grinding After grinding 
• raw data 47 – 193% 37 – 177% 
• 1st derivative 21 – 26% 38 – 79% 
• 2nd derivative 21 – 23% 32 – 55% 
 
Based on these results, it can be concluded that the coating of the Viagra®  
tablets has no negative influence on the quantitative analysis of the active 
ingredient in the six Viagra® tablets.  
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Moreover, the average difference after grinding has increased, compared to 
the results before grinding. Apparently, the fluorescence background 
increases after grinding, which can cause a larger error in quantification.  
 
9.8 Conclusion 
 
Based on the results of the quantitative analysis of counterfeit drugs some 
conclusions can be formulated: 
 
• In our case, dispersive Raman spectroscopy generates better results 
compared to FT Raman. Additionally, the benchtop Renishaw system 
yields better results than the mobile MArtA spectrometer.  
 
• Using the intensity of the three Raman bands generates better results 
than the use of the band areas, although the opposite would be 
expected since the band area is independent of broadening effects12.  
 
• Chemometrical approaches (PCA in combination with PCR) show 
better results than when based on a single Raman band. This is to be 
expected, since these chemometrical approaches incorporate the 
entire Raman spectrum. 
 
• Grinding and repressing of the tablets show no improvement, which 
demonstrates that the coating of tablets has no specific influence on 
the quantitative analyses. 
 
These results were confirmed with the use of a paired t-test (α = 0.05). Similar 
results were obtained when analyzing circa 18 different paracetamol tablets, 
commercial as well as generic brands13. These results show that Raman 
spectroscopy, although a excellent method for qualitative analysis, needs 
improvement before being used as a quantitative analysis method for 
counterfeit drugs detection.  
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Conclusion and summary 
 
The amount of counterfeit drugs on the international market has increased rapidly 
over the last decade. Counterfeiting is an age-old practice, and is motivated mainly 
by the huge profits that can be made. According to the World Health Organization 
(WHO), a counterfeit drug is one which is deliberately and fraudulently mislabelled 
with respect to its identity and/or source. It can apply to both, branded and generic 
products. Counterfeit drugs, may include products with the correct ingredients or with 
the wrong ingredients, without active ingredients, with insufficient active ingredient or 
fake packaging. 
 
Since counterfeiters are becoming more sophisticated, a simple visual inspection is 
not sufficient anymore. In literature, different analytical methods are described for the 
detection of counterfeit drugs. For instance, test-tube colour reactions, thin-layer 
chromatography (TLC), high performance liquid chromatography (HPLC), mass 
spectrometry (MS) and nuclear magnetic resonance (NMR). A downside of these 
methods is that it focuses on a specific active ingredient and gives less or no 
information of other substances present in the drugs. The method also requires 
extended sample preparation and highly trained analysts to interpret the results.  
 
Raman spectroscopy (chapter 2 and 3) requires no sample preparation, the sample 
can be measured through glass or blister package, and above all, this technique is 
non-destructive. This research, focuses on the use of Raman spectroscopy for the 
fast detection of counterfeit drugs.  
 
Examples of the qualitative analysis of counterfeit drugs with Raman spectroscopy 
are described in chapter 5. These counterfeit drugs are seized in Belgium and 
consist of erectile dysfunction drugs (Viagra® tablets, a gel with the active ingredient 
of Viagra® (sildenafil citrate) and tablets containing tadalafil, the same active 
ingredient as Cialis®), antibiotic (Amoxil®) used to treat numerous infections, and a 
drug to treat horses against parasites (Noromectin®). With the use of Raman 
spectroscopy, not only the content of these drugs were analysed, but the packaging 
and labels as well. By comparing these Raman spectra to those of the genuine 
products, the counterfeits could easily be detected.  
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This detection was based on the active ingredient, excipients present in the drug or 
inks used for the labels. These results, however, are only based on one or two seized 
examples of a specific drug. 
 
Chapter 6 describes the qualitative analysis of 50 antimalarial tablets from southeast 
Asia, with the active ingredient artesunate. Based on the Raman spectra, 26 tablets 
contained the correct active ingredient but 24 tablets consisted of different 
substances. These tablets contained no detectable levels of artesunate and 
consisted of paracetamol (4-acetamidophenol), calcite (CaCO3), or starch. The 
results are consistent with the results obtained by a colorimetric test for artesunate 
and by liquid chromatography mass spectrometry (LC-MS). Moreover, principal 
component analysis (PCA) combined with hierarchical cluster analysis (HCA) was 
used to establish an automated approach for the discrimination between different 
groups of counterfeits and genuine artesunate tablets. 
 
Additionally, 18 possible counterfeit Viagra® tablets are qualitatively analysed 
(chapter 7). All the tablets contained the correct active ingredient, namely sildenafil 
citrate. However, when focusing on the Raman bands of excipients used in the 
tablets, differences could be noted. From the 18 tablets investigated, 6 are 
considered as genuine Viagra® tablets while 12 tablets are counterfeited since they 
contain less or other inactive compounds. Additionally, PCA combined with HCA, 
confirmed these findings.  
 
Since counterfeits are detected, based on excipients present in the drugs, a 
database of excipients is established. For this database the Raman spectra of 43 
commonly used pharmaceutical excipients are analysed and are presented in 
chapter 8.  
 
So far, Raman spectroscopy shows to be a fast and easy detection method for the 
qualitative analysis of counterfeit drugs. Unfortunately, since the counterfeiters are 
becoming more sophisticated, quantitative analysis will be necessary as well. Since 
the intensity of the vibrational bands is directly proportional to the concentration of 
the species, Raman spectroscopy can be used for quantitative analysis.  
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The accuracy of the quantitative analysis can be significantly influenced by the 
homogeneity of the tablets used. The first step in the quantitative analysis process, 
described in chapter 9, is to develop homogenized calibration tablets. For this 
research, mixtures of paracetamol tablets are made, which were mixed during 
different times. Afterwards, tablets were pressed and a mapping was performed with 
the use of Raman spectroscopy. Based on the standard deviation of the intensity of 
the Raman band at 855 cm-1, it was established that the homogeneity stabilized after 
60-90 minutes of mixing.  In order to minimize the error caused by inhomogeneity, 
the mixing time for the calibration tablets was set at  360 minutes.  
 
Secondly, the influence of rotating the tablet during the analysis was investigated. 
Although the average intensity was similar for the analysis with and without rotation, 
the standard deviation of the measurements without rotation is circa 4 times higher. 
This research confirmed that the error between analyses  significantly decreased by 
rotating the tablet. Based on these results, the tablets were rotated during 
quantitative analyses.   
 
Next, chapter 9 describes the quantitative analysis of 11 antimalarial tablets and 6 
Viagra® tablets. Results are compared to LC-MS or HPLC combined with diode array 
detection (DAD) for the antimalarial tablets and Viagra® tablets, respectively. The 
quantitative analysis is either based on a single Raman band (intensity or area) or by 
using PCA combined with principal component regression (PCR), which integrates 
the entire Raman spectrum. Differences (%) are calculated between the amount of 
active ingredient as calculated with Raman spectroscopy and LC-MS or HPLC-DAD. 
Additionally, a paired t-test, with a 95% interval, is used to confirm these results.  
 
First, quantitative analysis is performed by using the intensity of a specific Raman 
band. Calibration tablets are analysed and the function of the calibration curve based 
on the Raman bands is used to calculate the amount of active ingredient in the 
possible counterfeit tablets. The difference (%) between this amount and the 
reference method (LC-MS or HPLC-DAD) is calculated.  
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Based on this analysis, the difference for the antimalarial tablets ranges from 40 to 
57% (MArtA spectrometer) while the difference for the Viagra® tablets ranges from 33 
to 54% (MArtA spectrometer) and 29 to 32% (Renishaw System-1000 spectrometer). 
According to the paired t-test, the analysis with the MArtA spectrometer were 
predominantly significantly different compared to HPLC-DAD while the results with 
the Renishaw System-1000 spectrometer showed no significant difference (95% 
confidence interval). Therefore, for further quantitative research, the Renishaw 
System-1000 spectrometer is used. Since the area of a Raman band is independent 
of broadening effects, these last results are recalculated by using the area of the 
three Raman bands. However, using the area, instead of a decrease, the average 
difference with HPLC-DAD increased from 29 - 32% up to 30 - 39%.  With the use of 
the paired t-test (α = 0.05) no significant difference (P > 0.05) could be noted 
between the calculations based on the intensity and the area of the three Raman 
bands (P = 0.58, P = 0.61 and P = 0.89). 
 
Chemometrical approaches (PCA combined with PCR) are used on the Raman 
spectra (Renishaw system-1000) of the Viagra® tablets. Calculations are performed 
using the first 5 principal components (PC), in combination with the raw data or 
derivatives (1st and 2nd). By using derivatives, the influence of the broad-featured 
fluorescence background can be minimized. The average difference for the Viagra® 
tablets ranges from 47 to 193% (raw data), 21 to 26% (1st derivative) and 21 to 23% 
(2nd derivative). By using derivatives, a higher accuracy is created when comparing 
these to the results based on the intensity of a single Raman band. In addition, a      
t-test shows that there is significant difference between PCR results based on the 
raw data and results based on HPLC-DAD analysis. No significant difference based 
on the paired t-test can be found between the results based on the 1st and 2nd 
derivative.  
 
Commonly, quantitative analysis is performed with Fourier Transform (FT) Raman 
spectroscopy rather than dispersive Raman spectroscopy (MArtA and Renishaw 
System-1000). In order to check if the analysis can be improved, the Viagra® tablets 
are analysed with a Bruker Equinox 55S FT Raman spectrometer. However, FT-
Raman spectroscopy shows less promising results than by using the Renishaw 
System-1000 spectrometer. This can be caused by difficulties positioning the tablets 
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in the laser beam, due to the standard sample holder of the Bruker Equinox 55S 
instrument. With the Renishaw system-1000 spectrometer, the microscope enhances  
focusing the laser beam on the sample. Moreover, when using the Bruker Equinox 
55S spectrometer the samples could no be rotated, to cover sample inhomogeneity. 
Based on this quantitative analysis, the best results were achieved by using 
dispersive Raman spectrometry (Renishaw System-1000). Results with the use of 
PCA in combination with PCR showed the most promising results when used in 
combination with the 1st or 2nd derivative.  
 
Finally, the presence of the blue coating of the Viagra tablets might have an influence 
on the quantitative analysis. The Viagra® tablets were grinded, thoroughly mixed and 
repressed and analysed (Renishaw system-1000 spectrometer). When comparing 
the results before and after grinding, no improvement can be detected, indicating that 
the coating has no negative effect on the quantitative analysis with Raman 
spectroscopy.  
 
This research shows that Raman spectroscopy can be used as a fast and easy  
method of analysis for the qualitative detection of counterfeit drugs. A major topic of 
interest still remains; improving the quantitative analysis of counterfeit drugs with 
dispersive Raman spectroscopy. For further research, other chemometrical 
approaches, such as partial least squares regression (PLS-regression) can be 
investigated to see if the analysis can be improved. Additionally, the use of Raman 
spectroscopy as quantitative method of analysis should to be demonstrated on a 
larger number of counterfeit drugs, in order to see if our findings are consistent. This 
is an interesting item for further research and a real challenge to demonstrate the use 
of dispersive Raman spectroscopy for the detection of counterfeit drugs, qualitative 
as well as quantitative.  
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De laatste jaren is de hoeveelheid vervalste geneesmiddelen op de internationale 
markt snel toegenomen. Vervalsingen bestaan al eeuwen en de voornaamste 
drijfveer zijn de enorme winsten die behaald kunnen worden. Volgens de 
Wereldgezondheidsorganisatie (World Health Organization, WHO) worden 
vervalsingen als volgt gedefinieerd: doelbewust en frauduleus verkeerd gelabelde 
producten met betrekking tot identiteit en/of oorsprong. Zowel merk- als generische 
producten kunnen worden vervalst. Er zijn verschillende soorten vervalsingen, 
namelijk met de correcte ingrediënten in de verkeerde verpakking, met de verkeerde 
ingrediënten, zonder actieve ingrediënten of met een te lage concentratie actief 
ingrediënt.    
 
Aangezien vervalsers steeds beter worden in het vervalsen van geneesmiddelen, is 
een eenvoudige visuele inspectie van het medicijn en haar verpakking niet meer 
voldoende. In de literatuur worden verschillende analytische methoden beschreven 
voor de detectie van vervalste geneesmiddelen. Enkele voorbeelden hiervan zijn 
colorimetrie, dunnelaagchromatografie (TLC), hogedrukvloeistofchromatografie 
(HPLC), massaspectrometrie (MS) en kernspinresonantie (NMR). Een nadeel van 
deze methoden is dat zij gericht zijn op een specifiek actieve ingrediënt en er weinig 
of geen informatie vrijkomt over andere stoffen aanwezig in het medicijn. Bovendien 
vergen deze methodes veel monstervoorbereiding en is er een gespecialiseerde 
analist nodig om de resultaten te interpreteren.  
 
Dit onderzoek richt zich op de snelle detectie van vervalste geneesmiddelen met 
behulp van Raman spectroscopie. Raman spectroscopie (hoofdstuk 2 en 3) vereist 
geen monstervoorbereiding, het medicijn kan geanalyseerd worden door glas of de 
plastic verpakking en is bovenal niet destructief.  
 
Hoofdstuk 5 beschrijft enkele voorbeelden van de kwalitatieve analyse van vervalste 
geneesmiddelen met Raman spectroscopie. Deze vervalsingen zijn onderschept in 
België en bestaan uit erectiepillen (Viagra tabletten, een gel met het actieve 
ingrediënt van Viagra (sildenafil citraat) en tabletten met tadalafil, hetzelfde actieve 
ingrediënt als Cialis), antibiotica (Amoxil) gebruikt voor verschillende infecties en 
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een medicijn gebruikt voor het bestrijden van parasieten bij paarden (Noromectine). 
Met behulp van Raman spectroscopie is niet alleen de inhoud van deze 
geneesmiddelen geanalyseerd, maar eveneens de verpakking en etiketten. De 
Raman spectra zijn vergeleken met spectra van de originele producten en op basis 
hiervan konden de vervalsingen eenvoudig gedetecteerd worden. De vervalsingen 
zijn gedetecteerd op basis van het actieve ingrediënt of vulmiddelen gebruikt in het 
medicijn of op basis van de inkt gebruikt voor de labels. Deze resultaten zijn echter 
alleen gebaseerd op 1 à 2 stalen van een specifiek medicijn.  
 
Hoofdstuk 6 beschrijft de kwalitatieve analyse van 50 antimalaria tabletten uit 
Zuidoost-Azië met het actieve ingrediënt artesunaat. Op basis van de Raman 
spectra, kon worden bepaald dat 26 tabletten het juiste actieve ingrediënt bevatten 
en dat 24 tabletten bestonden uit andere producten. Na verdere analyse bleek dat de 
24 tabletten bestonden uit paracetamol (4-acetamidophenol), calcium carbonaat 
(CaCO3) of zetmeel. Deze resultaten komen overeen met de resultaten van een 
colorimetrische test specifiek voor artesunaat en vloeistofchromatografie gekoppeld 
met massaspectrometrie (LC-MS). Door middel van het gebruik van principale 
componenten analyse (PCA) en hiërarchische clusteranalyse (HCA) konden de 
vervalsingen eveneens van de echte tabletten worden onderscheiden.  
 
Voorts werden er 18 mogelijk vervalste Viagra tabletten kwalitatief geanalyseerd 
(hoofdstuk 7). Op basis van de Raman spectra bleek dat alle tabletten het correcte 
actief ingrediënt (sildenafil citraat) bevatte. Wanneer echter werd gekeken naar 
Raman banden afkomstig van vulmiddelen, konden verschillen worden 
waargenomen. Van de 18 tabletten bleken 12 tabletten vervalst te zijn, aangezien ze 
minder vulmiddel of andere vulmiddelen bevatten. Deze resultaten werden bevestigd 
door het gebruik van PCA in combinatie met HCA.  
 
Aangezien een deel van de vervalsingen konden worden gedetecteerd op basis van 
de vulmiddelen in het medicijn, is er een databank opgezet. Deze databank bevat de 
Raman spectra van de 43 meest gebruikte vulmiddelen en wordt beschreven in 
hoofdstuk 8.   
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Tot nu toe is aangetoond dat Raman spectroscopie een gemakkelijke en snelle 
detectiemethode is voor de kwalitatieve analyse van vervalste geneesmiddelen. 
Helaas worden de vervalsers steeds geraffineerder en is kwantitatieve analyse 
noodzakelijk geworden. Aangezien de intensiteit van de Raman banden evenredig is 
met de concentratie kan Raman spectroscopie gebruikt worden voor kwantitatieve 
analyse. De nauwkeurigheid van de kwantitatieve analyse kan worden beïnvloed 
door de homogeniteit van de te analyseren tabletten.  
 
De eerste stap bij kwantitatieve analyse is het produceren van homogene calibratie 
tabletten (hoofdstuk 9). Voor deze analyses worden mengsels voor paracetamol 
tabletten voor een bepaalde tijd gemengd. Hierna worden de tabletten geperst en 
wordt er een mapping uitgevoerd van de tablet met behulp van Raman 
spectroscopie. Met behulp van de standaarddeviatie van de intensiteit van de Raman 
band (855 cm-1) blijkt dat deze constant blijft na een mengtijd van circa 60 minuten. 
Op basis hiervan is besloten dat voor de aanmaak van de calibratie tabletten een 
mengtijd van 360 minuten word gebruikt om de homogeniteit van de tabletten zeker 
te stellen.  
 
Eveneens is er gekeken naar de invloed van rotatie van het tablet tijdens de 
analyses. Voor dit onderzoek werd een paracetamol tablet 30 maal geanalyseerd 
met behulp van rotatie en zonder rotatie. Na 30 analyses bleek de gemiddelde 
intensiteit gelijkaardig te zijn. De standaarddeviatie van analyses zonder rotatie bleek 
echter ca. 4 maal hoger te liggen dan met rotatie. Op basis van deze resultaten is 
besloten tijdens kwantitatieve analyses de tabletten te roteren. 
 
Vervolgens wordt in hoofdstuk 9 de kwantitatieve analyse van 11 antimalaria 
tabletten en 6 Viagra tabletten weergegeven. Deze resultaten werden vergeleken 
met LC-MS en HPLC in combinatie met diode array detectie (DAD) voor de 
antimalaria en Viagra tabletten, respectievelijk. De kwantitatieve analyse is 
gebaseerd op de intensiteit of oppervlakte van een enkele Raman band of met 
behulp van PCA in combinatie met Principale Componenten Regressie (PCR), die 
gebruik maakt van het hele Raman spectrum.  
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Verschillen worden berekend (%) tussen de hoeveelheid actieve ingrediënt bepaald 
met Raman spectroscopie en LC-MS of HPLC-DAD. Om te bepalen of er significant 
verschil is tussen de twee methoden, wordt er een gepaarde t-toets (95% 
betrouwbaarheids niveau) uitgevoerd.  
 
Als eerste wordt de kwantitatieve analyse uitgevoerd op basis van de intensiteit van 
een specifieke Raman band. Met behulp van calibratietabletten wordt de 
calibratiecurve opgesteld. De functie van deze calibratiecurve wordt gebruikt om de 
hoeveelheid actief ingrediënt in de mogelijke vervalste tabletten te berekenen. Het 
verschil in percentage wordt bepaald tussen deze hoeveelheid en de 
referentiemethode (LC-MS of HPLC-DAD).  Gebaseerd op deze analyse varieert het 
verschil voor de antimalaria tabletten tussen de 40 en 57% (MArtA spectrometer) 
terwijl het verschil voor de Viagra tabletten varieert tussen 33 en 54% (MArtA 
spectrometer) en tussen de 29 en 32% (Renishaw system-1000 spectrometer). Aan 
de hand van de gepaarde t-toets bleek dat de resultaten bepaald met de MArtA 
spectrometer significant verschillen met de referentie analyses terwijl de resultaten 
met de Renishaw system-1000 spectrometer niet significant verschillen. Voor 
verdere analyses werd er dus gebruik gemaakt van de Renishaw system-1000 
spectrometer.  
 
Bij kwantitatieve analyses wordt er voornamelijk gebruik gemaakt van de oppervlakte 
van een band in plaats van de intensiteit. Dit komt omdat de oppervlakte van een 
band onafhankelijk is van mogelijke verbredingseffecten. De resultaten verkregen 
voor de Viagra® tabletten met de Renishaw system-1000 spectrometer worden 
herbekend op basis van de oppervlakte. Uit deze resultaten blijkt echter dat het 
verschil niet afneemt, maar  toeneemt van  29 – 32% tot 30 – 39%. De resultaten van 
de gepaarde t-toets (α = 0,05) laten zien dat er geen significant verschil (P > 0,05) is 
tussen beide methoden (P = 0,58, P = 0,61 en P = 0,89). 
 
Chemometrische analysemethoden (PCA in combinatie met PCR) worden gebruikt 
op de analyse van de Viagra tabletten met de Renishaw system-1000 spectrometer. 
Berekeningen worden uitgevoerd met gebruik van de eerste vijf principale 
componenten (PC). Niet alleen de onbewerkte data, maar ook de 1ste en 2de 
afgeleide van deze data worden gebruikt.  
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Door middel van het gebruik van deze afgeleiden van de Raman spectra, kan de 
invloed van de achtergrondfluorescentie worden geminimaliseerd. Het gemiddelde 
verschil voor de Viagra tabletten varieert van 47 tot 193% (onbewerkte data), van 
21 tot 26% (1ste afgeleide) en van 21 tot 23% (2de afgeleide). Met behulp van de 
afgeleiden worden er betere resultaten verkregen dan in vergelijking met analyses 
gebaseerd op een enkele Raman band. Met behulp van de gepaarde t-test bleek er 
een significant verschil te zijn tussen de HPLC-DAD resultaten en de Raman analyse 
op basis van de onbewerkte Raman data. Er bleek echter geen significant verschil te 
bestaan voor de resultaten gebaseerd op de 1ste en 2de afgeleide.  
 
In het algemeen wordt kwantitatieve analyse vaak uitgevoerd met behulp van  
Fourier Transform (FT) Raman spectroscopie in plaats van het dispersieve Raman 
spectroscopie (MArtA en Renishaw system-1000). Daarom worden de Viagra 
tabletten nogmaals geanalyseerd, nu met behulp van een Bruker Equinox 55S – FT 
Raman spectrometer. Desondanks resulteerden deze analyses in slechtere 
resultaten dan met behulp van de Renishaw system-1000 spectrometer. Dit kan 
veroorzaakt worden de problemen met het focusseren van de laser op de tablet, 
aangezien bij de Bruker Equinox 55S gebruik wordt gemaakt van een 
standaardhouder. Bij de Renishaw system-1000 spectrometer wordt de laser met 
behulp van een microscoop gefocusseerd op het staal. Eveneens kan bij de Bruker 
Equinox 55S het staal niet worden geroteerd tijdens de analyses.  
 
Gebaseerd op deze kwantitatieve analyses, blijken de beste resultaten verkregen te 
worden met behulp van de dispersieve Raman spectrometer (Renishaw          
system-1000). PCA in combinatie met PCR gaf de meest belovende resultaten 
wanneer gecombineerd met de 1ste of 2de afgeleiden. Als laatste wordt de invloed van 
de blauwe coating van de Viagra tabletten onderzocht. De tabletten worden 
vermalen, gemengd en opnieuw geperst. Hierna worden de tabletten opnieuw 
geanalyseerd met de Renishaw system-1000 spectrometer. Uit vergelijking van deze 
resultaten met de analyses voordat de tabletten werden vermaald, blijkt dat er geen 
verbetering optreedt. Dit betekent dat de coating geen negatieve effect heeft op de 
kwantitatieve analyse met behulp van Raman spectroscopie.  
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Dit onderzoek toont aan dat Raman spectroscopie gebruikt kan worden als een 
snelle en gemakkelijke analysemethode voor de kwalitatieve detectie van vervalste 
geneesmiddelen.  
 
Een belangrijk onderwerp voor toekomstig onderzoek is de kwantitatieve analyse van 
de vervalsingen met behulp van dispersieve Raman spectroscopie. Voor 
vervolgonderzoek kunnen andere chemometrische methoden worden onderzocht, 
zoals bijvoorbeeld partiële kleinste kwadraten regressie (PLS). Eveneens zou het 
gebruik van Raman spectroscopie voor kwantitatieve analyse op een grotere 
hoeveelheid vervalste geneesmiddelen moeten worden onderzocht, om na te gaan of 
deze techniek geschikt is. Dit is een zeer interessant onderwerp voor verder 
onderzoek en een belangrijke uitdaging om in de toekomst Raman spectroscopie, 
zowel kwalitatief als kwantitatief, te kunnen toepassen voor de detectie van vervalste 
geneesmiddelen.  
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Appendix: Chemometrics 
 
Chemometrics is used for many different applications in chemistry, for instance in 
physical chemistry (kinetics, equilibrium studies, etc.), reaction optimisation in 
organic chemistry, theoretical chemistry and in many areas of chromatography and 
spectroscopy1.  
 
In this appendix, different chemometrical techniques used during this research 
project are briefly described. These chemometrical techniques are: 
 
1. Window functions:     - moving average filters (MA) 
      - Savitsky-Golay filters 
- derivatives (first and second) 
2. Principal Component Analysis (PCA) 
3. Principal Component Regression (PCR)  
4. Hierarchical Cluster Analysis (HCA) 
 
1 Window functions 
 
Every signal contains always a certain amount of noise, which influences the quality 
of the signal in a negative way. This hampers the interpretation of spectroscopic 
data. An increase of noise can also lead to an increase in error during calibration. 
Therefore, an important step in using chemometrics for spectroscopic methods like 
Raman spectroscopy, is smoothing of a spectrum. A number of filters have been 
developed to decrease the amount of noise in a spectrum whilst the intensity of the 
signal remains. In this part, only the moving average filter as well as the Savitsky-
Golay filter will be described.  
 
An example of an easy to apply filter is the moving average (MA) filter, which comes 
with 2N+1 points, with N being a positive integer. For instance, the 3 points MA filter 
uses an average for each point made from itself, the point before and the point after, 
hence, a 3 points filter1. As can be expected, the 5 points MA filter includes 2 points 
before and 2 points after the re-calculated data point. This is illustrated in figure 1, 
where part from the Raman spectrum of a genuine artesunate tablet is shown.  
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Figure 1. The solid line represents the raw data of the Raman spectrum of an artesunate 
tablet, the striped line is the filtering of the data with a 5 points MA filter, and the dotted line is 
the filtering of the data with a 7 points MA filter 
 
When increasing the number of points in the MA filter, the influence of the noise 
decreases, but the signal becomes more flattened. Another disadvantage of these 
MA filters is that a linear approximation is used, while the bands in a Raman 
spectrum are best estimated by using a polynomial function1.  
 
Abraham Savitsky and Marcel J.E. Golay presented an alternative for the MA filters 
in 19642. This filter involves simple summations and is widely used in analytical 
chemistry, especially in chromatography3. The principal goal of the Savitsky-Golay 
filter is to smooth the data, to decrease the noise level, and to avoid blurring of the 
signal.   
 
Each filter is characterized by a window size and an order of a polynomial (quadratic, 
cubic, etc.)3. The next step is to multiply each data point within the window with a 
specific coefficient (ci+j) and then to divide it by the normalization constant, depending 
on the window size and order of polynomial. Here, ci represents the coefficient of the 
point in the spectrum which is re-calculated with the Savitsky-Golay filter and j 
represents the data points below and above this data point.  
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The normalization constant is the sum of the Savitsky-Golay coefficients, size 
depending on a 5, 7 or 9 points filter. The coefficients and normalization constants for 
these three filters are shown in Table 1.  
 
Window size j 5 points 7 points 9 points 
- 4   - 21 
- 3  - 2 14 
- 2 - 3 3 39 
- 1 12 6 54 
0 17 7 59 
1 12 6 54 
2 - 3 3 39 
3  - 2 14 
4   - 21 
normalization constant 35 21 231 
 
Table 1. Quadratic Savitsky-Golay coefficients ci+j for smoothing1,2,5.  
 
The coefficients ci+j in table 1 are used to obtain the coefficients (number depending 
on how many points are used in the filter) which will be used to calculate the 
smoothed value from the raw data1,2,3.  
 
For instance, the five coefficients for a 5 points quadratic filter are:  
 ci-2   =  ci+2  =  - 3 / 35  =  - 0.086 
 ci-1  =  ci+1  =  12 / 35  =  0.343  
 ci  =  17 / 35  =  0.486 
 
These coefficients are then used to multiply them with the data; the sum is the 
smoothed value of the data1:   
 
Xi,new = - 0.086 · Xi-2 + 0.343 · Xi-1 + 0.486 · Xi,original  + 0.343 · Xi+1 – 0.086 · Xi+2  
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where Xi,original  represents the original datapoint being re-calculated into Xi,new. Xi-1 
and Xi-2 represents the two datapoints left from Xi,original while Xi+1 and Xi+2 represents 
the datapoints right from Xi,original. 
 
In figure 2, the effect of the Savitsky-Golay filter is illustrated by using the raw data of 
the Raman spectrum of a genuine artesunate tablet as shown in figure 1. It shows 
the raw data (solid line) and the effect of Savitsky-Golay filters (5 and 7 points), 
presented as the striped and dotted line.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. The solid line represents the raw data of the Raman spectrum of an artesunate 
tablet, the striped and dotted line represent the filtering of the data with two different 
quadratic Savitsky-Golay filter, namely the 5 (striped) and 7 points filters (dotted).  
 
The moving average filter and the Savitsky-Golay filter both smooth the Raman 
spectrum by removing part of the noise. The downside of these filters is the decrease 
in intensity, which is more obvious with the MA filters than the Savitsky-Golay filters. 
To emphasize these differences, figure 3 shows in more detail a small part of the 
spectra shown in figure 1 and 2.  
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Figure 3. (A) Moving average filters (detail figure 1) and (B) Savitsky-Golay filters (detail 
figure 2). The red line represents the raw data of the Raman spectrum while the blue and 
green line represent the filtering of the data with a 5 and 7 points filters, respectively.  
 
When focussing on the intensity of the Raman band between 717 cm-1 and 718 cm-1 
it turns out that MA filters tend to broaden the bands more than the Savitsky-Golay 
filters. Hence, this illustrates that Savitsky-Golay filters are better suitable than 
moving average filters, which is logical since the Savitsky-Golay filter is based on a 
polynomial function.  
 
Once the Raman spectrum has been smoothed, the maximum of a Raman band can 
be determined by a simple method, using derivatives, mainly first and second1. The 
principle behind the method is that inflection points (maximum of a Raman band) 
become turning points in the derivatives. The first derivative equals zero at the centre 
of the peak and exhibits two turning points. The second derivative has a minimum at 
the centre of the peak and crosses zero at the positions of the turning points of the 
first derivative3. By using the first derivative, it is easy to pinpoint the exact position of 
the Raman band, but overlapping Raman bands are not detected. However, with the 
second derivative two overlapping bands can be easily separated. This can be seen 
in figure 4 were two closely overlapping bands are shown (A) and the first (B) and 
second derivative (C). The second derivative clearly indicates two bands, and fairly 
accurately pinpoints their positions1.  
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Figure 4. Two closely overlapping bands (A, solid line) together with their first (B, striped line) 
and second derivatives (C, dotted line)1. 
 
In order to use derivatives, the Raman bands have to consist of sufficient data points, 
so that there is sufficient information for calculating the derivatives3. A disadvantage 
of derivates is that noise is amplified substantially1.  
 
2 Principal Component Analysis (PCA) 
 
After applying the filters and/or derivatives, principal component analysis (PCA) can 
be applied. PCA is mathematical method for reducing a large dataset to a much 
smaller, more manageable dataset, which can be interpreted more easily1. This is the 
most widespread multivariate chemometric technique used nowadays1,3. It can be 
used when a dataset which contains a large number of variables, as for instance with 
spectroscopic data.  
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During PCA, the principal components (PC’s) are calculated, which are the variables 
that account for the majority of the variability in the spectroscopic data3. A benefit of 
this method is that, even though the dataset has been reduced, a very high 
percentage of the information content is retained (usually more than 99,9%)3.  
 
PCA results in an abstract mathematical transformation of the original data matrix, 
which takes the following form (equation 4.1)1:  
 
EPTX +⋅=         (eq. 4.1) 
    
X = original data matrix 
T = scores (as many rows (samples)as the original data matrix) 
P = loadings (as many columns (wavelengths) as the original data matrix) 
E = error matrix 
 
The scheme, as presented in figure 5, visualizes this process.  
 
 
 
Figure 5. Principal Component Analysis (PCA)1. 
 
X 
 
T 
 
P 
data points (wavelength) 
PCA 
S
a
m
ples
 
  
198 
To illustrate the use of PCA, the Raman spectra of the artesunate tablets, measured 
from 200 till 1800 cm-1, which involves about circa 1600 data points for each 
spectrum are used.  
 
The averages of three spectra recorded for each tablet, have been used to construct 
a data matrix. This matrix consists of circa 1600 columns and 50 rows (samples). 
The first 10 principal components (PCs) were calculated. Table 2 shows the 
percentage of the variance that is captured by each PC and the cumulative 
percentage of the variance captured. 
 
PC Number % variance captured by PC % variance captured total 
1 94.54 94.54 
2 3.20 97.74 
3 1.39 99.13 
4 0.44 99.57 
5 0.20 99.77 
6 0.09 99.86 
7 0.05 99.90 
8 0.02 99.93 
9 0.02 99.95 
10 0.01 99.96 
 
Table 2. Information of the first 10 PCs on the data matrix of the Raman spectra of the 50 
artesunate tablets from the antimalarial research project. 
 
The first PC (94.54 % variance captured) is the direction through the data that 
explains the largest possible variation in the data and accounts for most of the 
information5. The second PC (3.20 % variance captured) is orthogonal to the first PC 
while  PC 3 (1.39 % variance captured)  is at right angles to the first two PCs.  It 
shows that the first three principal components contain more than 99 % of the 
variance (information) that can be retrieved from the circa 1600 data points for the 50 
tablets. 
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3. Principal Component Regression 
 
Principal component regression (PCR) is considered as a form of factor analysis and 
has been very useful in spectroscopy since the 1970s and is used for quantitative 
analysis1. PCR is of significant interest when analysing mixtures, for instance drugs, 
with Raman spectroscopy, since not all compounds in the drug are known or can 
even be identified. There are a few steps that need to be undertaken when 
performing PCR, which are shown in figure 6.  
 
 
Figure 6.  Principal Components Regression (PCR)1. 
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The first step is to obtain a matrix with the data of all the samples, for instance a 50 x 
1600 data matrix for the case of the artesunate samples. The next step is to perform 
PCA on the data to obtain the scores (T) and loadings matrices (P).  
 
A crucial step is to determine how many PCs should be retained in order to perform 
PCR. In this step a relationship is determined between the scores (T) and the true 
concentrations (c) of each sample by using the equation c = T · r. Where r stands for 
a column vector, whose length equals the number of PCs retained, also called a 
rotation or transformation vector1.  
 
The principles behind PCR are fairly straightforward and involve performing a PCA 
and subsequently regressing the components. The final step is to establish a 
correlation between the Raman spectrum and the concentration1.  
 
4 Hierarchical Cluster Analysis (HCA) 
 
The final step in our qualitative analysis of counterfeit drugs, is hierarchical cluster 
analysis (HCA). In this process, the results of PCA are used. Cluster analysis can be 
used by chemists, to see if there is a relationship between different samples in a 
dataset1.  
 
Using a few principal components, it is possible to see if there is a similarity between 
different samples and draw a picture of these similarities, such as a dendrogram. In 
this dendrogram, the groups that are closely related, are closer to each other and the 
groups with less similarity are presented further from each other.  
 
The first step in HCA is to determine the similarity between different Raman spectra3. 
A number of common numerical measures of similarity are available; in this appendix 
the correlation coefficient, Euclidian distance and Mahalanobis distance will be 
discussed1,3.  
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• Correlation coefficient 
 
The correlation coefficient has a value between -1 and +1. A correlation 
coefficient of 1 (+1 or -1) implies identical characteristics, while a value near zero 
makes it difficult to use a variable to predict another3. The coefficient is calculated 
using the equation 4.21,5,6. 
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     (eq. 4.2) 
 
rxy = Pearson correlation coefficient 
covxy = Covariance of the variables x and y 
sx, sy = Standard deviations of x and y 
xi, yi = Samples x and y 
yx,  = Sample means of variables x and y 
I = Number of measurements 
 
• Euclidean distance 
 
The distance between samples k and l can be calculated using equation 4.33,6: 
 
∑
=
−=
I
i
likikl xxd
1
2)(        (eq. 4.3) 
 
dkl = Euclidean distance between k and l 
I = Number of measurements 
k,l = Indices for objects k and l 
xkj = jth measurement on sample k 
 
The Euclidean distance works the opposite way, compared to the correlation 
coefficient, since a value close to zero means a higher similarity3. Sometimes the 
equation is presented in matrix format (equation 4.4)1,6. 
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')()( lklkkl xxxxd −⋅−=       (eq. 4.4) 
 
Were xk and xl represents the column vectors for object k and l, respectively. In 
this format, the objects are row vectors making it easy to implement in excel or 
matlab1.  
 
• Mahalanobis distance 
 
This method is quite similar to the Euclidean distance, but it also takes into 
account that some variables may be correlated and so measure more or less the 
same properties1. The distance between samples k and l is defined in matrix 
terms by equation 4.51: 
 
)'()( 1 lklkkl xxCxxd −⋅⋅−= −      (eq 4.5) 
 
where C is the variance-covariance matrix of the variables, whose elements 
represent the covariance between any two variables. This variance-covariance 
matrix is inserted as a scaling factor and that distinguishes this Mahalanobis 
distance from the Euclidean distance1. The downside of this method is that it can 
not be easily applied to a matrix where the number of variables exceeds the 
number of objects, since in that case, the variance-covariance matrix can not 
have an inverse.  
 
The next step in the hierarchical cluster analysis, is to link the different objects. There 
are numerous linkage methods, but the most commonly used one is the 
agglomerative clustering where the objects are connected to each other in groups1,3.  
 
The first step in this clustering protocol is to find the two most similar objects from the 
raw data. These will be the object with the highest correlation coefficient or smallest 
distance and these two objects will form a “group”3. The next step is to look at the 
numerical similarity values between this new group and the remaining objects, for 
this there are three important methods available, namely1,3:  
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• Nearest neighbour 
 
With this method, the new group is compared to the other objects. The object with 
the highest similarity is then linked to this new group. This method will continue 
until all objects are linked to each other, also called a dendrogram1,3.  
 
• Furthest neighbour 
 
This method is the opposite of the nearest neighbour, and hence the lowest 
similarity within the group is used3.  
 
• Average linkage 
 
There are two different ways of applying the average linkage, namely unweighted 
or weighed, which is according to the size of each group being joined together1.  
 
If they are equal of size both methods are equivalent1.  
 
- Weighted. The distance d to a new object or cluster k is computed by 
calculating the average distance from the objects A and B to i. The new 
similarity is given by equation 4.66: 
 
2/)( BiAiki ddd +=         (eq. 4.6) 
 
- Unweighted. The number of objects in a cluster is used for weighting the 
cluster distances which is given by (eq. 4.7)6:  
 
Bi
B
Ai
A
ki d
n
nd
n
nd +=     with  BA nnn +=    (eq. 4.7) 
 
where nA and nB are the numbers of object in a clusters A and B,   
respectively6.   
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The next steps consist of continuing with one of these linkage methods until all the 
data form one large group1,3. At each step, the most similar pair of objects or clusters 
are identified, then they are combined into one new cluster until all objects have been 
joined1.  
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